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  This project investigated the role of biopsychosocial variables in predicting 
positive well-being and health-promoting behaviors in individuals with autoimmune 
diseases.  The predictors included disease severity, depression, arthritis self-efficacy, and 
social support.  The dependent variables were positive well-being and health-promoting 
behaviors.  Participants included 175 individuals with connective tissue or 
musculoskeletal autoimmune diseases who were over age 18.  Participants were recruited 
through various health agencies and clinics serving people with autoimmune diseases and 
eligible respondents completed the survey online.  Results of the study showed that 
disease severity and social support are not related, suggesting that an individuals’ ability 
to access and utilize social support is unrelated to the severity of their autoimmune 
disease.  Second, a significant relationship was found between self-efficacy and 
depression suggesting that individuals who believe they can handle the consequences of 
their disease report lower depression.  Third, it was found that depression and social 
support predict both positive well-being and health promoting behaviors.  Depression and 
social support added significant contributions to the regression model predicting well-
being and healthy behaviors.  Self-efficacy and disease severity did not add significant 
contributions to this model.  It was found that self-efficacy does not mediate the 
 
relationship between depression and positive well-being but social support does.  Fourth, 
a cluster analysis revealed four different clusters of participants that react to their 
autoimmune disease in four different ways.  The cluster analysis suggested that, in 
general, people may react strongly favorably, strongly unfavorably, or not at all to their 
autoimmune disease.  Finally, qualitative data for three open-ended questions related to 
perceived causes of disease, openness to counseling or psychotherapy, and positive 
consequences of autoimmune diseases were analyzed by three independent raters.  









ROLE OF BIOPSYCHOSOCIAL VARIABLES IN PREDICTING POSITIVE WELL-



















Dissertation submitted to the Faculty of the Graduate School of the  
University of Maryland, College Park in partial fulfillment  
of the requirements for the degree of 








Dr. Mary Ann Hoffman, PhD, Chair 
Dr. Nancy Atkinson, PhD 
Dr. Clara Hill, PhD 
Dr. Kim MacDonald-Wilson, ScD 















© Copyright by 









This project is dedicated to my Grandmother, Bernice “Beets” Trizulny, who died on 
March 13, 2008, just a few weeks before the completion of this project.  My grandmother 
did not have the same opportunities I have had, so it is with great honor that I completed 
this project in her memory.  She lived for many years with Rheumatoid Arthritis, while 
serving as a caretaker to others.  She was filled with positive energy, hope, optimism, and 


























Thank you to everyone who helped me in this process.  Thank you to my parents, 
Mike and Linda Taylor for supporting me in getting my PhD and for your love at every 
step along the way.  Thank you to my wonderful advisor, Dr. Mary Ann Hoffman, who is 
the most compassionate person I know and who was always able to encourage and inspire 
me.  Thanks also to friends who have supported me along the way including Jess Stahl 
who helped me formulate my ideas for this project on many long walks and Nancy 
Hensler-McGinnis who was always there to cry or laugh with me along the way.  Thank 
you to Scott Pierson for your very nice support and for being there to listen to my 
dissertation trials and tribulations.  
A special thank you to all of the participants in the study who told me their stories 
and who have inspired me to continue research in this area.  Thank you to all of my 
committee members for your feedback, support, and encouragement.  Thank you to Dr. 
Mark Gourley at the National Institute of Arthritis and Musculoskeletal and Skin 
Diseases for your support of my original project and for all of the wonderful work you 
already do in focusing on the psychosocial issues of people with autoimmune diseases.  
Thank you to the Arthritis Foundation of Iowa and Julie Jaschik at the Mercy Arthritis 
Clinic for your help in recruiting participants.  Thank you to Bruce and Mollie Herman at 
the Towson University Counseling Center for your support, encouragement, and Friday 
morning dissertation meetings. 
 
iv 
Table of Contents 




Table of Contents................................................................................................................... iv 
 
List of Tables ......................................................................................................................... vi 
 
List of Figures ........................................................................................................................ vii 
 
Chapter 1: Introduction .......................................................................................................... 1 
 
Chapter 2: Review of the Literature....................................................................................... 10 
 Autoimmune Diseases ............................................................................................... 11 
 Theoretical Foundation .............................................................................................. 20 
 Biopsychosocial Factors Associated with Chronic Illness ........................................ 24 
      Biological Issues ................................................................................................... 24 
       Psychological Issues ............................................................................................. 26 
      Self-efficacy.......................................................................................................... 27 
      Other psychological variables............................................................................... 30 
      Social support........................................................................................................ 36 
 Outcome Variables..................................................................................................... 38 
      Positive well-being................................................................................................ 38 
      Health promoting behaviors.................................................................................. 41 
 Conclusion ................................................................................................................. 43 
 
Chapter 3: Statement of the Problem..................................................................................... 45 
 Hypotheses................................................................................................................. 46 
 Research Questions.................................................................................................... 47 
 
Chapter 4: Method ................................................................................................................. 52 
 Design Statement ....................................................................................................... 52 
 Power Analysis .......................................................................................................... 52 
 Participants................................................................................................................. 53 
 Measures .................................................................................................................... 55 
 Procedures.................................................................................................................. 66 
      Participant recruitment.......................................................................................... 66 
      Survey development.............................................................................................. 68 
      Participant protocol............................................................................................... 69 
 Description of an analysis of open-ended questions.................................................. 71 
  
  
Chapter 5: Results .................................................................................................................. 75 
 Data Analysis ............................................................................................................. 75 
 Primary Analyses ....................................................................................................... 80 
 
v 
 Additional Analyses................................................................................................... 93 
 Analyses of Qualitative Data ..................................................................................... 97 
 Summary of the Findings...........................................................................................104 
  
 
Chapter 6: Discussion ............................................................................................................107 
 Overall Summary of Results......................................................................................107 
 Discussion of Results: Hypotheses ............................................................................109 
 Discussion of Results: Research Questions ...............................................................116 
 Qualitative Data .........................................................................................................127 
 Limitations .................................................................................................................133 
 Implications for Future Research...............................................................................137 
 Implications for Practice ............................................................................................141 
 Conclusions................................................................................................................146 
 
Appendix A: Demographic Form .......................................................................................... 149 
Appendix B: World Health Organization-Disability Assessment Schedule II...................... 151 
Appendix C: Center for Epidemiologic Studies-Depression Scale ....................................... 155 
Appendix D: Arthritis Self-Efficacy Scale ............................................................................ 157 
Appendix E: Medical Outcomes Study-Social Support Scale............................................... 159 
Appendix F: Scales of Psychological Well-Being................................................................. 161 







List of Tables  
 
 
Table 1:  Autoimmune disease prevalence in women compared to men............................... 12 
 
Table 2:  Percent of population affected by autoimmune diseases ........................................ 14 
 
Table 3:  Demographic information about the participants in the current study ................... 54 
 
Table 4:  Psychometric and scoring information about measures.......................................... 65 
 
Table 5:  Kappa inter-rater agreement for open ended questions .......................................... 72 
 
Table 6:  Correlation matrix of key variables ........................................................................ 77 
 
Table 7:  Means, standard deviations and ranges of the measures of interest in the current  
    study........................................................................................................................ 78 
 
Table 8:  Reliability data of measures for current sample ..................................................... 79 
 
Table 9:  Linear multiple regression analysis testing predictor variables effects on 
               subjective positive well-being (SPWB) .................................................................. 82 
 
Table 10: Linear multiple regression analysis testing predictor variables effects on Health     
                Promoting Life Style Profile (HPLP) .................................................................... 83 
 
Table 11: An evaluation of the criteria necessary for mediation in the current study............ 84 
 
Table 12: Tukey post-hoc comparisons between cluster on other variables .......................... 89 
 
Table 13: Means, standard deviations, and comparisons by clusters .................................... 90 
 
Table 14: Types of autoimmune diseases in current sample.................................................. 96 
 




List of Figures 
 








 Why study autoimmune diseases?  What is so unique about autoimmune diseases 
that the research on other chronic illness cannot just be applied to the experiences of 
people with autoimmune diseases?  Previous research and anecdotal evidence suggest: 
there is a unique experience common to individuals with autoimmune diseases.  As Ellyn 
Kaschak writes, “For autoimmune diseases, the question of the medical profession has 
been, ‘Is it real or is it psychological?’ This is entirely the wrong question, one based not 
only in a dualistic epistemology, but even more deeply in a bias against ‘women’s 
illnesses’.” (Kaschak, 2001, p.1). 
 Imagine this situation: a young woman is experiencing significant pain in her 
joints and feels tired and achy all the time.  Her knees, shoulders, and knuckles have been 
swollen for a few months and she has been perpetually exhausted.  A former marathon 
runner, she was forced to stop running due to excruciating pain in her knees.  The pain in 
her shoulders has made it difficult for her to pick up her young children and the joint 
swelling in her hands makes writing nearly impossible.  She is a single mother and the 
burden of caring for her two young children alone, while she is in so much pain, is 
causing her to experience significant anxiety about whether she will still be able to 
support her family on her limited income.  The pain alone makes it difficult to get out of 
bed in the morning, but recently, she has been feeling so down that she has to force 
herself to go to work each day.   
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 Although this woman has limited financial resources, she consults a doctor who 
tells her that she has rheumatoid arthritis.  She is immediately confused: arthritis is what 
her grandfather has, not something that a woman in her early thirties should have.  She 
leaves her doctor’s office and shares her diagnosis with friends and family and is met 
with more uneasiness.  They do not know how to help her and they have a hard time 
understanding how much pain she is experiencing.  She begins to think seriously about 
the lifestyle changes that must occur, including perhaps quitting her job because standing 
on her feet all day is just exacerbating her pain.  She contemplates a future filled with 
having to explain her complicated symptoms to others and the many barriers she may 
encounter in her social life.  In addition, she worries about who she will rely on for help.  
She has already drifted away from some of her closest friends because they socialized 
while training for marathons together.  This woman is aware of the difficulty she has 
asking for help from friends and she is resolved not to burden other people with what she 
considers to be her problem. 
 While the above scenario is entirely fictional, many of the problems that the 
woman is experiencing are common among individuals with autoimmune diseases like 
rheumatoid arthritis.  Significant physical impairment, psychological difficulties, and 
changes in social support are all commonly associated with this class of disorders (White, 
Lemkau, & Clasen, 2001).  She had difficulty getting out of bed in the morning, anxiety 
about how she will support her family, and fears about asking other people for help, 
experiences that are common among people with physical illness. 
 Like this woman, individuals face many biological, psychological, and social 
consequences after being diagnosed with an autoimmune disease.  In many cases, severe 
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physical impairments and debilitating symptoms force people to drastically change their 
occupational and social lives to account for the physical disability that accompanies their 
disease (Chrisler, 2001).  Psychologically, these individuals can experience depression 
and anxiety, with the physical diagnosis either exacerbating an underlying predisposition 
for these psychological symptoms or bringing about psychological distress due to the 
stress and transition that accompanies the chronic illness.  People with autoimmune 
diseases may struggle to rely on others for help, both physically and emotionally; asking 
for help can be in stark contrast to their previous ways of relating to the world (Chrisler, 
2001).    
 Previous studies have shown that individuals who are recently diagnosed with 
rheumatoid arthritis (an autoimmune disease) are more depressed than the general 
population (Mangelli et al., 2002).  Though the causal relationship between depression 
and autoimmune diseases has not been established, some previous studies have 
investigated variables associated with psychological well-being.   
 For example, research has been conducted on how depression and anxiety can 
affect pain and other disease symptoms in individuals with autoimmune diseases, though 
these studies have not incorporated the biopsychosocial model.  Consistent findings have 
linked depression and pain in individuals with autoimmune diseases (Barsky, Orav, & 
Ahern, 1999; Mangelli et al., 2002; Westbrook & Nordholm, 1986).  In a study of 
individuals attending a rheumatology clinic, positive well-being was found to be an 
important moderating variable between pain and depression, such that people with a 
higher positive well-being were less likely to get depressed even with pain levels that 
were similar to those of participants who did ultimately become depressed (Mangelli et 
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al., 2002).  Other studies have used more objective measures of disease severity (joint 
measurements, immunological assays) and found that individuals with more severe 
symptoms are also more depressed (Cohen & Herbert, 1996). 
 Depression may also be due to individuals’ attributions about their disease 
etiology.  Westbrook and Nordholm (1986) investigated individuals’ attributions about 
the cause of their chronic illness.  They found that individuals with diseases with a low 
lifestyle component (i.e., diseases where health behaviors were not likely to influence the 
development of the disease) were less depressed when they accurately blamed chance 
causes for the development of the disease.  The low lifestyle component diseases that 
they investigated were arthritis and cancer.  On the other hand, when those same 
individuals blamed themselves for the development of their disease, they were more 
depressed and coped poorly.  The opposite was true for diseases with a high lifestyle 
component (stroke, heart disease), where they were less depressed and coped better when 
they accurately blamed themselves and their lifestyle choices for the development of their 
diseases (Westbrook & Nordholm, 1986).   
The emotional toll that these physical symptoms can have is highlighted by the 
loneliness that comes with the diagnosis of a relatively rare disease, concerns about one’s 
future prognosis, and self blame for the development of the disease (Chrisler, 2001).   
The most common types of autoimmune diseases are connective tissue diseases.  
Connective tissue diseases include specific types of autoimmune disease in which the 
body attacks its own connective tissue (ligaments, cartilage, tendons, skin and any other 
substance that serves to bind together, support, and protect organs); a painful process just 
to imagine.  Because each individual autoimmune disease is relatively rare, people may 
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not have the same level of social support garnered by a more prevalent and 
understandable disease such as cancer (White, Lemkau, & Clasen, 2001).  Social changes 
may occur due to the necessary lifestyle changes that accompany an autoimmune disease 
as well as the difficulties that are associated with asking for and giving and receiving help 
in social and romantic relationships.  Autoimmune diseases are generally progressive and 
have no cure.  Some periods of ups and downs will recur but the general course of the 
disease worsens over time.  Studies on the social support of individuals with autoimmune 
diseases show that people with more severe diseases and who have been diagnosed for 
longer periods of time have less social support than their newly diagnosed and less severe 
counterparts, perhaps due to the necessary lifestyle changes that one must make after a 
diagnosis (Fyrand et al., 2002).   
Connective tissue diseases include the most common autoimmune diseases like 
rheumatoid arthritis, lupus, and multiple sclerosis.  In addition, it is an umbrella term that 
encompasses other types of arthritis syndromes, rheumatic diseases, and musculoskeletal 
disorders.  Autoimmune connective tissue diseases were included in the current study as 
were all autoimmune disorders, including autoimmune endocrine disorders, autoimmune 
gastrointestinal disorders, and other organ and tissue specific autoimmune diseases.  
Individuals with autoimmune disease represent the fourth largest group of people with 
chronic illness (Chrisler, 2001) and commonly face personal challenges due to the 
physical and psychosocial effects of autoimmune syndromes.  Autoimmune diseases have 
an overall prevalence of 3-4% of the population, but, due to differences in diagnosis and 
a lack of standardization in criteria, the exact population and lifetime prevalence 
estimates are not available.  Also, many individuals are diagnosed with multiple types of 
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autoimmune diseases, contributing to variability in prevalence estimates (Gaubitz, 2006).  
Sjogren’s Syndrome, for example, is one of the most common autoimmune diseases and 
its estimated prevalence range is 0.5-3% in the population, and it is often diagnosed 
alongside other autoimmune disorders (Gaubitz, 2006).  
Individuals with autoimmune diseases often face a more difficult adjustment to a 
new diagnosis due to the isolation that comes with having a rare disorder that may not be 
widely recognized by friends and family.  For example, friends may respond differently 
when told about a diagnosis of cancer compared to Hashimoto’s Thyroiditis (a type of 
autoimmune disease).  Cancer treatments are more familiar to the general public and 
many people have developed a cognitive schema for understanding cancer based on their 
previous experiences.  People with autoimmune diseases may not be easily identifiable 
and may not look sick.  Since the course of autoimmune diseases is often unpredictable, 
including periods of relapse and remission, supportive others may have a difficult time 
understanding that these individuals can sometimes function well and at other times be 
completely debilitated.  These individuals cannot be easily categorized, which can make 
accessing and maintaining social support more complicated endeavors (Gaubitz, 2006).  
If social support is available from someone else with a similar disease, like in a 
support group, their experience of the disease is often vastly different due to factors such 
as differing periods of relapse and remission and greater or lesser symptom severity.  In 
addition, it often takes many years to get an accurate diagnosis of an autoimmune 
disorder, which can cause emotional turmoil as people start to believe that their 
symptoms are “all in their heads,” or are not taken seriously by their medical 
professionals.  Individuals with autoimmune diseases tend to blame themselves for their 
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illness, which has been proven to relate to negative outcomes, both physically and 
emotionally (Barsky et al., 1999).  In summary, autoimmune diseases are difficult to 
diagnose, physically painful, socially and vocationally limiting, and are often associated 
with psychological symptoms like anxiety and depression, especially when individuals 
blame themselves for their disorder.  
A common course of disease progression includes bouts of severe impairment 
interspersed with periods of remission, though some individuals experience a more 
gradual prognosis without punctuation.  The insidious nature of the disease is heightened 
by their incurable nature, treatment side effects, general unfamiliarity or ignorance from 
the general population, and the isolation associated with the disease (Chrisler, 2001). 
 Aside from all of the difficult symptoms and life changes that accompany 
autoimmune diseases, some positive benefits can result from the diagnosis.  Finally 
having a name to put to one’s varied symptoms, starting treatment, and re-evaluating 
one’s priorities have been benefits that individuals have reported in the past.  Some sense 
of increased positive well-being and decreased pain is associated with individuals being 
able to find benefits after their diagnosis (Katz et al., 2001; Mohr et al., 1999).  
 Investigating the impact of chronic physical illness has been difficult due to the 
numerous factors that affect psychosocial adjustment to illness as well as the varied 
physical impairments that can have an impact on an individual’s adjustment to their 
disease.  The biopsychosocial model (Hoffman & Driscoll, 2000) provides a good 
framework for integrating the various biological, psychological, and social factors that 
influence health outcomes and progression.  It also takes a positive psychology approach 
to chronic illness and does not rely solely on the disease focus of the medical model.  For 
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these reasons, the biopsychosocial model was chosen as the theoretical framework for the 
current study. The biopsychosocial model has been applied to a number of diseases and 
contexts including HIV, cancer, and community interventions (Schmidt, Hoffman, & 
Taylor, 2006).  In the current study, the biopsychosocial model was applied to 
understanding how people respond to living with autoimmune diseases. Autoimmune 
diseases were chosen as the disease model for the current study because they have many 
psychological, emotional, and social considerations and accompanying concerns. 
 The link between physical and mental health has become increasingly clear in 
recent years, however, individuals with chronic physical illness often find the 
psychosocial aspects of their disease ignored and do not get interventions such as 
psychotherapy that they may need (Goodheart, 2006).  The aim of the biopsychosocial 
model (Hoffman & Driscoll, 2000) is to better understand how biological, psychological, 
and social factors contribute to overall health status and to consider health factors in a 
multi-level analysis.  Some research has been done on how one or two of the factors 
contribute to a given area of health, but few studies have investigated all three types of 
variables and their impact on health.  Specifically, the focus of the biopsychosocial model 
is on positive well-being and few studies have applied the biopsychosocial model to 
investigating positive health outcomes.  
 Unlike previous studies on autoimmune diseases, this study investigated all three 
components of the biopsychosocial model at the same time.  The current study 
investigated how biopsychosocial variables affect positive well-being and health-
promoting behaviors in individuals with autoimmune diseases.  These two variables have 
been shown to have a significant impact on both physical and mental health.  In the 
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current study, specific biological, psychological, and social variables have been chosen to 
fully investigate the relationship between those specific health factors on well-being and 
health promotion.  It was hoped that the variables that affect well-being and health-
promoting behaviors can be isolated to determine how to enhance prevention in the 
future.    
In response to the dearth of information about the factors that affect individuals 
with chronic illness, the current study investigated health-promoting behaviors (e.g. 
involvement in exercise, eating healthfully, and reducing stress levels) and positive well-
being in a population with autoimmune diseases.  Health promoting behaviors and 
positive well-being were selected as criterion variables in the current study due to their 
direct impact on quality of life.  Major goals for health promotion include finding ways to 
encourage people to engage in healthy behaviors and improving overall well-being and 
life satisfaction.  These two variables best encompass these goals.  They are closely 
aligned with the leading health indicators set forth by the government task force to 
improve overall health called Healthy People 2010 (www.healthypeople.gov, 2007).   
This study attempted to address the paucity of information on the biopsychosocial 
factors of individuals with chronic illnesses in general.  The participants in this study 
were individuals with chronic illness, specifically autoimmune diseases, a population 
whose physical health needs are often the focus of research but whose psychosocial 





Review of the Literature 
People with autoimmune diseases may note that their physical ailments and pains 
impact their overall well-being and even their willingness to engage in social interactions.  
For example, someone with arthritis might say, “I just feel like staying in bed today.”  
Even though some individuals may draw connections between their physical and mental 
health, psychological and medical research has been slow to examine these important 
connections.  Although the important relationship between mind and body is often 
acknowledged (Barsky et al., 1999, Mangelli et al., 2002, Westbrook & Nordholm, 
1986), research has not been able to examine this integration in a manner that allows 
professionals in both medical and psychological fields to translate findings to help people 
adjust both physically and psychologically to their disorders.   
The basis for this study grew out of several different bodies of literature, each 
understudied in their own way.  This study investigated how biopsychosocial factors can 
affect individuals with chronic physical illness.  Research on individuals with physical 
disease usually has a focus on either the medical treatment of the disease or, if it is more 
psychologically oriented, addresses issues like treatment adherence and outcome rather 
than exploring how biological, psychological, and social factors intersect to predict 
positive health behaviors and well-being.  
This review of the literature will start with an overview of autoimmune diseases 
so the reader can understand the symptoms and prevalence of the disorders that are 
included in the current study.  In addition, the justification for choosing these diseases as 
the model for the current study will be presented.  The theoretical foundation of the 
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paper, the biopsychosocial model, will then be discussed.  Previous research on each of 
the variables of interest that comprise the biological, psychological, and social 
components of the model will then be presented.  Finally, since there has been limited 
research on the biopsychosocial effects of chronic illness in general, other research on 
this area will be briefly explored.  This literature review will provide a comprehensive 
grounding in the rationale for the current study.  
Autoimmune Diseases 
 Autoimmune diseases were chosen as the model for chronic illnesses in the 
current study because they incorporate a variety of diseases and symptoms, yet they have 
similarities in their levels of debilitating effects and comorbid psychosocial symptoms.  
Stress and emotion have long been proven to have an effect on one’s immune system, 
thus suggesting a natural link between autoimmune diseases and psychological health 
(O’Leary, 1990).  Though no direct causes of autoimmune disease are known, stress is 
often viewed as a precipitating factor in all autoimmune diseases (O’Leary, 1990).    
 “Autoimmune disease” is an umbrella term for over 80-100 diseases that affect 
the immune system in humans.  Various parts of the body are affected in each disease, 
with the immune system turning against its own tissues and organs and failing to 
distinguish between “self” and “non-self” when attacking cells.  Each of the 80 diseases 
is not extremely prevalent in the US population, however, taken as a whole autoimmune 
diseases represent the fourth largest cause of disability in women 
(www.wrongdiagnosis.com, 2006).  The prevalence of autoimmune diseases as a whole, 
their unusual disease progression, and the confusion around accurate diagnoses leading to 
feelings of isolation and depression are just a few of the many reasons why autoimmune 
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diseases were chosen as the model disease group for the current study.  The 
psychological and emotional symptoms that are often associated with diagnosis of an 
autoimmune disease make this choice even more appropriate.   
 Autoimmune diseases are more prevalent in women than men.  In general, women 
are three times more likely to have an autoimmune disease than men are 
(www.wrongdiagnosis.com, 2006).  Table 1 lists the most common autoimmune diseases 
and their ratio of prevalence in women to men.   
Table 1: Autoimmune disease prevalence in women compared to men 
Hashimoto’s disease/hypothyroiditis (ages 40-60) 50:1 
Systemic lupus erythematosus (ages 20-40) 9:1 
Sjogren’s syndrome (age 50) 9:1 
Antiphospholipid syndrome 9:1 
Primary biliary cirrhosis 9:1 
Mixed connective tissue disease 8:1 
Chronic active hepatitis 8:1 
Graves’ disease/hyperthyroiditis (ages 20-40) 7:1 
Rheumatoid arthritis (ages 30-50) 4:1 
Scleroderma 3:1 
Myasthenia gravis (ages 20-30) 2:1 
Multiple sclerosis (age 30) 2:1 
Chronic idiopathic thrombocytopenic purpura 2:1 




 The overall prevalence of autoimmune diseases in the US is 1 in 31.  That is, just 
over 3% of Americans are diagnosed with some type of autoimmune disease.  Once a 
person is diagnosed with the disease, they are considered to have the disease for the rest 
of their lives and there is no cure.  Table 2 shows some of the most common autoimmune 
diseases.  There are over 80 diseases that are currently classified as autoimmune diseases, 
with more under consideration.  Diseases in question include chronic fatigue syndrome, 
irritable bowel syndrome, vasculitis, and others (Chrisler, 2001).  It is interesting to note 
how common autoimmune disorders are in comparison to other types of chronic illness.  
The National Institutes of Health estimates that about 23.5 million Americans have an 
autoimmune disease, while only 9 million are affected by cancer and 22 million by heart 
disease.  Research on autoimmune diseases is sorely underfunded, receiving only $591 
million in public funding compared to $6.1 billion for cancer and $2.4 billion for heart 
and stroke related diseases (www.aarda.org, 2008).   
 Autoimmune diseases are either organ-specific (e.g. Hashimoto’s thyroiditis 
attacks the thyroid, pernicious anemia attacks the stomach, Addison’s disease attacks the 
adrenal glands, and insulin-dependent diabetes mellitus attacks the pancreas) or non-
organ specific (e.g. rheumatoid arthritis, systemic lupus erythematosus (SLE), and 
dermatomyostis (www.aarda.org, 2006).  Individuals with one autoimmune disease are 
prone to developing others and disease progress and prognosis is often varied, causing 
significant psychological distress.  Even though there are periods of relapse and 




Table 2: Percent of population affected by autoimmune diseases 
Rheumatoid arthritis (RA) 0.92%, 1 in 108 
Type I diabetes mellitus 0.12%, 1 in 800 
Hashimoto’s Thyroiditis 0.55%, 1 in 182 
Systematic Lupus Erythematosis (SLE) 0.51%, 1 in 194 
Multiple Sclerosis (MS) 0.14%, 1 in 700 
Crohn’s Disease 0.18%, 1 in 544 
Sjogren’s Syndrome 0.37%, 1 in 272 
Pernicious anemia 0.15%, 1 in 680 
Grave’s Disease 1.12%, 1 in 89 
Celiac Disease 0.40%, 1 in 249 
Glomerulonephritis 0.02%, 1 in 4,428 
Scleroderma 0.11%, 1 in 906 
Myasthenia gravis 1 in 20,000 









The etiology of autoimmune diseases is largely unknown.  The best understanding 
at this point is that bacteria, viruses, toxins, or drugs may act as a trigger in individuals 
who have a genetic predisposition to develop a disorder.  An inflammation response is 
typically involved such that the body may become sensitized to the inflammation 
response, which then transfers to a “self” system or organ rather than just attacking the 
“non-self” foreign body (www.aarda.org, 2006).  Additionally, some people believe that 
defective T-lymphocytes may misregulate the immune system (Chrisler, 2001).   
 With the increased frequency of autoimmune diseases in women (See Table 1) 
and the most common age of diagnosis during childbearing years, some question the 
possible endocrinological involvement in the etiology of autoimmune diseases.  Stress is 
believed to play a role in disease development and severity, which is common in women 
of childbearing age especially as they try to balance work and family.  Family members 
are more likely to develop an autoimmune disease if another family member has one and 
some believe a genetic component is responsible for a 20% penetrance rate 
(www.aarda.org, 2006).   Some autoimmune diseases vary by ethnicity, geographic 
region, and exposure to various toxins like airplane fuel, hair dyes, silicone breast 
implants, and vinyl chloride (Chrisler, 2001).   
 Symptoms of autoimmune disease vary depending on the disease but are often 
hard to diagnose and it is difficult to make accurate differential diagnoses among the sub-
types.  The variability and inconsistency of these symptoms may cause some 
psychosocial consequences which are of interest in the current study.  A common course 
of disease progression includes bouts of severe impairment interspersed with periods of 
remission, though some individuals experience a more gradual prognosis without 
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punctuation.  The insidious nature of the disease is heightened by their incurable nature, 
treatment side effects, general unfamiliarity or ignorance from the general population, 
and the isolation associated with the disease (Chrisler, 2001).  Individuals often report 
significant loneliness or stigma associated with their disease because they do not know 
anyone else with a similar diagnosis, though others suggest that being a part of a 
community with others who are aware of their disease can be difficult due to the different 
levels of impairment, potential for remission, and varying treatments associated with the 
disease.  Since not all individuals with SLE are equal, for example, an individual with a 
more severe case may not feel optimistic when supported by a friend with the disease 
who faces less functional impairment.   
Treatment of individuals with autoimmune diseases is complex both medically 
and psychologically.  No common treatment procedure exists and use of complementary 
and alternative medical (CAM) treatments is prevalent among individuals with 
autoimmune diseases with estimates ranging from 28-90% of individuals with rheumatic 
conditions, depending on the types of treatments that are included in the definition.  CAM 
is more popular with individuals with autoimmune individuals than other types of chronic 
illnesses, perhaps due in part to the complexity of the disease symptoms and the lack of 
standardized treatment (Taibi & Bourguignon, 2003). 
 The most common autoimmune diseases (shown in Table 2) can be classified into 
different categories.  Connective tissue diseases include Systemic Lupus Erythematosus 
(SLE), which is an inflammation of the connective tissues; Rheumatoid Arthritis, in 
which immune cells inflame and attack the cartilage and membranes around joints and 
occasionally the heart, lungs, and eyes; Scleroderma which produces scar tissues in the 
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skin, internal organs, and blood vessels and skin thickening; Sjogren’s Syndrome in 
which individuals slowly become unable to secrete saliva and tears.  Neuromuscular 
diseases include Multiple Sclerosis (MS), which attacks the central nervous system and 
leads to numbness and tingling in the limbs and Myasthenia Gravis which is 
characterized by progressive muscle weakness.  Endocrine diseases include Hashimoto’s 
Thyroiditis in which the immune system destroys the thyroid; Grave’s Disease in which 
the body produces an excessive amount of thyroid hormone, and Type I Diabetes in 
which too little insulin is produced by the pancreas.  Gastrointestinal diseases include 
Crohn’s disease and ulcerative colitis in which the small intestine is attacked.  Other 
autoimmune diseases attack blood vessels (Vasculitis); red blood cells (Hematologic 
Autoimmune Diseases); and the skin (www.aarda.org, 2006).  
 Autoimmune diseases are particularly important to study from a psychological 
perspective because they are extremely disempowering.  Individuals with autoimmune 
diseases face debilitating pain, a myriad of symptoms that are difficult to diagnose and 
often face years of medical consultations before receiving a diagnosis (Chrisler, 2001).  
Friends, family, and colleagues of individuals with autoimmune diseases may believe that 
the symptoms are “all in their heads” and not be supportive of accommodations that need 
to be made.  The pain associated with the diseases is debilitating and can lead to 
significant functional impairments.  The etiology of autoimmune diseases is basically 
unknown though theories of genetic predispositions, bacterial causes, psychiatric 
connections, comorbid diseases, and neuroendocrinological factors have been studied 
(White, Lemkau, & Clasen, 2001).  Due to the diffuse potential causes, diagnosis and 
treatment are difficult.  The conditions can be managed through biopsychosocial 
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interventions such as education, pharmacological treatments, exercise, stress 
management, and therapy (White, Lemkau & Clasen, 2001) or complementary and 
alternative medicine (Taibi & Bourguignon, 2003).   
 An alternative explanation for psychological symptoms that are associated with 
autoimmune disease is that immune system over-responding can lead to depression 
(Dantzer et al., 2008).  Some researchers suggest that uncontrolled activation of the 
peripheral immune system, such as in a systemic infection like an autoimmune disease, 
may lead the pro-inflammatory cytokines that are released by the immune system to 
trigger the brain to exaggerate sickness behaviors.  Cytokines have been linked to 
depression-like sickness behaviors including withdrawal from the physical and social 
environments, pain and malaise, and anhedonia, so these researchers suggest that 
cytokine-triggered brain changes and depression may be indistinguishable.  They state 
that, “Inflammation is therefore an important biological event that might increase the risk 
of major depressive episodes, much like the more traditional psychosocial factors (46)” 
Dantzer et al., 2008). 
 Similarly, the field of psychoneuroimmunology, or the study of interrelations 
between the central nervous system and the immune system, has begun to investigate the 
interplay of stress and immune system changes that can lead to autoimmune diseases.  
This perspective is more biomedical than biopsychosocial and some interesting studies 
exist which have examined the biological and immune system changes with 
psychologically stressful events.  They have shown in retrospective studies that stressful 
life events and non-supportive atmospheres can exacerbate autoimmune diseases (Cohen 
& Herbert, 1996).  One benefit of these studies is that they use objective information 
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about disease severity rather than self-report data to draw connections between 
psychological stressors and autoimmune symptoms.   
One study found that individuals with rheumatoid arthritis who underwent a 
cognitive-behavioral intervention program had reduced pain intensity, inflammation, and 
serum levels of rheumatoid factor post-treatment compared to a control group and a 
social support group (Cohen & Herbert, 1996).  Similar results were found by O’Leary et 
al. (1988) when individuals with RA went through a cognitive-behavioral intervention 
and were given joint swelling ratings by rheumatologists who were blind to their 
treatment or control group status.  These objective rheumatologists rated the CBT 
treatment group as having significantly improved joint conditions compared to the 
control group (O’Leary et al., 1988). 
Another explanation for the accompanying psychological symptoms found in 
many autoimmune diseases is that the process of diagnosis and treatment can be 
excruciating.  The relief that someone feels when a diagnosis is finally reached may not 
outweigh the significant emotional toll that the wait takes on a person.  With 
fibromyalgia, a disease with some autoimmune components, individuals wait an average 
of 6.7 years to receive an accurate diagnosis (Liller, 1994).  Even though they may 
experience some relief at being able to put a name to their symptoms, these individuals 
still have to face living with a chronic disease and integrating that into their identity.   
 Feminist scholars suggest that there are societal explanations for disease that are 
important to consider including a biased scientific method and a fascination with 
fashionable explanations for inexplicable symptoms (White, Lemkau, & Clasen, 2001).  
Autoimmune diseases continue in the infamous tradition of women being marginalized 
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by medicine.  Dating back to the days of 19th century diagnoses of hysteria and 
neurasthenia, autoimmune diseases like fibromyalgia continue to limit women.  Women 
are assumed to be avoiding work, showing psychological weakness, shirking their duties, 
or resisting gender roles and expectations (Shorter, 1992).  It is essential that researchers 
and therapists consider the range of biopsychosocial factors that affect people with 
autoimmune diseases and work from an adaptive framework in which they do not limit or 
stigmatize the individuals they study or with whom they work.   
Theoretical Foundation 
The theoretical foundation for this study, the biopsychosocial model, is based on 
the belief that the body and mind are profoundly connected and should be treated as such 
by medical and mental health professionals (e.g. Engel, 1977, Hoffman & Driscoll, 
2000).  So often emotional and social concerns are not addressed in a physical exam and 
conversely, a client’s physical distress is not addressed by mental health professionals.  
Integrating physical health issues into our understanding of mental health issues may be 
key to providing the best treatment possible for individuals with autoimmune diseases. 
Individuals with disabilities or chronic illnesses experience marginalization in 
their daily lives, which can have a profound effect on mental health.  A significant article 
in setting up the theoretical foundation of this study was written by Chrisler in 2001.  She 
set forth some ideas about how autoimmune diseases should be evaluated from a feminist 
and systems approach and discussed how medical professionals should recognize the 
personal and societal impact of autoimmune diseases.  Based on her extensive personal 
experience with autoimmune diseases, research on the psychological effects of the 
diseases, and clinical practice with clients with the diseases, Chrisler explicated ideas for 
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future research and theoretical conceptualizations necessary for studies on autoimmune 
diseases. 
 Often, research on biomedical issues tends to take a diagnostic perspective that 
works from a pathology perspective rather than a strengths perspective.  Engel (1977) 
was the first to propose a biopsychosocial model, in contrast to the biomedical models in 
existence at the time.  He posited that adjustment to a physical illness involves more than 
just which antibodies are being produced by the body or what part of the body hurts.  
Engel moved to include psychological and social factors in our understanding of medical 
illnesses (1977). 
Expanding upon Engel’s work, Hoffman and Driscoll (2000) propose a 
biopsychosocial model that emphasizes strengths and moving towards health and well-
being, rather than focusing on deficits and disease.  Their perspective is firmly 
differentiated from a classic medical model and has many implications for the current 
study.  
Historically, common models of adjustment to chronic illness include the 
biomedical, psychosocial, and biopsychosocial models (Walker, Jackson, & Littlejohn, 
2004).  For the current study, it is important to not just understand the biomedical 
underpinnings of autoimmune diseases, which are the focus of most medical research, but 
to instead integrate knowledge of biological factors with important psychosocial factors 
that are known to be present in individuals coping with chronic illness.  The 
biopsychosocial model encompasses aspects of both the biomedical and psychosocial 
models but also incorporates environmental and cultural contributors to health, thus 
extending the previous understanding of illness adjustment (Hoffman & Driscoll, 2000).  
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The biopsychosocial model embraces a strengths perspective that emphasizes 
empowerment, in contrast to the medical model, which typically focuses on deficits. 
The biopsychosocial model has become more popular in conceptualizing chronic 
illness and as a framework for some research studies.  Nicassio & Smith (1995) collected 
writings on the biopsychosocial perspective in their book, Managing chronic illness: A 
biopsychosocial perspective.  The book uses the biopsychosocial perspective throughout 
to enhance clinical work, assessments, and treatment from a psychological perspective.  It 
has more of a focus on mental illness than chronic physical illness but offers some 
valuable ideas about how to apply the biopsychosocial model in practice (Nicassio & 
Smith, 1995).   
Another popular application of the biopsychosocial model is in understanding 
chronic pain.  Chronic pain is associated with high personal and public costs in both 
physical and mental health care throughout the world.  Recent advances in treating 
chronic pain have embraced the biopsychosocial model since many pain-related 
symptoms have biological/neurological, psychological, and even social underpinnings.  
In an excellent review of the current biopsychosocial understanding of chronic pain, 
Gatchel et al. (2007) summarize the ways that biopsychosocial issues can contribute to 
pain.  The authors included a detailed review of how findings related to genetics, 
neuroscience, emotion, anxiety, depression, anger, cognitive factors, control, and self-
efficacy can help explain levels of chronic pain and suggest ways for treatment.  Contrary 
to early biomedical work in this area, Gatchel et al. (2007) suggest that “total 
biopsychosocial functioning must be carefully considered in order to maximize the 
probability of treatment success (607).” 
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Rheumatoid arthritis has been the most popular of all autoimmune diseases to 
study with the biopsychosocial perspective (Cohen & Herbert, 1996).  Earlier researchers 
were struck by the important contributions of psychological components in predicting 
disease activity in RA.  Parker et al. (1991) examined joint counts of painful/swollen 
joints taken by an experienced nurse clinician, peripheral blood immunophenotypic 
counts of lymphocyte subpopulations known to be associated with inflammatory 
responses, and self-reports of health status as biological variables.  They also examined 
helplessness and depression as psychological measures in individuals with RA.  Finally, 
age and education level were the social variables they considered.  The researchers 
controlled for the biological variables so they could examine the unique contributions that 
the psychosocial variables played in predicting disease activity.  They found that the 
psychological variables predicted worsening joint swelling over time.  Depression and 
helplessness were significant predictors of decreasing health status at three and six month 
intervals (Parker et al., 1991).  The Parker et al. study offered support for further research 
using the biopsychosocial model for research on autoimmune diseases.   
Researchers have also begun to conceptualize their research with the 
biopsychosocial model in mind.  For example Schoenfeld-Smith et al. (1996) chose both 
biological (disease activity, pain, and physical functioning) and psychological 
(helplessness, psychological functioning, and depression) variables to evaluate a model of 
progressive disease disability.  They found that both pain levels and helplessness 
mediated the relationship between disease activity and future disability in people with 
rheumatoid arthritis, which was a significant contribution to the field at the time when 
biomedical perspectives were still most accepted (Schoenfeld-Smith et al., 1996). 
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The biopsychosocial model was applied to the current study with the goal to 
determine which biopsychosocial factors influence health behaviors and well-being of 
persons with autoimmune diseases.  In other words, understanding which factors 
contribute to people’s perception of positive outcomes about their health and well-being 
will be a major emphasis of the current study.  
 
Biopsychosocial Factors Associated with Chronic Illness 
Biological Issues Associated with Chronic Illness. 
A basic understanding of the physical effects of living with an autoimmune 
disease is important in understanding the individual’s entire experience of these diseases.  
A description of some of the common symptoms of autoimmune diseases was provided 
in the previous section on autoimmune diseases to help delineate among the different 
diseases.   Given the biopsychosocial framework that is used for the current study, it is 
difficult to totally separate each of the variables, however, in this section, some research 
on how disease severity and symptoms affect other psychological and social variables 
will be explored.   
Some studies suggest that those with more severe disease experience decreased 
psychological well-being, while others suggest the opposite.  An example of increased 
psychological well-being was found in studies of individuals with cancer and lupus (Katz 
et al., 2001) and multiple sclerosis (Mohr et al., 1999) who reported less pain and more 
benefit finding, suggesting that disease severity limits benefit finding.   
Fyrand, Moum, Finset, and Glennas (2002) studied disease variables and duration 
on social support in 264 women with rheumatoid arthritis and found that women with 
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longer disease duration had less emotional support than those who had not been 
diagnosed for as long.  Also, women with more severe rheumatoid arthritis reported less 
social support.  In addition, extroverts and people who scored low on neuroticism 
reported having more daily social support than introverts and those low on neuroticism.  
Unfortunately, a strongly significant relationship between disease duration (longer) and 
disease severity (worse) and social companionship existed such that individuals with 
more severe and longer disease duration had lower levels of companionship and problem-
focused emotional support (Fyrand et al., 2002).  The current study will assess disease 
severity and duration to account for its impact on psychosocial adjustment to living with 
an autoimmune disease. 
 The biological or biomedical issues associated with autoimmune diseases were 
discussed above in the section explaining the types of diseases that will be included in 
this study.  This study will focus on the physical symptoms that an individual is 
experiencing.  Although some studies have used objective measures of disease severity 
like joint measurements to assess the swelling (Barsky et al., 1999) or immunological 
assays of the synovial fluid in joints (Friedman, Hayney, Love, Singer, & Ryff, 2007) to 
examine the level of inflammation factors present, these are beyond the capabilities of the 
researcher and outside the scope of the current study.  Though the instruments used to 
assess physical symptoms in the current study were self-report measures, they have been 
shown to accurately assess general physical functioning in individuals with autoimmune 
diseases.   
 The overall conclusion that can be drawn from these previous studies on the 
biological factors in autoimmune diseases is that many studies have explored the link 
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between physical symptoms and psychosocial factors and have made the clear correlation 
that as physical health declines, positive well-being and psychological health also 
decline.  This will be explored in more depth in the following sections. 
Psychological Issues Associated with Chronic Illness. 
 Of particular interest to researchers studying chronic illness is developing an 
understanding of how people adjust to the psychosocial stressors associated with the 
disease.  This section will address the psychological variables chosen for the current 
study: depression and self-efficacy. 
Studies have shown that there is a large psychosocial impact associated with 
having a chronic illness.  Depression and anxiety are often comorbid conditions with 
chronic illness.  The psychological impact of chronic illness has been well documented in 
the literature (e.g., Taylor, 1983; Afflect & Tennen, 1996 as cited in Katz, Flasher, 
Cacciapaglia & Nelson, 2001).  
 Many studies have found that living with a chronic illness is often associated with 
decreased psychological well-being.  Depression and anxiety increase and individuals 
have a more difficult time coping.  One psychological factor that is more prevalent in 
individuals with autoimmune diseases is self-blame, which has been shown to have an 
impact on depression and anxiety.  Research on these areas will be discussed in this 
section.  Contrary to these findings that psychological health always decreases with 
negative changes in physical health, a brief overview of research on positive benefit 
finding will also be presented here. 
A study by Mangelli et al. (2002) reported that individuals with rheumatoid 
arthritis are more likely to be depressed or anxious, thus suggesting that newly diagnosed 
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individuals with RA may need counseling interventions immediately following their 
diagnosis.  Similar results were found in a study by Nagyova, Stewart, Macejova, 
vanDijk, & van den Heuvel (2005).  They called for more attention to the emotional 
factors associated with RA, a link that has been missing from the treatment 
recommendations for individuals with RA commonly made by physicians.  In their study 
of 160 recently diagnosed European individuals with rheumatoid arthritis, they employed 
structural equation modeling to determine what mediates the relationship between pain 
and positive well-being, as demonstrated by Mangelli et al. (2002).  They found that an 
individual’s self-esteem and adjustment mediated the correlation between pain and 
positive well-being.  The personality variables of self-esteem and adjustment had a 
profound effect on the pain and positive well-being link.  This finding suggests that 
counselors can help people with chronic disease boost their self-esteem and adjustment to 
the disease in order to improve their outlook on life (Nagyova et al., 2005).  Both the 
Mangelli et al. (2002) and Nagyova et al. (2005) studies emphasize the importance of 
monitoring depression and anxiety in individuals with autoimmune diseases.   
Self-efficacy. 
 Self-efficacy is a concept that was originally introduced by Bandura in 1977 and 
has been widely applied to many contexts.  Bandura defines self-efficacy as “Beliefs in 
one’s capabilities to organize and execute the course of action required to produce given 
attainments” (Bandura, 1997, p.3 as cited in Barlow, Cullen, & Rowe, 2002).  Dealing 
with a chronic illness requires much coordination of appointments, accommodation in 
one’s schedule, balancing of various roles, and a huge amount of flexibility.  Also, in the 
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case of autoimmune diseases, individuals must face physical debilitation and some 
psychological consequences.   
 In previous studies of individuals with autoimmune diseases, low self-efficacy has 
predicted depression (Wright et al., 1996), low self-efficacy has been significantly 
correlated with psychological distress and worse physical functioning (Beckham. Rice, & 
Talton, 1994), and that self-efficacy and pain predict physical functioning (Dwyer, 1997).   
Lorig et al. (1989) developed a self-efficacy scale specifically designed for use in 
individuals with arthritis and arthritis-related diseases like autoimmune diseases.  
Arthritis self-efficacy has been defined as the “perceived ability to control, or manage, 
various aspects of arthritis, such as pain, fatigue, and emotional distress” (Barlow et al., 
2002, p. 12). 
In a study of 60 individuals with rheumatoid arthritis in the UK, self-efficacy 
about perceived ability to manage disease symptoms mediated the relationship between 
pain and psychological well-being (Barlow, Cullen, & Rowe, 2002).  For clients who 
believed in their own ability to manage their health, they were likely to experience less 
depression or anxiety (Barlow, Cullen, & Rowe, 2002).  Participants completed 
inventories on depression, anxiety, positive mood, and disease characteristics.  They also 
completed the Arthritis Self-Efficacy Scale.  Lower arthritis self-efficacy was associated 
with worse physical disability, more pain and fatigue, a less positive mood, and more 
anxiety and depression.  They also found that depression (as measured by the Hospital 
Anxiety and Depression Scale) was correlated with worse disease symptomatology, pain, 
and fatigue.  Barlow, Cullen, and Rowe (2002) found weak correlations between the 
physical and psychological variables and when they controlled for arthritis self-efficacy, 
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they found that those correlations did not remain statistically significant, thus indicating 
that disease self-efficacy may play a mediating role in the relationship between physical 
and psychological health.     
Similarly, perceptions of illness were linked to worse depression, less life 
satisfaction, and longer morning stiffness in a study of 154 individuals with rheumatoid 
arthritis with varying lengths of diagnosis.  This was found to be especially pronounced 
in those individuals who had been diagnosed for less than six months.  Optimism was 
significantly correlated with lower reported pain and social support was correlated with 
less fatigue in these individuals (Treharne, Kitas, Lyons, & Booth, 2005). 
 Self efficacy is a construct that has been investigated in a variety of different 
contexts.  In a study of 235 older adults, Callaghan (2005) found that self-efficacy in 
general and self-efficacy for one’s ability to take care of one’s self (self-care) was 
significantly related to health promotion (as measured by the Health-Promoting Lifestyle 
Profile II).  They found a direct link between people’s beliefs about their ability to take 
care of themselves and they actual behaviors they engaged in.   
 In another study of individuals with MS, self-efficacy was evaluated as a mediator 
of the relationship between physical activity and quality of life (Motl, McAuley, & 
Snook, 2007).  This study was unique in that it measured physical activity by having 
participants wear a pedometer and accelerometer for a week rather than relying on self-
reports of activity, which are often unreliable.  They measured self-efficacy using the 
Exercise Self-Efficacy Scale and the Barriers Self-Efficacy Scale, both situation-specific 
measures.  They found that both self-efficacy and functional limitations mediated the 
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relationship between physical activity and quality of life.  These relationships were 
independent of perceived social support (Motl et al., 2007). 
 Self-efficacy has been shown to be an important predictor of outcome variables, 
mediator of physical and psychological variables, and relevant factor to consider for 
individuals with autoimmune diseases.   
Other psychological variables. 
In one study of individuals with Multiple Sclerosis, three factors were found that 
described their ways of adjusting to the disease.  They were demoralization, deteriorated 
relationships, and benefit-finding (Mohr et al., 1999).  Demoralization encompasses the 
feelings of helplessness and vulnerability that come with having MS.  Deteriorated 
relationships address the changes in social relationships and feelings of victimization that 
were associated with MS.  Conversely, benefit-finding covered the positives that grew 
out of a diagnosis with a chronic illness which include things like deeper relationships, 
appreciation of life, and spirituality (Mohr et al., 1999).  This same factor structure is 
believed to exist in other chronic illnesses, as Mohr et al.’s results were replicated by 
Katz, Flasher, Cacciapaglia, and Nelson (2001) who used Mohr’s chronic illness 
psychosocial measure with individuals with both cancer (N=56) and lupus (N=31).   
 The Katz et al. (2001) study found that an individual’s pain rating was inversely 
related to their benefit-finding score suggesting that those in more pain are less likely to 
see the bright side of their diagnosis.  Without proving causality, the inverse that 
individuals who see more benefits experience less pain could also be true.  Katz et al. 
raise the question of how this might relate to an intervention such that if clients are asked 
to find the silver lining to their disease, will they actually do better and perceive that they 
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have less pain?  That question inspired the current study to look at what affects 
individual’s positive well-being. 
 Surprisingly to some, benefit finding and other positive coping variables are 
consistently found in the chronic illness literature.  Constructs like post-traumatic growth 
(Tedeschi & Calhoun, 1995) have repeatedly emerged from studies with individuals with 
chronic illness.  In the present study, health promoting behaviors and positive well-being 
will be investigated.  
The three factors that emerged from Mohr et al.’s study of 94 individuals with MS 
illustrate the variability in responses that individuals have to chronic illness.  Certainly, 
some people experience the entire range of reactions from demoralization to benefit 
finding, but others tend towards one extreme or another.  Just like there is variability in 
whether we are optimists or pessimists, it is easy to picture individuals in a hospital ward 
who have decided to fight their disease, live each day as if it’s their last, and advocate for 
other individuals as well as those who are so depressed they do not want to live another 
day.  The personality factors that affect an individuals’ reaction to a chronic illness are 
important to study and the current study will investigate how these variables also affect 
behavior choices.  According to Taylor (1983), most individuals who suffer through a 
traumatic event regain their original level of happiness or even surpass it within a year 
after the event.  Cognitive adaptation theory proposes that regained happiness is caused 
by a combination of three factors: searching for meaning in the experience, regaining 
mastery over the event and life in general, and struggling to regain self-esteem after the 
setback.  Individuals who have faced a serious illness or trauma often discuss how the 
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experience forced them to reconsider their priorities and find meaning in their lives, 
especially in their relationships.   
Two factors that are unique to autoimmune diseases and the psychological impact 
of these diseases warrant consideration here.  These factors are self-blame and 
attributions of one’s illness.  Self-blame has been associated with depression and anxiety 
and inaccurate attributions have also been linked to poor well-being. 
One of the factors that differentiates autoimmune diseases from other types of 
chronic illness is that, by definition, the body is attacking itself.  Whereas other diseases 
with a known origin like a specific type of bacteria or virus are more understandable, 
individuals with an autoimmune disease are typically left with many questions about why 
they have developed their disease.  People with autoimmune diseases tend to blame 
themselves more than individuals with other types of chronic illness (Westbrook & 
Nordholm, 1986) and this self-blame has huge consequences for the psychological well-
being of these individuals.  Self-blame is associated both with depression and anxiety, the 
psychological variables of interest in the current study.   
Self-blame plays a large role in determining how an individual with an 
autoimmune disease will adjust to their illness.  When an individual blames herself or 
himself for the development of disease, they often experience poorer well-being and 
depression.  In diseases where lifestyle factors are not believed to be at blame for the 
development of the disease, individuals who blame themselves are especially worse off.  
A study by Westbrook and Nordholm (1986) compared individuals with diseases with 
either high or low lifestyle involvement.  The high lifestyle involvement individuals had 
strokes or heart attacks and the low lifestyle involvement group had arthritis or cancer; 
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meaning that the factors contributing to the development of the disease had very different 
levels of lifestyle-contributing factors causing the disease.  Individuals made attributions 
about the development of the disease that were either self-focused or chance-focused.   
Individuals who blamed themselves when there was actually a medical basis for 
that attribution (i.e. the self-blaming group with strokes or heart attacks) were rated as 
coping better and acting more appropriately and typically by the rating health care 
practitioners.  On the other hand, individuals who blamed themselves for the 
development of their cancer or arthritis were rated as more depressed, poorly adjusted, 
coping poorly, not accepting their disability, and needing counseling and information.  
Also included in the study were accident victims; when they were self-blaming, they 
were judged as more dependent, less likeable, and having poorer prognoses than accident 
victims who accurately blamed chance for their accident.  In individuals who had realistic 
self-blame when they had a disease with lifestyle factors, they coped better but self-
blamers who had low lifestyle involvement diseases felt stigmatized. These results 
indicate that having realistic self-blame, when appropriate, is helpful to an individuals’ 
well-being (Westbrook & Nordholm, 1986).     
Individuals with autoimmune disorders may be influenced by their doctor’s 
misattributions about the etiology of their disease, which may increase the individual’s 
self-blame.  When physical health issues are addressed by psychologists, there is a 
tendency to blame the client for her/his role in the development of the disorder.  For 
example, people with lung cancer are chastised for smoking, individuals with HIV for 
their risky sexual behaviors, and people with heart disease for their poor diet and lifestyle 
habits.  Few health care practitioners take time to think about the societal issues that 
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affect the individuals who are sick—tobacco companies targeting children with 
advertising at a young age, a lack of safer-sex education and widespread homophobia, 
and an emphasis on long work days and the importance of financial security in exchange 
for healthy lifestyle practices, just to name a few.  When individuals are blamed for their 
choices, their sense of empowerment decreases and they adhere less to their health care 
regimens (Goodheart, 2006).  This will be examined through asking participants in the 
current study about their health-promoting behaviors.   
Some research has been done on what individuals attribute to be the cause of their 
disease.  To investigate how individuals with chronic illness attribute the causes of their 
disease, Benedict (1995) studied 203 individuals with chronic illnesses.  Participants had 
a variety of diseases themselves and were asked to rank the contributing causes of their 
own disease and then rank the causes of an illness that an anonymous other person had.  
A pilot study was first conducted in a different population to determine common causes 
that people mention for generic chronic illnesses.  This list was given to the 203 
participants in the study so they could choose from a predetermined list.  Causes were 
divided into “blaming” (bad habits, diet, lack of exercise, and stress), “not blaming” 
(accidents, bad luck, genetic predisposition, location/weather), and “neither” (emotional 
suffering/life crisis, natural aging process, problems associated with work, and other).   
 The results of the study indicate that older participants used more blaming 
attributions than did younger ones.  Also, individuals who had more concomitant health 
problems (which was surveyed through an extensive health inventory) were less likely to 
use blaming attributions for themselves but more likely to blame others for their illnesses.  
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Benedict (1995) also found that individuals who used blaming attributions for themselves 
were more likely to be depressed than those who believed non-blaming causes.  
 A critique of the Benedict (1995) study is that participants were not separated by 
disease or even type of disease.  Individuals with more serious ailments may react 
differently than those with less debilitating diseases.  Since the participants were asked to 
rank the causes of an anonymous other’s illness, it would have been impossible for the 
participants to separate their own previous knowledge during that task.  If a participant 
had a strong family history of a certain illness, they might think of that disease first when 
asked to list attributions of someone else’s disease whereas a person without much 
exposure to chronic illness would have more of a blank slate when choosing attributions.  
The Benedict (1995) study could have been improved with significant methodological 
changes.   
 The consistent findings about the psychological impact of living with a 
autoimmune disease is that most people will develop psychological symptoms like 
depression and anxiety unless they reduce self-blame for the development of their disease 
and try to engage in positive benefit-finding.  It is unclear how much biological variables 
like pain and restriction of activities will contribute to depression and what the 
directionality of that relationship is.  For example, does increased pain cause increased 
depression or does depression cause increased pain?  The relationships among these 
variables will be examined in the current study.  There is limited support on the 
effectiveness of seeking psychotherapy for these psychological symptoms, though 
previous studies have shown that social support is an important factor in the well-being of 
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people with autoimmune diseases.  This will be further explored in the next section of 
this review of the literature.  
 
Social Support 
Across many studies of individuals with chronic illness, those who have more 
social support do better.  Social support is important in a number of different forms, 
specifically emotional support and logistical support.  An individual who is sick needs 
someone to listen to them and help them talk about their problems just as much as they 
need someone to help drive them to doctor’s appointments or bring them food.  Some of 
this support can come from a counselor, but friends and family members often are the 
first line social support providers when someone is facing a chronic illness.  
Some research on the importance of social support has already been discussed in 
the previous sections.  For example, the Fyrand et al. (2002) study found that women 
with less social support had more severe rheumatoid arthritis.  They also found that levels 
of social support deteriorated over time.  This finding supports the anecdotal evidence 
that individuals with autoimmune diseases have a difficult time asking for help and that 
friends and family members are not able to understand how to help and what to do.   
Another study about social support that was previously discussed was the Mohr et 
al. (1999) study, which found that people with Multiple Sclerosis commonly experienced 
deteriorated relationships after their diagnoses and they had feelings of victimization after 
being diagnosed.   
Some general studies have been conducted that show that individuals experience a 
better immune system response when they have social support and that they do better 
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overall with a cancer diagnosis when they have a sense of perceived social support.  
Immunologic studies have been conducted that show clear links between good levels of 
social support and an improved immune response (in diseases like cancer and infectious 
diseases where an improved immune response is desired unlike the current study).  These 
general studies are outside the realm of this review of the literature but are nicely 
reviewed in Cohen and Herbert (1996). 
Previous studies have shown that individuals with a strong social support network 
do not seek therapy as often.  Perceptions about the availability of social support may 
actually be more significant than whether those individuals are available to them when 
they are in need (Phillips & Murell, 1994).   Social support has been shown to have a 
significant relationship with psychological well-being in previous studies (Phillips & 
Murell, 1994).   
 For example, Kettmann and Altmaier (2008) found that social support was an 
important predictor of depression in individuals who had undergone a bone marrow 
transplant.  In a study of 86 individuals who had undergone bone marrow transplants, 
social support (as measured by the MOS-SSS) taken before the transplant predicted 
depression after the transplant (as measured by the CES-D), even more accurately than 
pre-transplant levels of depression (Kettmann & Altmaier, 2008). 
These biopsychosocial variables are believed to have an impact on the overall 
sense of positive well-being and health-promoting behaviors in individuals with 
autoimmune diseases.  These two variables were chosen as criterion variables in the 
current study because of their impact on overall health status.  An overview of these 





 The overall goal for both medical and mental health professionals is to improve 
the well-being of individuals with autoimmune diseases.  As was discussed in the 
previous sections, overall well-being can be affected by biological, psychological, and 
social factors as well as the interaction among these variables.   
Positive well-being has been studied in many different populations in previous 
research.  The importance of positive well-being in individuals with physical health 
problems has been validated in different studies.  A high correlation between physical 
health status and psychological well-being (r = 0.66) was observed, such that individuals 
with poor physical health also reported doing worse psychologically (Phillips & Murell, 
1994).  In that study, which was comprised of older adults (over age 55), individuals who 
expressed emotional and psychological difficulties were more likely to talk to their 
medical doctor about those problems than to any other type of health care or mental 
health provider.   
 The concept of well-being is broad, far-reaching, and encompasses many different 
topics ranging from happiness to satisfaction to positive growth.  Ryff (1989) attempted 
to consolidate the various ideas about positive well-being into a more parsimonious 
theoretical structure.  She views self-acceptance, positive relations with others, 
autonomy, environmental mastery, purpose in life, and personal growth as being the main 
components of positive well-being.  Ryff compared her ideas about positive well-being to 
the structure of other measures of well-being and found that her structure was robust and 
held many opportunities for research applications.  Positive and significant correlations 
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with past measures of well-being were found to range from 0.25 to 0.73.  The previous 
measures used were life satisfaction, affect balance, self-esteem, internal control, and 
morale (Ryff, 1989).   
Part of psychological well-being is resilience, or one’s ability to handle and 
recover from a crisis.  Resilience is an important adaptive factor for people diagnosed 
with chronic illness.  Individuals who are able to find positive meaning in their lives, and 
to “bounce back” from significant life setbacks like chronic illness, experience better 
mental health.  Positive well-being appears to measure resilience, as defined by Ryff 
(1996).  Subscales of positive well-being (PWB) include autonomy, environmental 
mastery, personal growth, positive relations with others, purpose in life, and self-
acceptance.  These scales have been shown to change with age, such that older 
individuals experience less purpose in life and personal growth and more environmental 
mastery (Mangelli, Gribbin, Buchi, Allard, & Sensky, 2002).  In the current study, 
positive well-being will be evaluated using the Psychological Well-being Scale (Ryff, 
1989). 
In a study of 104 individuals with rheumatoid arthritis, the participants reported 
significantly lower positive well-being scores on all of the subscales, especially in the 
personal growth and purpose in life subscales as compared to a community sample drawn 
from the United States.  Low scores on positive well-being were correlated with higher 
levels of depression and anxiety and higher levels of pain were associated with more 
depression and anxiety (Mangelli et al., 2002).  These findings highlight the difficulty 
that many individuals with rheumatoid arthritis experience and the importance of 
encouraging resilience and positive growth in clients with autoimmune diseases.  The 
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results also indicate that positive well-being is associated with chronic disease in general 
but the disease-specific effects of rheumatoid arthritis were less significant.  This finding 
gives support to the current study, which will investigate autoimmune diseases as a whole 
rather than as specific diseases.  Mangelli et al.’s findings illustrate the importance of 
attending to general psychosocial factors with individuals with chronic illness.   
One additional study of psychological well-being in individuals with autoimmune 
diseases bears discussion here.  A study conducted by Friedman, Hayney, Love, Singer & 
Ryff (2007) investigated the relationship between psychological well-being and levels of 
plasma inflammatory factors in aging women.  In a study of 135 women between the ages 
of 61 and 91, interleukin-6 (IL-6) levels were measured along with giving participants a 
number of psychological measures to complete.  IL-6 has been associated with 
inflammation associated with Alzheimer’s disease, osteoporosis, rheumatoid arthritis, 
cardiovascular disease, and some forms of cancer.  Previous research had shown IL-6 
levels to be easily affected by psychological stresses, for example depression is often 
associated with elevated IL-6 levels.  The Friedman et al. (2007) study found that IL-6 
levels were lower in individuals who had higher levels of psychological well-being, 
specifically lower IL-6 levels were related to higher scores on purpose in life scales.  In 
addition, participants who had high social support had lower levels of IL-6.  These results 
are especially significant because the researchers controlled for other demographic 
variables.   
Positive well-being encompasses a number of different types of variables and has 
been shown to be related to life satisfaction and other measures of well-being in 
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numerous studies (Ryff, 1996).  Another well-researched outcome variable in the current 
study was health promoting behaviors.   
 
 
Health Promoting Behaviors. 
 The definition of health has expanded beyond the physical to include mental 
health, as well as other nuanced areas of well-being.  Positive health is defined as 
physical, mental, and social well-being and negative health is disease and infirmity.  
Research on positive health is scarce and the current study will expand on some of the 
limited existing research available.   
 In order to improve overall health, individuals with chronic illness need to choose 
healthy behaviors and follow the medical recommendations made for them.  In addition, 
effective coping skills and attitudes such as having a sense of optimism and 
psychological well-being are important.  Individuals with chronic disease must also make 
choices that will benefit their mental health.  Health promotion has been cited as a goal of 
the biopsychosocial model (Hoffman & Driscoll, 2000) and some research has been done 
on what characteristics comprise healthy behaviors.  “A multidimensional pattern of self-
initiated actions and perceptions that serve to maintain or enhance the level of wellness, 
self-actualization, and fulfillment of the individual (p.77) ” is how Walker, Sechrest, and 
Pender (1987) define a health promoting lifestyle.  Those authors went on to research 
what behaviors contribute positively to a healthy lifestyle.  The main goal of the Walker 
et al. model of health promotion is increasing autonomy over health and educating others 
about ways to increase good health practices. 
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 Previous studies have found that scores on the HPLP II are correlated with 
population health determinants and individual risk factors for a variety of diseases, 
suggesting that the HPLP is measuring what it claims to measure.  In a study of  women 
at risk for cardiovascular disease, the HPLP II encompassed many of the risk factors that 
predicted women’s risk for heart disease and was correlated with physical measures given 
to the participants (Sawatzky & Naimark, 2005). 
 Health promoting behaviors have been researched across cultures and the Health 
Promoting Lifestyle Practices Profile II (HPLP II) contains questions about behaviors 
such as exercise, eating fruits and vegetables, and believing that life has purpose that 
have been validated in multiple samples.  One study of the HPLP II compared the health 
practices of nursing students in both Canada and Jordan (Haddad, Kane, Rajach, 
Cameron, & Al-Ma’aitah, 2004).  The results showed that Canadian students took more 
personal responsibility for their health and felt better about their interpersonal 
relationships.  Those two areas represent two of the subscales of the HPLP II; others are 
physical activity, nutrition, spiritual growth, and stress management.  The HPLP II has 
been used in many different samples and has been shown to be a useful measure of health 
promotion.   
 In a study conducted in the UK, researchers designed an intervention aimed at 
increasing the level of health-promoting activities in people with Multiple Sclerosis, as 
well as enhancing self-efficacy and quality of life (Ennis et al., 2006).  Participants in the 
program were 62 adults with any kind of MS who completed an eight-week 
interdisciplinary program.  It was an outpatient health promotion and education program 
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aimed solely at increasing the knowledge, skills, and self-efficacy needed to improve 
one’s level of health-promoting activities. 
They found that the treatment group (compared to the control group which only 
completed the paper measures) reported significantly higher levels of health promoting 
activities after the program.  This was measured using the HPLP II and they also had 
higher self-efficacy for completion of those activities.  Those levels of increased health-
promoting behaviors were maintained for three months after the program.  Individuals in 
the treatment group also reported higher levels of mental health and general health 
immediately after the program and three months later, compared to the control group.  
Many of the participants also expressed positive feedback about the intervention and the 
assistance they received in improving their health-promoting behaviors (Ennis et al., 
2006).   
Conclusion 
 This review of the literature has covered an overview of autoimmune diseases and 
discussed the important biological, psychological, and social factors involved in adjusting 
to these disorders.  It is clear from the presentation of the existing research in these areas 
that these factors have an effect on each other, for example, decreased physical 
functioning was shown to affect psychological well-being and a lack of social support is 
associated with disease severity.  The distinct contributions of these factors to the overall 
picture of well-being has not been examined and, in keeping with the biopsychosocial 
model, the goal of this study is to provide a more integrative model of how well-being 
and health promoting behaviors are affected by living with an autoimmune disease.   
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 Many different biopsychosocial variables exist that can be considered in 
investigating how someone copes with their autoimmune disease.  For the current study, 
the relationship of disease severity, depression, self-efficacy, and social support to the 
selected outcome measures were examined. These variables were chosen because of their 
commonality among the population of individuals with autoimmune diseases and because 
it was believed that they would have a significant impact on the outcome variables 
chosen for the current study: positive well-being and health promoting behaviors.   
 The goal of the biopsychosocial model (Hoffman & Driscoll, 2000) is to enhance 
health promotion and improve health status.  The outcome variables chosen for the 
current study addressed two different aspects of positive health.  Positive well-being is 
associated with overall adjustment and life satisfaction, obviously an important part of 
positive health.  Health-promoting behaviors serve to prevent the development of further 
illness and allow individuals to take control of the lifestyle components of their illness. 
Taken together, these two outcome variables contribute important information about the 
overall health status of individuals with autoimmune diseases.  The broad scope of the 
biopsychosocial variables chosen for the current study enhance our ability to tease apart 






Statement of the Problem 
Taken as a whole, autoimmune diseases represent the fourth most common type 
of chronic illness (www.aarda.org, 2008) and the unique clinical presentation of 
autoimmune diseases made them an ideal disease model for the current study.   
Individuals with autoimmune diseases in particular are often marginalized through 
their interactions with medical professionals and are underserved by mental health care 
services (Chrisler, 2001) because of the difficulty receiving an accurate diagnosis of an 
autoimmune disease, the cycles of remission and relapse that make treatment challenging, 
and the complicated psychological and physical symptoms.  Because of this, it is crucial 
that we better understand variables that predict engaging in health-promoting behaviors 
for individuals with autoimmune diseases and those that have an effect on their sense of 
positive well-being.  
Chrisler’s (2001) article was the only theoretical article found that investigated the 
psychosocial issues facing individuals with autoimmune disease.  This is an understudied 
population and limited empirical work has been done investigating biopsychosocial 
factors that influence positive well-being and health promoting behaviors.  Because there 
is a paucity of research examining biopsychosocial variables that predict positive well-
being and health promoting behaviors, no theoretical justification could be found to 
support some of the questions of interest in the current study; therefore research questions 
rather than hypotheses formed the foundation for this research.  Several hypotheses are 





Hypothesis 1:  A negative relationship will exist between disease severity and social 
support, such that the more severe the reported disease symptoms, the lower the level of 
social support.    
 Fyrand et al. (2002) found that individuals with longer courses of rheumatoid 
arthritis had less social support and this hypothesis will attempt to confirm that finding.  
This hypothesis will measure disease severity based on symptom self-report rather than 
longevity of the disease.   
 Fyrand, along with other researchers, studied the impact of rheumatoid arthritis on 
social support using a number of different methods in multiple studies.  First, they looked 
at the size of social networks of women with autoimmune diseases.  They believed that 
the sheer number of social contacts would decrease as a result of having rheumatoid 
arthritis (Fyrand et al., 2000).   
 Next they studied social support using self-report inventories in women with 
autoimmune diseases (Fyrand et al., 2001).  In the 2000 and 2001 studies, they compared 
individuals with autoimmune diseases to control groups without such diagnoses.  In a 
follow-up study, they looked at rheumatoid arthritis duration and disability in women 
with rheumatoid arthritis to see how the disease impacted their social support.  All three 
studies found significant evidence that social support worsened after a diagnosis of an 
autoimmune disease, regardless of how social support and disease disability were 
measured (Fyrand et al., 2000; Fyrand et al., 2001, Fyrand et al., 2002).   
 
Hypothesis 2:  A negative relationship will exist between Arthritis self-efficacy and 
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depression, such that the higher the reported level of self-efficacy, the lower the level of 
depression. 
  Previous research by Barlow, Cullen and Rowe (2002) found that psychological 
health was correlated with self-efficacy and physical disability status was also correlated 
with self-efficacy in a sample of 82 individuals with rheumatoid arthritis.  They examined 
interventions aimed to increase self-efficacy and found that those interventions improved 
depressive symptoms as well.   
 A debate about how to study self-efficacy has existed in the literature.  Should it be 
measured as a global construct or is it best studied through specific measures?  Bandura 
(1997) indicated that self-efficacy is best studied using a specific task or goal.  In the 
current study, the Arthritis Self-Efficacy scale (Lorig et al., 1989) measured specific self-
efficacy about one’s perceived ability to decrease disease symptoms.  This hypothesis 
was designed to replicate the findings of the Barlow et al. (2002) study to investigate the 




Research Question 1:  How do biopsychosocial variables affect positive well-being in 
individuals with autoimmune diseases? 
 Previous studies have shown that individual biological, psychological, and social 
variables do have an impact on positive well-being in individuals with autoimmune 
diseases, though few studies have evaluated the unique contributions of multiple 
biopsychosocial variables on well-being.   
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 Studies like Mangelli et al. (2002), Barsky et al. (1999), and Westbrook and 
Nordholm (1986) found significant correlations for objective measures of disease severity 
with depression, self-blame, and overall well-being, suggesting that biological variables 
like disease severity do play a role in influencing positive well-being.   
 Psychological variables like depression, illness intrusion, and self-efficacy are also 
believed to be related to positive well-being.  By definition, positive well-being involves 
positive affect and not symptoms of depression (Ryff, 1989) and illness intrusion has 
been shown to have a negative effect on well-being in other types of illnesses (Devins et 
al., 1997). 
 The connection between social support and positive well-being was explored by 
Friedman et al. (2007), where they found that participants with more social support 
scored higher on positive well-being.  In addition, the participants who had higher well-
being had lower levels of inflammatory factor in their blood, again suggesting a 
relationship between biological factors and well-being.  However, psychological 
variables were not investigated in this study. 
 Therefore, the current study used all three components of the biopsychosocial 
model (Hoffman & Driscoll, 2000) to explore relationships to well-being in greater depth. 
 
Research Question 2:  How do biopsychosocial variables affect health-promoting 
behaviors in individuals with autoimmune diseases? 
 The foundation of the Health Promoting Behavior Profile which was used in this 
study to examine health behaviors is based in the idea that the measured behaviors help 
individuals promote their health and decrease the effects of their disease.  Extensive 
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research on correlations between the items in the HPLP-II and health promoting activities 
was conducted (Walker, Sechrist, & Pender, 1987).  This research question examined the 
relationship between selected biopsychosocial variables and health-promoting behaviors 
to help clarify factors that predict self-report of engagement in healthy behaviors.   
 Walker, Sechrest, and Pender (1987) define health-promoting behaviors as: “A 
multidimensional pattern of self-initiated actions and perceptions that serve to maintain 
or enhance the level of wellness, self-actualization, and fulfillment of the individual 
(p.77).”  The relationship between the biopsychosocial variables examined in the current 
study and wellness, self-actualization, and fulfillment had not been studied in persons 
with autoimmune diseases but it was believed that these variables would play a role in 
health-promoting behaviors based on studies conducted in women with cardiovascular 
disease (Sawatzky & Naimark, 2005). 
 
Research question 3:  Do psychosocial variables mediate the relationship between the 
biopsychosocial variables and positive well-being?  
Research question 3a: Does self-efficacy mediate the relationship between depression 
and positive well-being? 
 Previous studies have shown that self-efficacy has played a role in mediating other 
psychological variables (Lowe, 2008).  In the current study, disease-specific self-efficacy 
was examined to see if it mediated the relationship between depression and self-efficacy.  
Previous studies have demonstrated the link between autoimmune diseases and 
depression (e.g.. Mangelli et al., 2002), so it was expected that this sample would report a 
high level of depression.  Depression has been linked to decreased levels of well-being 
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(Ryff, 1989), so it is expected that depression and low levels of well-being will be 
associated.  The current study examined whether self-efficacy served to mediate that 
relationship between depression and well-being.   
Research question 3b: Does social support mediate the relationship between depression 
and positive well-being? 
 The connection between social support and positive well-being was explored by 
Friedman et al. (2007), where they found that participants with more social support 
scored higher on positive well-being.  Another study about social support that was 
previously discussed was the Mohr et al. (1999) study, which found that people with 
Multiple Sclerosis commonly experienced deteriorated relationships after their diagnoses 
and that they had feelings of victimization after being diagnosed.   
 The relationship between depression and social support has been shown in previous 
studies (Kettmann & Altmaier, 2008) and the current study attempted to follow-up on 
previous findings to see if social support was actually a mediator.   
 Previous studies have demonstrated the link between autoimmune diseases and 
depression (e.g.. Mangelli et al., 2002), so was expected that this sample would report a 
high level of depression.  Depression has been linked to decreased levels of well-being 
(Ryff, 1989), so was expected that depression and low levels of well-being would be 
associated.  The current study examined whether social support served to mediate that 
relationship between depression and well-being. 
 
Research Question 4: How will natural groupings form among individuals with 
autoimmune diseases on the predictor variables of interest (disease severity, depression, 
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self-efficacy, and social support)? 
 This research question served as an extension of the previous two research 
questions.  Cluster analyses allow researchers to look at data in a different way by 
identifying groups of individuals who form clusters based on the variables of interest, and 
thus, some relationships among these variables may become clearer through this 
approach  and add to the findings of the other analyses used in the current study (Borgen 
& Barnett, 1987).   
 The natural groupings that form may suggest a rationale for future studies, such as 
intervention studies, to group participants in specific ways.  In other words, Ward’s 
(1963) clustering method is designed to allow researchers to use exploratory data 







 In this chapter, an overview of the study design, participants, procedures, and 
measures will be presented.  Information about how the study was conducted, how 
measures were chosen, and how data were analyzed will be provided.   
Design Statement 
 This study used a correlational, field-study, cross-sectional design.  There were four 
predictor variables and two criterion variables.  The predictor variables measured the 
three components of the biopsychosocial model (biological, psychological, and social).  
The biological variable was disease severity.  The psychological variables were 
depression and self-efficacy.  The social variable was social support.  The criterion 
variables were positive well-being and health-promoting behaviors. 
 Data were analyzed using Pearson correlations and multiple regression analysis. 
Data were also analyzed using Ward’s (1963) method of cluster analysis to identify 
natural groupings in the data.  The goals of cluster analysis are exploration, confirmation, 
and simplification of data (Borgen & Barnett, 1987).  Survey data and some brief 
qualitative data were collected from participants using an online survey.   
Power Analysis 
 An a priori power analysis for a multiple regression design with a power equal to 
0.80 and an α level equal to 0.05 yielded a sample size of 75 to detect a medium effect 
size (0.20).  Data needed to be collected from approximately 75-120 participants to 
ensure a large enough sample size to detect a medium effect size.  Data were collected 




 Participants in the current study were 175 individuals with autoimmune diseases.  
They were self-selected for the study and all of them reported being diagnosed with a 
valid autoimmune disease.  See Table 3 for a summary of the participants.   
 Participants were all individuals who had been formally diagnosed with 
autoimmune diseases by a health care provider and were over age 18.  Participants with 
non-connective tissue or non-musculoskeletal-type autoimmune diseases were eliminated 
from the final sample.  More information about the diagnoses of the participants can be 
found in Table 14.  In addition, participants who did not indicate a diagnosis were 
eliminated from the final sample.  They ranged in age from 18-84.  Most of them were 
female (90%) and white/European-American (94%).  Participants represented at least five 
different ethnicities, even though the overwhelming majority of participants were white.  
Many were well educated with only 14% reporting a high school degree or less.  
Participants reported a wide range of occupations, disease symptoms, and ways that their 
autoimmune disease had impacted their lives.  No restrictions were placed on the amount 
of time since the individuals were diagnosed with an autoimmune disease so the length of 
time since diagnosis ranged from within the past month (2%) to over 20 years ago (11%).  





Table 3: Demographic information about the participants in the current study (Total 
N=175) 
Demographics Groupings Valid N 
(Percentage) 
Age 18-24 10 (6%) 
 25-34 26 (15%) 
 35-44 34 (19%) 
 45-54 50 (29%) 
 55-64 38 (22%) 
 65-74 13 (7%) 
 75-84 4 (2%) 
Gender Female 157 (90%) 
 Male 17 (10%) 
Race/Ethnicity Asian-American/Pacific Islander 2 (1%) 
 White/European-American 165 (94%) 
 Hispanic/Latino(a) 1 (1%) 
 Biracial/Multiracial 2 (1%) 
 Black/African-American 4 (2%) 
Highest Education completed Middle school/Junior High 1 (1%) 
 High School 24 (14%) 
 Technical School 10 (6%) 
 Two-year college 26 (15%) 
 Some college 27 (15%) 
 Four year college degree 36 (21%) 
 Some graduate school 10 (6%) 
 Masters degree 26 (15%) 
 Doctoral/Professional Degree 15 (9%) 
Time since diagnosis Within the past month 3 (2%) 
 1-6 months ago 8 (5%) 
 6 months-1 year ago 4 (2%) 
 1-2 years ago 16 (9%) 
 2-5 years ago 36 (21%) 
 5-10 years ago 44 (25%) 
 10-20 years ago 44 (25%) 
 More than 20 years ago 20 (11%) 
Weekly hours worked for 
pay? 
0 53 (30%) 
 1-5 13 (7%) 
 6-20 11 (6%) 
 21-40 42 (24%) 
 41-60 47 (27%) 
 Over 60 3 (2%) 





 Participants were recruited through multiple online methods including snowball 
emails, emails sent through the Arthritis Foundation of Iowa, and publication through 
online list-servs with the Myositis Association, National Multiple Sclerosis Society, 
Lupus Foundation of America, American Thyroid Association (Hypothyroidism and 
Hashimoto’s Disease), Celiac Disease Foundation, Sjögren’s Syndrome Foundation and 
some of the smaller regional branches of these associations.  Due to the mass emails that 
were sent out to many different contacts, it is impossible to tell how many people 
received the emails.  Membership in these organizations is not just limited to individuals 
with the disease and also includes family members, friends, and health care professionals 
in the field.  Participants were also recruited through in-person physician 
recommendations and posters at the National Institute of Arthritis and Musculoskeletal 
and Skin Diseases clinics in the Washington, D.C. metropolitan area and the Mercy 
Arthritis Clinic in Urbandale, Iowa. 
Measures 
Demographic Form.  (Appendix A)  Clients were asked to describe their disease 
state and specific type of condition, when they were diagnosed, types of limitations they 
experience, type of medical treatment received, age, family structure, race, education, 
income, job, disability status, and history of counseling.  A few open- ended questions 
were also included in the demographic form including, “What factors would affect your 
willingness to seek psychotherapy/counseling?”  “What do you think caused your 
autoimmune disease?”  and “What is a positive consequence you’ve experienced as a 




 World Health Organization Disease Assessment Schedule II (WHO-DAS II) (World 
Health Organization, 2000).  See Appendix B for more information about the WHO-DAS 
II.  The WHO-DAS II is used to assess daily functioning in six domains.  An overall 
score can be used to describe overall disability as well as functioning in each of the areas.  
The WHO-DAS II was designed to identify needs, match individuals to interventions, 
track functioning over time, and measure clinical outcomes and treatment effectiveness 
(www.who.int/icidh/whodas, 2008).  There are a few different versions of the WHO-DAS 
II available and the 36-item self-administered version was chosen for the current study 
due to its comprehensiveness and generalizability.  The WHO-DAS II is not a disease-
specific measure; instead, it is intended to give results of disability status that can be 
compared to other disease groups.   
 The WHO-DAS II has six subscales including Understanding and Communicating 
(sample item: In the last 30 days, how much difficulty did you have in: "Starting and 
maintaining a conversation), Getting Around ("Moving around inside your home?"), Self 
Care ("Washing your whole body?"), Getting along with people ("Dealing with people 
you do not know?"), Life Activities ("Getting all the household work done that you 
needed to do?"), Work ("Doing your most important work/school tasks well?"), and 
Participation in Society ("How much of a problem did you have in joining in community 
activities (for example, festivities, religious or other activities) in the same way as anyone 
else can?").  Items are scored on a 5-point Likert scale ranging from 1=Not at all to 
5=Extremely and all items have the prompt, "In the last 30 days, how much difficulty did 
you have in…” An overall score can be obtained without the work subscale for 
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individuals who do not work.  In the current study, many participants reported not 
working so the overall score without the work subscale was used.  A total score is 
obtained by using SPSS syntax, which contains algorithms that are inputted directly into 
SPSS, that scores the inventory by summing the scores on each of the items and dividing 
the scores by 100 and the resulting total score can range from 0-100.  The work subscale 
included four items.  The total scores still ranged from 0-100 without the work subscale 
because the scores were standardized relative to the total number of items (32 versus 36 
on the subscale).  This syntax was available directly from the World Health Organization.  
Most commonly, the total score is used to indicate an individual’s perception of their 
disability status.  Subscales can be used to describe functioning in specific areas but the 
total score was used in the current study (without the work subscale).   
 The WHO-DAS II is designed to serve as an indicator of one’s perception of their 
disability and corresponds to functional impairment as measured by the International 
Classification of Disability system.  It has been used as an estimate of disease severity, 
but is most effectively used as a marker of functional impairment.   
 Reliability and validity data have been collected in 16 testing centers across 14 
countries with a wide range of populations.  For the total scale, as described above and 
used in the present study, Cronbach's α of .91-.93 were found by Adib-Hajbaghery and 
Aghanhoseini (2007) and .95 by Chwastiak and Von Korff (2003).  Test-retest-reliability 
ranges from .65-.78 (Chwastiak & Von Korff, 2003).  The WHO-DAS II has high levels 
of convergent validity with other scales measuring disease severity including the Medical 
Outcomes Study SF-36 (r=-0.77, Chwastiak & Von Korff, 2003); the Patient Health 
Questionnaire (r= 0.71, Chwastiak & Von Korff, 2003); and the Work Limitations 
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Questionnaire, physical subscale (r= 0.71, Chwastiak & Von Korff, 2003).  Note that the 
negative correlation with the MOS SF-36 is due to a higher score on the SF-36 
representing better functioning, whereas a higher score on the WHO-DAS II represents 
increased physical impairment.  The Cronbach's α for the current study was .95.    
Psychological Measures 
Center for Epidemiological Studies-Depression Scale (Radloff, 1977).  The CES-
D is a 20-item scale that includes a list of items associated with depression like “I felt 
lonely.” And “I did not feel like eating, my appetite was poor.”  Participants were asked 
to rate the items on a four point Likert scale with identifiers ranging from 0=rarely to 
3=all of the time.  A total score is obtained by summing the scores on all items.  Scores 
range from 0 to 60 with higher scores indicating more depressed mood.  The CES-D has 
been widely used in studies of depression based on its close relationship to components 
of depression that have been identified in the literature (Gignac et al., 2004).  Because of 
its inclusion of some physical items, it has been ideal for investigating depression in 
individuals with physical health issues.  It has been validated for samples with arthritis 
(Blalock et al., 1989) and is a well-validated and well-respected instrument.  It has been 
shown to have good factorial, discriminant, and construct validity (Orme, Reis, & Herz, 
1986).  The original internal consistency α for a general population was 0.85 and for a 
patient population was 0.90 (Radloff, 1977).  Test-retest reliability was found to be 0.51 
in a health comparison group and 0.57 in a patient population (Hann, Winter, & Jacobsen, 
1999). Please see appendix C for a sample of the items.   
The CES-D has been used in similar populations including a group of 54 
individuals with Rheumatoid Arthritis who also had confirmed diagnoses of depression 
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(Parker et al., 2003) and 492 individuals with Rheumatoid or Osteoarthritis who were 
working (Gignac et al., 2004).  The Parker et al. study found a Cronbach’s α of 0.89 and 
the Gignac et al. study found a Cronbach’s α of 0.92.  Scores greater than 16 indicate 
evidence of depression.  Recent studies have evaluated the CES-D for use in rheumatoid 
arthritis populations and have determined that 19 would be a more appropriate cut-off for 
levels of clinical depression due to the overlap of somatic symptoms (Covic et al., 2007).  
The Gignac et al. study or working people with arthritis found a mean of 10.88 and a 
standard deviation of 10.06 with an overall range of 0-48 (Scale range is 0-60).   Parker et 
al. study compared groups with different kind of treatments for their depression.  One 
group received cognitive-behavioral therapy and pharmacologic treatment, another group 
participated in a psychoeducational group to serve as a control for the cognitive-
behavioral therapy and received pharmacologic treatment; another group received 
pharmacologic treatment and no therapy or psychoeducation.  All of the groups continued 
to receive their ongoing rheumatologic care.  The pre-intervention score for the three 
groups on the CES-D was 28.9, post-intervention was 14.9, at a six-month follow up was 
15.8, and at a 15 month follow up was 11.9 (Parker et al., 2003) suggesting that this 
measure reflected response to treatment.  The Cronbach's α for the current study was .91. 
Arthritis Self-Efficacy.  (Lorig, Chastain, Ung, Shoor, & Holman, 1989) Please see 
appendix D for a copy of the measure.  The Arthritis Self-Efficacy Scale (ASE) measures 
whether people feel confident in their ability to manage their pain, functionality, and 
other symptoms (including psychological symptoms).  Many autoimmune diseases have 
arthritis-type symptoms and the scale has been designed for use in individuals with 
autoimmune and musculoskeletal disorders due to the similarity in symptoms.  It has 
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been used in individuals with rheumatoid arthritis (Barlow et al., 2002), osteoarthritis 
(Hartman et al., 2000), fibromyalgia (Gowans et al., 2001) and general, non-specific 
musculoskeletal disorders (Malmgren-Olsson & Branholm, 1992).   
It is a 20-item scale that has been used with people with arthritis and arthritis-
related diseases.  Since most autoimmune diseases have impairment that is similar to 
arthritis, it was chosen for the current study.  Items are rated on a 10-point Likert scale 
ranging from 1=very uncertain to 10=very certain, with a total score ranging from 20-
200.  Higher scores indicate higher levels of self-efficacy.  No items are reverse scored.  
Subscales include the 5-item Pain Self-Efficacy (PSE) subscale (sample item: “How 
certain are you that you can decrease your pain quite a bit?”), 9-item Functional Self-
Efficacy (FSE) subscale (“How certain are you that you can walk 100 feet on flat ground 
in 20 seconds?”), and the 6-item Other Symptoms Self Efficacy (OSE) subscale (“How 
certain are you that you can manage your arthritis symptoms so that you can do the things 
you enjoy doing?”). Previous research has shown that the FSE subscale is highly 
correlated with measures of severity and symptomatology (Lorig et al., 1989).  The 
overall ASE total score was used in the current study.   
Internal consistency for the ASE has been good.  In a sample of 97 individuals 
with arthritis or arthritis-related diseases, Cronbach’s α of .75 for the PSE, .90 for the 
FSE, and .87 for the OSE were obtained (Lorig et al., 1989).  Test-retest reliability has 
also been good with .87 for the PSE, .85 for the FSE, and .90 for the OSE (Lorig et al., 
1989).  Many previous studies have omitted the FSE due to high correlations with other 
disability scales so internal consistency and test-retest reliability data are reported for the 
subscales here, though the full scale was used in the current study and that has been 
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shown to be an acceptable use of the scale as well (Lorig et al., 1989).  Validity studies 
have shown high levels of correlation between the FSE and Health Assessment 
Questionnaire (Lowe et al., 2008).  Readability and clarity of the scale have been 
adapted; creators of the ASE redesigned it so it had a 10-item Likert Scale to get a more 
complete range.  Previous piloting by the creators of the scale showed that participants 
tended to circle the labels for the numbers if they were anchored in the middle so they 
changed the design to place anchors at the end of the scales.  They recommended coding 
the lower number if two numbers were concurrently circled (Lorig et al., 1989), however, 
this was not a problem in the current study because the survey was available online and 
only one number could be selected.  The Cronbach’s α for the current study for the total 
score was .94.   
Social Measures. 
Medical Outcomes Study-Social Support Scale (Sherbourne & Stewart, 1991).  
The MOS-Social Support Survey is one part of the larger Medical Outcomes Study, 
which is a large-scale study of individuals with various medical problems.  The MOS-
SSS is made up of four subscales, which include emotional/informational support, 
tangible support, affectionate support, and positive social interaction, though a total social 
support score is determined by summing all items.  The overall scale, used in the present 
study, consists of 19 items, which participants ranked on a five point Likert scale, ranging 
from 1=None of the time to 5=All of the time.  Sample items include “Someone to 
confide in or talk to about yourself or your problems” and “Someone to help with daily 
chores if you were sick”.  Total scores can range from 19 to 95 with higher scores 
indicating more social support.   Internal consistency estimates in previous studies are 
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above 0.91 for all of the subscales and 0.97 for the overall scale and test-retest reliability 
is 0.78 for the entire scale (Sherbourne & Stewart, 1991).  The MOS-SSS has been 
widely used and has high levels of validity, showing strong correlations with indices of 
loneliness, role functioning, social activity, functional support, and marital functioning 
(Sherbourne & Stewart, 1991). 
Previous studies have used the MOS-SSS in samples of newly registered people 
with HIV/AIDS (Burgoyne & Saunders, 2000), individuals who had undergone bone 
marrow transplants (Kettman & Altmaier, 2008), and women with postpartum depression 
(Surkan et al., 2006) among others.   These studies show the consistent link between 
diminished social support and depression.  Please see appendix E for a copy of the 
measure.  The Cronbach’s α for the total scale which was used in the current study was 
.95. 
Outcome Measures. 
Positive Well-Being (Ryff, 1989).  The Scales of Psychological Well-Being 
(SPWB) are made up of different aspects of positive functioning.  There are six 
subscales, which represent self-acceptance, positive relations with others, autonomy, 
environmental mastery, purpose in life, and personal growth.  The total score is used to 
measure overall psychological well-being and was used in the current study.  Each 
subscale was equally split between positively and negatively worded items.  In the 
current study, 20 items were positively worded and 22 were negatively worded.  The 
items are scored on a six-point Likert scale ranging from 1=strongly disagree  to 
6=strongly agree with higher scores indicating higher levels of positive well-being.  Prior 
to analysis, the negatively worded items were reverse scored, such that higher scores 
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indicate increased well-being.  Total scores can range from 42 to 252.  Examples of items 
include “I enjoy making plans for the future and working to make them a reality” and “I 
have difficulty arranging my life in a way that is satisfying to me.”   
Internal consistency α coefficients for each of the six scales range from 0.82 to 
0.90 (Schmutte & Ryff, 1997).  The total scale has high internal consistency (α range 
0.86-0.93, Ryff, 1989) and test-retest reliability (α range 0.81-0.88, Ryff, 1989) and has 
been widely used in studies of positive well-being (Ryff & Singer, 1996).  The 42-item 
version of the scale was found to have enough items to support a six-item structure and 
had strong internal consistency.  Though previous studies have used scales with varying 
numbers of items, the 42-item scale (7 items on each of the 6 subscales) was chosen for 
the current study (Abbott, Ploubis, Huppert, Kuh, Wadsworth, & Croudace, 2006).  The 
total score on the SPWB has high correlations with other measures of happiness, 
satisfaction, and depression including the CES-D, Zung Depression Scale, Affect Balance 
Scale, single-item happiness measures, and Life Satisfaction Index (Ryff & Keyes, 1995).  
Please see appendix F for a copy of the scale. Cronbach’s α for the current study was .92.   
Health-Promoting Lifestyle Profile II (Walker, Sechrist, & Pender, 1987).  The 
HPLP II is a revised version of the original Health Promoting Lifestyle Profile.  It was 
revised to incorporate more recent research about health promoting behaviors and to 
accurately reflect what is known about the health benefits of different activities.  
  It is a 52-item scale that is scored on a four-point Likert scale (responses are never, 
sometimes, often, or routinely).  Items were scored so that 1=never, 2=sometimes, 3-
often, and 4=routinely.  Total scores can range from 52 to 208 with higher scores 
indicating more health promoting behavior practices such as exercising more frequently 
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and eating more fruits and vegetables.  The overall score, which was used in the present 
study, can be used as an index of health promoting behaviors and the subscales (health 
responsibility, physical activity, nutrition, spiritual growth, interpersonal relations, and 
stress management) can be used individually.  Items include things like “Choose a diet 
low in fat, saturated fat, and cholesterol” and “Take part in leisure-time (recreational) 
physical activities (such as swimming, dancing, bicycling).  
 Validity and reliability were measured in a sample of 712 adults (Walker & Hill-
Polerecky, 1996).  Construct validity has been supported by factor analyses in various 
samples that support a six-factor solution.  Cronbach’s α for the entire scale was 0.94 and 
ranged from 0.74 to 0.87 for the subscales.  Three-week retest stability was 0.89 (Walker 
& Hill-Polerecky, 1996).  High correlations with the Personal Life Questionnaire and 
other measures of quality of life and perceived health status were observed (Walker & 
Hill-Polerecky, 1996).  Please see appendix G for a sample of the items.  Cronbach’s α 
for the current study was .94. 
 Summary of Measures.  Information about the measures and their psychometric 
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 Participant Recruitment.  Participants who had been previously diagnosed with an 
autoimmune disease and were over age 18 were eligible for the study.  Participants were 
recruited through online and in-person methods.  Participants were told that they could 
enter their email address at the end of the survey to have a chance of winning one $50 
Target gift card.  One participant was selected at random and contacted via email to 
inform them that they had won the gift card, which was subsequently mailed to the 
address they provided.   
 The Arthritis Foundation of Iowa assisted in recruitment and requested an online 
survey that could be sent to potential respondents via email, list-servs, and in online 
newsletters rather than paper surveys.  Participants were also recruited from the National 
Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), at the National 
Institutes of Health (NIH) through posters placed at their clinics directing them to the 
survey website link.  
 Recruitment of participants occurred at two sites through NIAMS (Cardozo Clinic, 
located in Washington, D.C. and the National Institutes of Health main campus located in 
Bethesda, Maryland) via posted announcements of the study.  The Community Health 
Center provides health care services to individuals primarily from the Cardozo 
community that is approximately 40% African-American, 40% Latino(a), and 20% 
Caucasian and Asian-American.  The Clinical Center located in Bethesda, MD reaches an 
international population and also includes individuals from the Washington D.C. 
metropolitan community.  Participants were directed to participate in the study by posters 
placed around the clinic.  The results of the study indicate that very few participants from 
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the NIAMS clinics participated in the study because the online methods of recruitment 
were far more successful than were the posters soliciting participation.   
 Participants were also recruited through the Arthritis Foundation of Iowa.  The 
Director of the foundation requested that an online survey be made available to their 
sample because he believed that the participants would complete an online survey more 
readily than paper surveys.  Through the foundation list-servs, the director sent an email 
to 180 individuals with Rheumatoid Arthritis and invited them to participate.  The 
hyperlink to the survey was made available in the email so participants could click on the 
link and be directly connected to the survey.  The staff of the Arthritis Foundation of Iowa 
was also extremely helpful in recruiting participants.  Many of them sent personal emails 
to their friends and colleagues with Rheumatoid Arthritis or Lupus and encouraged them 
to participate.  This strategy was highly effective in getting eligible individuals to fill out 
the survey.   
 Physicians and research staff at the Mercy Arthritis Clinic in Urbandale, IA were 
helpful in previewing the survey and verifying that it would be relevant for people with 
autoimmune diseases.  The Mercy Arthritis Clinic was willing to help with recruitment 
but the other methods were successful so quickly that their population was not utilized.  
Also, due to the initial demographic bias towards white, female participants, it was 
determined that adding participants from the Mercy Arthritis Clinic would not diversify 
the sample at all.  This population is largely Caucasian and from a rural background.  
These individuals have a higher SES, on average, than the participants that were recruited 
from the Cardozo Clinic.  They received similar types of medical care as the participants 
from the NIAMS clinics but are not enrolled in other research studies.   
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 Emails were sent to the major national foundations for the most common 
autoimmune diseases.  These included the Myositis Association, National Multiple 
Sclerosis Society, Lupus Foundation of America, American Thyroid Association 
(Hypothyroidism and Hashimoto’s Disease), Celiac Disease Foundation, Sjögren’s 
Syndrome Foundation and some of the smaller regional branches of these associations.  
The National Multiple Sclerosis Society and Myositis Association responded that they 
sent out the website link to their members, and there was a large representation of those 
individuals in the final sample. 
 Finally, participants were recruited through snowball techniques through the 
researcher’s personal and professional contacts.  Friends, family members, colleagues, 
and students sent out the website hyperlink to others and encouraged them to participate.  
This was the method by which the majority of participants were recruited.  Collectors 
were set-up in Survey Monkey to differentiate among the means by which people heard 
about the survey.  This did not track IP addresses or contact information of the 
participants but was able to record the most popular recruitment methods.   
 Participants that were recruited via the internet were also given the opportunity to 
receive a paper copy in the mail or receive an email with an attachment with the survey to 
mail back in an envelope.  Five participants requested this method of survey submission.  
These individuals indicated that they were not “internet-savvy,” did not have a computer, 
or had disability that impaired with their ability to use a computer.  These participants 
were given a stamped and addressed envelope in which to mail back the survey after they 
completed it.   
 Survey Development.  The survey was created using Survey Monkey 
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(www.surveymonkey.com).  Survey Monkey is a website that is designed to help 
researchers input their survey questions directly and it formats the webpage for users.  
Some customization is available but the program has a similar format for each survey, 
which aided in the ease of survey design.  Unfortunately, Survey Monkey does not allow 
for counterbalancing of measures so all participants took the measures in the same order.   
 Participant Protocol.  After participants received the website hyperlink via email or 
after seeing it on a poster, they were directed to the specific website for this study.  The 
first page of the survey was the consent form.  Participants had to read through the 
consent form and click on a button at the bottom of the page indicating that they had read 
the entire page and agreed to participate (over age 18 and diagnosed with an autoimmune 
disease).  They were made aware of the risks and benefits of participation and that they 
could discontinue at any time.  They were also informed that the survey was anonymous 
and their responses would not be linked to their contact information or names. 
 The entire survey had a graphic at the top of the page that allowed participants to 
see how much of the survey remained (e.g. after page one, they could see that had 
completed 11% of the survey).  The survey was designed so that participants could 
always read the question prompts and item anchors, even if they scrolled down the page 
because the prompts and anchors were repeated midway through each page.  The survey 
took approximately 30 minutes to complete. 
 After the introduction and consent form, participants filled out the Arthritis Self 
Efficacy Survey, Scales of Psychological Well-Being, Medical Outcomes Survey-Social 
Support Scale, Health Promoting Lifestyle Profile II, Center for Epidemiological Studies-
Depression Scale, World Health Organization Disability Assessment Schedule, followed 
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by the demographic form which included the open ended questions.  The last page of the 
survey was the place for participants to leave their email address if they wanted to 
register for the gift card lottery.  The order of measures was chosen to alternate longer 
and shorter measures. 
 A total of 362 individuals visited the survey website and participated or perused the 
survey past the first page.  Of these, 216 individuals completed the survey, which was 
60% of the site visitors. It is important to note that health care professionals and others 
could visit the survey website so it is difficult to ascertain what percentage of those 
visiting the website actually met the criteria for participation.  A total of 22 individuals 
did not indicate a diagnosis and were eliminated from the final sample.  A total of 16 
individuals were eliminated from the final sample for having autoimmune diseases that 
were not considered connective tissue diseases or musculoskeletal type autoimmune 
diseases.  A final 3 participants were eliminated for leaving large portions of the survey 
blank (an entire measure or more), resulting in a final sample of 175 participants.   
 A hit counter was created for the various methods of distributing the survey, 
tracking participants via a different website link sent to participants from each recruiting 
source.  The website links directed participants to the same copy of the survey but 
tracking of the differential recruitment rates occurred through the different links that 
participants originally received.  This counter tallied responses after individuals clicked 
past the first page of the survey.  Posted signs at the Mercy Arthritis Clinic, NIAMS, and 
the Arthritis Foundation only generated 2 survey hits.  Emails sent to the primary 
investigator’s students generated 26 responses, snowball emails generated 217 responses, 
and emails sent to the primary investigator’s professional contacts generated 117 
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responses.  Clearly, the recruiting methods distributed to personal contacts via email were 
most effective.  Emails sent to the online support groups of the various organizations 
were linked to the snowball email collector. 
 After participants completed the surveys and demographic form, which followed 
the surveys, they were given the opportunity to enter their email address for a chance to 
win a $50 gift certificate.  Participants were made aware that this was not connected to 
their responses and was not mandatory.  Out of the 216 participants, 152 included their 
email address into the lottery.  Following that, a thank you page appeared to let 
participants know they were finished and that their participation was appreciated. 
Description of an analysis of open-ended questions. 
 To further be able to describe and explore the characteristics and experiences of the 
participants, nine open-ended questions were included in the survey and four were 
analyzed.  The five questions that were not analyzed were: “How has your autoimmune 
disease affected your ability to work?” “How has your autoimmune disease affected your 
relationships?” “What types of treatments have you received for your autoimmune 
disease(s)” and “What other health problems do you have?” and “What else would you 
like to tell us about your experience?”  These questions were not analyzed for a few 
different reasons.  In the case of the last question, very few participants answered “What 
else would you like to tell us about your experience?” and no common themes were 
found among those that did respond.  The questions about work and relationships were 
deemed too far beyond the scope of the current study and the questions about treatments 
and other health problems provided a context for the individual’s experience but it was 
determined that analyzing the type of autoimmune disease that an individual gave enough 
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qualitative background for the current study (See Table 14). 
 The questions that were chosen for analysis were: “What do you believe caused 
your autoimmune disease?”  “Have you been given a medical explanation for the cause of 
your autoimmune disease?”  “What is a positive consequence you have experienced as a 
result of having an autoimmune disease?”  and “What would affect your willingness to 
seek counseling or psychotherapy?”  The questions that were not coded were deemed 
outside the realm of the study (e.g. effects on work and relationships, other medical 
problems and treatments) and because responses to the questions were too diffuse.  The 
final question included some interesting responses but was difficult to code due to 
participants’ wide range of comments.   
 Participants’ responses to these questions were coded by three raters.  First, the 
researchers (a professor in the Counseling Psychology department and a graduate student 
in Counseling Psychology) came to consensus about the coding categories.  Then, the 
questions were rated by the graduate student researcher and two other graduate students 
in Counseling Psychology with extensive experience in qualitative research.  Inter-rater 
agreement on the three questions was calculated in SPSS using Cohen’s kappa.  This 
statistic is commonly used in qualitative research to explore inter-rater agreement and is 
designed to compare raters two at a time.  Those kappa statistics are shown in Table 5. 
Table 5: Kappa inter-rater agreement for open-ended questions 
Question Raters Kappa 
1 1-2 .95 
1 1-3 .94 
1 2-3 .94 
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2 1-2 .79 
2 1-3 .79 
2 2-3 .84 
3 1-2 .80 
3 1-3 .87 
3 2-3 .84 
 
 
 Overall, the raters had higher levels of agreement on question 1 compared to the 
other questions (“What do you believe caused your autoimmune disease?”) and lower 
levels of agreement on questions 2 (“What is a positive consequence you have 
experienced as a result of having an autoimmune disease?”)  and question 3  (“What 
would affect your willingness to seek counseling or psychotherapy?”). The average kappa 
score for all three raters on question 1 was .94, on question 2 was .81, and on question 3 
was .84.  Further description of the results of is found in the next chapter.  Kappa values 
over .61 are generally believed to acknowledge agreement while values over .80 are 
deemed very good (Landis & Koch, 1977).  Kappa values are generally higher when 
fewer categories are present, which was found in the current study because the first 
qualitative question had only five categories and a higher kappa while the other two 
questions had more categories and slightly worse inter-rater agreement.   
 Raters discussed the answers to questions in pairs when agreement was not present.  
For many questions, consensus was reached after a short deliberation among the raters.  
When raters could not agree, a fourth independent rater, unaware of the study’s 
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hypotheses, was brought in to offer another opinion.  When the fourth rater agreed with at 
least two out of three of the original raters, it was deemed that consensus was reached.   
A description of the categories that emerged from the data and summary of the results of 
the analyses conducted on the open-ended questions can be found in the results chapter.
 Further discussion of these categories can be found in chapter six.  A full 
explanation of the results is found in the following chapter.  All other results of the 








 Descriptive data for the sample were collected and are shown in the previous 
chapter (See Table 3).  The sample was predominantly female, as is typical of the 
population of individuals with autoimmune diseases although this sample’s proportion of 
females was higher than in the general population of individuals with autoimmune 
disease, mostly well-educated, and primarily white.  Autoimmune diseases are typically 
more common in women so the results of this study are not surprising.  Autoimmune 
diseases in general are also more common in whites but Systemic Lupus Erythematosis 
affects African-American and Hispanic individuals at a higher rate than other 
autoimmune diseases (www.cdc.gov, 2008).   Previous studies have found similar 
discrepancies between the number of women and men participants and the number of 
white vs. non-white participants (Barlow et al., 2002).  Some studies select only female 
participants and may not collect data on race/ethnicity (e.g. Fyrand et al., 2002; Plach, 
Heidrich & Waite, 2003). 
 Most participants in the current study were between ages 45-54 (29%) and most 
were between ages 35-64 (70%).  The sample was 90% female and 94% white/European-
American.  Overall, they were highly educated with 85% of the participants having 
completed at least a two-year college degree or some college.  Most of the participants 
had been living with their autoimmune disease for at least 5 years (61%).  There were a 
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substantial number of participants who were not working for pay (30%), but similar 
numbers who were working 21-40 hours per week (24%) and 41-60 hours per week 
(27%).  The majority of participants (119; 68%) reported that their autoimmune disease 
had not affected their ability to work.  Generally, 63.9% of the population over age 16 in 
the United States is part of the workforce, according to the results of the 2000 census 
(www.census.gov), so the results of the current study are not dramatically different than 
what would be expected to be found in the general population, although it is notable that 
a large proportion of those working in the present study were not working full-time.    
Only 71 (41%) reported that someone else in their family also had an autoimmune 
disease.   
Descriptive data is shown in Table 3 in the previous chapter.  The means, standard 
deviations, and ranges of the measures are reported in Table 7 in this chapter. In Table 8, 
the reliability data for the current study is reported.  All measures showed adequate to 
excellent reliability.  Correlations between the variables of interest are shown in Table 6 











Table 6: Correlation matrix of key variables 
 1 2 3 4 5 6 7 8 9 
1. CES-D          
2. ASE -.38**          
3. SPWB -.54** .35**        
4. SSS -.28** .17* .44**       
5. HPLP -.34** .20** .41** .40**      
6. WHO-
DAS II 
.48** -.67** -.34** -.13 -.17*     
7. Age -.19* -.08 .15* .12 .12 .04    
8. Sex -.03 .01 -.08 -.10 -.17* -.00 .14   
9. Educ -.13 .18* .06 -.04 .15 -.07 .16* .01  
10. Length -.11 .04 .20 .02 -.01 -.10 .22** -.06 .01 
Key to abbreviation in Table 6: CES-D (Center for Epidemiologic Studies-
Depression), ASE (Arthritis Self-Efficacy), SPWB (Scale of Psychological 
Well-Being), SSS (Medical Outcomes Study-Social Support Scale), HPLP 
(Health Promoting Lifestyle Profile II), WHO-DAS II (World Health 
Organization Disability Assessment Schedule II), Educ (Highest education level 
completed), Length (Length of time since diagnosis) 






Table 7: Means, standard deviations, and ranges of the measures of 
interest in the current study (N=175) 
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Table 8: Reliability data of measures for current sample 
Name of Scale Number of Items Cronbach’s α 
(current study) 
Arthritis Self-Efficacy (ASE)  20 0.94 




Social Support Scale (MOS-
SSS)  
19 0.95 
Health Promoting Lifestyle 
Profile II (HPLP II) 
52 0.94 
Center for Epidemiologic 
Studies (CES-D) 
20 0.91 
World Health Organization 






 Given the large sample size, an alpha level of 0.01 was used to determine 
statistical significance for the correlation and regression analyses. Effect sizes are 
included to provide more robust support for the findings, as called for by recent 
guidelines (e.g. Frazier, Tix & Barron, 2004).  Effect sizes will be reported throughout 
the results using the following conventions.  When r is used as the effect size indicator 
for correlations, a small effect size is r= 0.1, a medium effect size is r=0.3, and a large 
effect size is r=0.5.  When f2 is used as the effect size, convention indicates that a small 
effect size corresponds to f2=0.02, a medium effect size is f2=0.15, and a large effect size 
is f2=0.35.  Effect sizes were calculated by using Pearson correlation coefficients for the r 
values and using the following formula for f2. The effect size f2=R2/(1-R2) where R2 is the 
population squared multiple correlation.  These guidelines were established by Cohen 
(1988).   
 Missing data was a problem in the original sample of 216 respondents.  Following 
the elimination criteria for the current study, individuals who did not list a diagnosis or 
who did not have a connective tissue or musculoskeletal autoimmune disease were 
eliminated from the final sample.  Some missing data was still present in the sample of 
175 and was replaced using linear interpolation. 
Hypothesis 1:  A negative relationship will exist between disease severity and social 
support, such that the more severe the reported disease symptoms are, the lower the level 
of social support will be.   
 This hypothesis was tested by calculating a Pearson’s r correlation between the total 
score on the WHO-DAS II and the total score on the MOS-SSS. 
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 This hypothesis was not supported.  Disease severity, as measured by the WHO-
DAS II total score was not correlated with social support, as measured by the MOS-SSS.  
As indicated in Table 6, a correlation of  r=.-.13, p=.09 was found.  To evaluate this 
hypothesis in another way, a Pearson’s r correlation was calculated between the total 
score on the one-item severity item “How severe is your disease?”  and the total score on 
the MOS-SSS. This correlation was not significant (r=-.01, p=0.91). 
Hypothesis 2:  A negative relationship will exist between self-efficacy and depression, 
such that individuals with high levels of self-efficacy will show lower levels of depression.   
 This hypothesis was tested by calculating a Pearson’s r correlation between the total 
score on the ASE and the total score on the CES-D.  This hypothesis was supported.  As 
indicated in Table 6, a correlation of r=-.38, p≦.00 was observed suggesting that higher 
levels of disease self-efficacy are associated with lower levels of depression.  This level of 
correlation corresponds to a medium effect size (r>0.3).     
Tests of Research Questions 
Research Question 1:  How do biopsychosocial variables affect positive well-being in 
individuals with autoimmune diseases? 
 A linear regression analysis was used to analyze this research question.  Each of the 
biopsychosocial variables (symptomatology, depression, self-efficacy, and social support) 
was entered into the model to determine their unique contribution to positive well-being.  
Multicollinearity was first examined to determine if any of the variables should be 
omitted from the regression and it was determined that none of the variables met criteria 
for elimination.  By examining the tolerance values and variation inflation factors, 
multicollinearity was not determined to be a problem.  No tolerance values were below 
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.20 and VIF values were not above 5, so multicollinearity was not a problem.  These 
guidelines are explicated by Mansfield and Helms (1982). 
 The overall model was significant F(4,170)=28.26, p=.000.  Social support, as 
measured by the MOS-SSS, made a significant contribution to the model as shown in 
Table 9 as determined by the β weight (.55) for the MOS-SSS in the regression model.  
(R2 for MOS-SSS is .20, f2 is .25).  Depression, as measured by the CES-D also made a 
significant contribution to the model as determined by the β weight (-.94) for the CES-D 
in the regression model.  (R2 for depression is .29, f2= .41).  The overall model was 
significant and demonstrated a large effect size of f2=.67.  In other words, lower levels of 
depression and higher levels of social support were unique predictors of positive well-
being in this sample.  Disease severity and self-efficacy did not contribute significantly to 
the model.   
Table 9: Linear multiple regression analysis testing predictor variables effects on 









(constant) 160.33 14.97  10.71 .00 
ASE .09 .05 .14 1.67 .20 
SSS .55 .11 .31 4.98 .00 
CES-D -.94 .17 -.39 -5.48 .00 
WHO-DAS -.03 .12 -.03 -.29 .77 
Note: N=175, R2=.40**, effect size f2=.67 
ASE= Arthritis Self Efficacy; SSS= Social Support Scale; CES-D= Center for 
Epidemiological Studies-Depression Scale; WHO-DAS=World Health Organization-
Disability Assessment Schedule 
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Research Question 2:  How do biopsychosocial variables affect health-promoting 
behaviors in individuals with autoimmune diseases? 
 A simultaneous linear regression analysis was used to analyze this research 
question.  Each of the biopsychosocial variables (symptomatology, depression, self-
efficacy, and social support) were entered into the model to determine their unique 
contributions to the model.  Multicollinearity was first examined to determine if any of 
the variables should be omitted from the regression and it was determined that none of 
the variables met criteria for elimination.  Health-promoting behaviors were measured by 
the Health Promoting Lifestyle Profile II, which measures all health-promoting 
behaviors; it is not just limited to autoimmune diseases. 
 The overall model was significant F(4,174)=12.03, p=.000.  Social support, as 
measured by the MOS-SSS, made a significant contribution to predicting health 
promoting variables as shown in Table 10 as determined by the β weight (.33) for the 
MOS-SSS (R2=.16, f2=.19), as did depression (R2=.11, f2=.12), as measured by the CES-
D determined by the β weight (-.23).  The overall model was significant and 
demonstrated a medium effect size of f2=.28.  In other words, health promoting behaviors 
can be predicted by lower levels of depression and higher levels of social support in this 
sample.  Disease severity and self-efficacy did not contribute significantly to the model.   
Table 10: Linear multiple regression analysis testing predictor variables effects on 








(constant) 105.96 13.72  7.73 .00 
 
84 
ASE .04 .05 .08 .85 .40 
MOS .47 .10 .33 4.66 .00 
CES-D -.46 .16 -.23 -2.91 .00 
WHO-DAS .04 .11 .04 .39 .70 
Note: N=175, R2=.22**, effect size f2=.28 
ASE= Arthritis Self Efficacy; SSS= Social Support Scale; CES-D= Center for 
Epidemiological Studies-Depression Scale; WHO-DAS=World Health Organization-
Disability Assessment Schedule 
 
Research question 3:  Do psychosocial variables mediate the relationship between the 
biopsychosocial variables and positive well-being?  
Research question 3a: Does self-efficacy mediate the relationship between depression 
and positive well-being? 
 Using the methods suggested by Frazier, Tix, and Barron (2004), the mediating 
effects of self-efficacy were tested.  Frazier, Tix, and Barron (2004) explicate a checklist 
for evaluating mediation analyses.  The answers to these questions are shown in Table 11. 
 
 
Table 11: An evaluation of the criteria necessary for mediation in the current 
study (From Frazier, Tix, & Barron, 2004) 
Question from Frazier, Tix, and Barron 
(2004) 
Self-efficacy as a mediator 





Was the predictor significantly related to Yes, depression was correlated with SPWB 
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the outcome? at r=-.54** 
Was there a theoretical rationale for the 
hypothesis that the predictor causes the 
mediator?  Can mediator be changed? 
Yes, Yes Yes, Yes 
What is the “effective sample size” given 
the correlation between the predictor and 
the moderator? 
140.31 155.36 
Was relation between the mediator and 
the outcome greater than or equal to the 
relation between predictor and mediator? 
No, .41 is not greater than -
.44 (but comparable in size 
and thus will be considered) 
Yes, .55 is 
greater 
than -.37 
Were the mediators adequately reliable 
(above alpha=.90); (See Table 3) 
Yes, alpha=.94 Yes, 
alpha=.95 





For this equation: 
Depression  Self-efficacy = path a (r=-.38) 
   Self-Efficacy 
        ASE 
     a     b    
 
 
Depression     Positive Well Being 
  CES-D          SPWB 
         c 
 
86 
Self-efficacy  SPWB = path b (r=.17) 
Depression  SPWB= path c (-.54) 
Depression  Self-efficacy  SPWB= path c’ (-.47) 
 The effects of self-efficacy as a mediator were analyzed using the procedures 
described by Frazier et al. (2004) using multiple regression.  The resulting beta weights 
are shown above. 
 ASE is not a significant mediator of the relationship between depression and 
positive well-being.  According to Frazier et al. (2004), one can calculate the significance 
of the effect by multiplying the unstandardized coefficients (a and b) and dividing that by 
the standard error term (calculated using the procedures explained by Baron and Kenny, 
(1986).  The standard error term for this mediation equation is .0675.  To test for 
significance, Frazier et al. (2004, p.131) suggest multiplying a (-1.6) times b (.072) and 
dividing that by the standard error term (.0675).  That produces a z-score of the mediated 
effect.  If that number is greater than 1.96, the effect is significant at the 0.05 level.  In 
this mediation equation, that z-score is 1.71.  Thus, the mediating effects of self-efficacy 
are not significant.  In this equation c= -.54 and c’=-.47, suggesting that the relationship 
between the predictor (depression) and the outcome (spwb) is weaker when self-efficacy 
is considered as a mediator.   
 
Research question 3b: Does social support mediate the relationship between depression 
and positive well-being? 
 Using the methods suggested by Frazier, Tix, & Barron (2004), the mediating 
effects of social support were tested.  Frazier, Tix, and Barron (2004) explicate a checklist 
 
87 
for evaluating mediation analyses.  The answers to these questions are shown in Table 11 
above.   
 
For this equation: 
Depression  Self-efficacy = path a (-.38) 
Social support  SPWB = path b (.31) 
Depression  SPWB= path c (-.54) 
Depression  Social support  SPWB= path c’ (-.45) 
The effects of social support as a mediator were analyzed using the procedures 
described by Frazier et al. (2004) using multiple regression.  The resulting beta weights 
are shown above. 
Social support is a significant mediator of the relationship between depression and 
positive well-being.  Using the same procedures described above (Frazier et al., 2004 and 
Baron & Kenny, 1986), the standard error term for this mediation equation is .0359.  To 
test for significance, a (-.49) was multiplied by b (.77) and divided by the standard error 
term (.0359).  The z-score of the mediated effect was 10.52, thus it is significant at the 
.01 level, according to the guidelines set forth by Frazier et al. (2004).  
Research Question 4: How will natural groupings form among individuals with 
connective tissue autoimmune diseases on the predictor variables of interest (disease 
 
            Social Support 
      MOS-SSS 
     a     b    
 
 
Depression     Positive Well Being 
  CES-D          SPWB 
         c 
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severity, depression, arthritis self-efficacy, and social support)? 
 This question was explored using Ward’s (1963) cluster analysis method, which is a 
hierarchical clustering method that allows researchers to see how natural groupings form 
among the participants.  ANOVA analyses will be conducted after the clusters are formed 
to see if significant differences exist between the clusters of the selected variables.  
 Ward’s (1963) method was used to group the participants who had responded to all 
questions necessary for the cluster analysis (N=110).  The Ward method is included in the 
Statistical Package for the Social Sciences (version 11.0) and is a common clustering 
method used in psychology.  Clusters were constructed into branches of the most closely 
related individuals (graphically represented by a dendogram) from n-1 clusters until they 
are all linked.  In essence, the analysis begins by pairing together the two most similar 
participants, then adds new pairings, combining those pairings into clusters and 
combining clusters into increasingly larger clusters.  Thus, the clusters are created in such 
a way that within-cluster variability is minimized and between-cluster variability is 
maximized at each stage of grouping (Borgen & Barnett, 1987).   
 After analyzing the resulting dendogram and graph of squared coefficient changes 
(similar to a scree plot), a 4-cluster solution seemed was determined to best fit the data.  
The cases where data was missing from any of the measures were removed, thus the 
cluster analysis was completed with N=110 while 107 cases were removed.  This method 
for determining the number of clusters was based on the technique used by Heppner et al. 
(1994).  Tukey post-hoc comparisons were used to control for the number of tests and to 
examine the differences between means.  The results of those comparisons for the 
continuous variables included in the cluster analysis are shown in Table 13.  Comparisons 
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on other demographic variables are shown in Table 12.   
Cluster comparisons are shown graphically in Figure 1.  This figure shows how 
the four clusters differ on each of the 6 continuous variables used in the cluster analysis.  
To distinguish between the groups, clusters that differed from the mean of the sample on 
each variable by ± 0.5 Z-score (a half standard deviation) were considered different than 
the others.  In the description column in Table 12, trends are listed based on demographic 
questions that were analyzed, however, since there was a small number of individuals 
who were male and non-white, this information is just provided as an observation of the 
trends and was not analyzed statistically.   
Table 12: Tukey post-hoc comparisons between clusters on other variables 
Variable Cluster 
differences 
p value Description 
Age 2 < 4 p=.013* 4=oldest cluster 
2=youngest cluster 
Gender 3>1, 3>4 p=.049, p=.059 3=most men 
Race No significant differences 1,3=all white 
Education No significant differences 2=highest education 
level 
Length since diagnosis No significant differences 1=longest since 
diagnosis 
Therapy No significant differences 









Table 13: Means, standard deviations, and comparisons by clusters 
Name N in cluster Variable Mean (Z) SD (Z) Tukey 
comparisons 
31 ASE .51 .72 1>3, 1>4 
 SPWB 1.01 .46 1>2, 1>3,1>4 
 MOS-SSS .69 .49 1>2, 1>3 
 CES-D -.92 .40 1<2, 1<3, 1<4 




 WHODAS -.53 .79 1<3, 1<4 
37 ASE .63 .58 2>3, 2>4 
 SPWB .06 .52 2<1, 2>3, 2>4 
 MOS-SSS -.00 .80 2<1, 2>3 
 CES-D .26 .69 2>1, 2<4 




 WHODAS -.42 .69 2<3, 2<4 
22 ASE -.41 .99 3<1, 3<2 
 SPWB -1.07 .69 3<1, 3<2, 3<4 
 MOS-SSS -1.41 .81 3<1, 3<2, 3<4 
 CES-D .63 .80 3>1 





 WHODAS .61 .91 3>1, 3>2 
20 ASE -.94 .65 4<1, 4<2 
 SPWB -.58 .71 4<1, 4<2, 4>3 
 MOS-SSS .30 .59 4>3 
 CES-D .80 .91 4>1, 4>2 

























Figure 1: Graphical Representation of Four Cluster Solution 
 
 
ASE=Arthritis Self Efficacy 
SPWB=Scales of Psychological Well-Being 
MOS=Medical Outcomes Study-Social Support Scale 
CESD=Center for Epidemiologic Studies-Depression Scale 
HPLP=Health Promoting Lifestyle Profile II 

























 Participants in Cluster One (N=31) had higher levels of self-efficacy, higher 
levels of positive well-being, higher scores on social support, lower levels of depression, 
higher levels of health promoting behaviors, and lower disease severity than the other 
clusters.  Participants in cluster one had been diagnosed for the longest period of time.  
All of the members of cluster one were white.  Cluster One is named the Healthy 
Exemplars. 
 Participants in Cluster Two (N=37) had higher levels of self-efficacy (the highest 
of all of the clusters) but moderate levels of all other variables.  Cluster Two is the 
youngest cluster and has the highest education level.  They reported the least severe 
autoimmune disease in the one-item measure.  Cluster Two is named the Efficacious 
Managers.  They differ from Cluster One, the Healthy Exemplars, because they have 
even higher levels of self-efficacy without the low levels of disease severity and 
depression that was notable in Cluster One.   
 Participants in Cluster Three (N=22) had very low levels of positive well-being, 
lower levels of social support, and lower levels of healthy behaviors, higher levels of 
depression and disease severity, and moderate to low levels of self-efficacy, compared to 
the other clusters.  Cluster three had more men than any of the other clusters.  All of the 
members of cluster three were white.  Cluster Three is named the Maladjusted Unwell. 
 Participants in Cluster Four (N=20) had moderate scores on all of the variables.  
They did not meet any of the cut-off scores (.5 Z-score above or below the mean).  
Cluster 4 is also the oldest cluster and reported the most severe levels of autoimmune 
diseases on the one-item measure.  Cluster Four is named the Impervious Moderates. 
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 External variable ANOVAs.  Clusters were compared on other variables to see if 
significant differences existed between clusters.  One way ANOVAs were conducted on 
continuous (or nearly continuous variables) to further examine the differences between 
the clusters.  Some significant differences emerged on the demographic variables.  Age: 
F(3, 102)=4.27, p=.007; and severity (as measured by the one item demographic 
question): F(3, 101)=7.95, p=.000.  Other demographic variables were not significant 
between clusters.  Tukey HSD post-hoc analysis revealed that there were significant 
differences between clusters (See Table 12).   
 
Additional Analyses. 
ANOVA differences on continuous variables. 
To provide a better description of the sample, the participants were compared on 
their demographic variables (age, gender, race, length of time since diagnosis, and 
education levels) using One Way ANOVAs.  The groups did not differ significantly by 
age on their levels of social support, health promoting behaviors, overall disease severity, 
positive well-being, or level of depression.  They were significantly different on levels of 
self-efficacy F(6,172)=3.61, p=0.002.  This suggests that the older a participant was, the 
less efficacious they felt about their ability to manage their disease.   
 When participants were compared on all of the continuous variables by gender, 
they did not differ by gender on levels of social support, self-efficacy, overall disease 
severity, positive well-being, or level of depression.  They were significantly different on 
the overall HPLP-II score, suggesting that women are far more likely than men to engage 
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in health promoting behaviors F(1,151)=14.89, p=0.000, r=.30, indicating a medium 
effect size.   
 Due to the small number of participants from racial/ethnic backgrounds other than 
white/European-American, the continuous variables were compared between white vs. 
non-white participants.  The only significant difference that emerged was on social 
support F (1,179)=12.52, p=0.001, r=.26 indicating a small effect size.  This suggests that 
participants who were white had somewhat more social support than the non-white 
participants.   
 No significant differences emerged when participants were compared on how 
long ago they were diagnosed, suggesting that the length of time since diagnosis is not a 
key factor in determining how well someone is functioning.  No significant differences 
emerged on education level but a trend was observed that participants who had completed 
a higher level of education reported more social support, F(8, 180)=2.32, p=0.020, r=.11 
indicating a small effect size. 
 The autoimmune diseases with the most representation were Multiple Sclerosis 
and Rheumatoid Arthritis.  Many other participants had Myositis or Systemic Lupus 
Erythematosus.  There were many other autoimmune diseases with fewer representative 
participants.  These results roughly correspond to the general population, though there 
were more individuals with Myositis that participated than in the general population.  
This may be due to the responsiveness of the Myositis Association and their publicity of 
the survey.  Also, many individuals with Myositis responded that they had not had an 
opportunity to participate in research, so they were enthusiastic about their participation.  
It is also interesting to note that many of the participants had more than one autoimmune 
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disease.  The individuals that were included in this category in Table 14 had to list 
multiple autoimmune diseases, not just multiple types of chronic illness.  For example, a 
few individuals listed an autoimmune disease and breast cancer and they were not 
included in the “multiple” category.  Please note that the total number of participants 
included in the analysis was 175, however the percentages in Table 14 do not add to 100 
due to some individuals citing multiple autoimmune diseases. 
Description of the sample 
 Some results of the primary analyses did not support the hypotheses, especially 
when disease specific factors were part of the hypothesis or research question.  The 
disease-specific variables included in this study were disease severity and arthritis self-
efficacy.  The other variables (health-promoting behaviors, depression, social support, 
and well-being) were not unique measures for this population.  Results including the 
autoimmune-specific variables were not significant.  For example, disease severity and 
arthritis self-efficacy did not add a significant contribution to the regression models and 
arthritis self-efficacy was not a significant mediator of the relationship between 
depression and well-being.  Overall, the results of the current study did not differentiate 
this population of individuals with autoimmune diseases from other populations with 
chronic illness.  The sample seemed to report higher levels of social support and lower 
levels of depression than previous studies of individuals with autoimmune diseases.  
Because of these unexpected differences, further analyses were conducted to describe the 
sample on their reported levels of depression and social support. 
 Very few studies have focused on the psychosocial impact of autoimmune 
diseases so some of the unique aspects of the current sample will be described in this 
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section.  Some findings will be briefly discussed in order to supplement the paucity of 
psychosocial information that is available about individuals with autoimmune diseases.  
Most research on autoimmune diseases have focused on one individual diseases (e.g. 
Rheumatoid arthritis (e.g. Covic et al., 2007) or Multiple Sclerosis (e.g. Mohr et al., 
1999)) but this background information is provided here to aid in understanding the 
larger population of individuals with autoimmune diseases and the context of the results 
of the current study. 
Table 14: Types of autoimmune diseases in current sample 
Type N Percent 
Multiple Sclerosis 42 24% 
Rheumatoid Arthritis 42 24% 
Myositis (Includes Polymyositis, Dermatomyositis, Inclusion Body 
Myositis) 
33 19% 
Systemic Lupus Erythematosus 27 15% 
Fibromyalgia 7 4% 
Mixed Connective Tissue Disease (MCTD) 4 2% 
Graves’ Disease 4 2% 
Sjögren’s Syndrome 3 2% 
Hashimoto’s Disease 3 2% 
Vasculitis 3 2% 
Psoriasis/Psoriatic Arthritis 3 2% 
Gout 2 1% 
Chronic Inflammatory Demyelinating Polyneuropathy 2 1% 
Pernicious Anemia 2 1% 
Antiphospholipid Antibody Syndrome 2 1% 
Scleroderma 2 1% 
Meinere’s Disease, Primary Biliary Cirrhosis, Myofascial Pain 
Syndrome, Reynaud’s Disease, CVID, Lyme’s Disease, Crohn’s 
Disease, Polymyalgia rheumatica, Ankylosing Spondylitis 
1 ea .5% 
Undetermined/Undifferentiated 3 2% 
Multiple Diseases 18 10% 
Other 3 1.4% 
Total 175  






Analyses of qualitative data. 
 There were three qualitative questions that were also analyzed for this project to 
get a better understanding of the experience of the participants.  Each question was 
categorized by the primary investigators (this author and a Counseling Psychology 
faculty member) by discussing refinements to the categories until consensus was reached.  
Next, three independent coders rated each question.  Inter-rater agreement was measured 
using Cohen’s kappa scores and those were reported in the previous chapter in Table 5.  
A more detailed explanation of the methods used in the qualitative analysis is described 
in the previous chapter.  A total of 5 categories were developed for the first question, 8 
for the second question, and 7 for the third question.  A description of the categories as 
well as the number of participants placed in each category by the three raters is found in 
table 15.   
 For the first question, the causality question, five categories emerged from the data.  
The percentage of respondents endorsing each category are presented in Table 15 in the 
following chapter.  Findings are discussed further in the Discussion chapter.  The first 
category was related to genetics and included responses like “heredity,” comments about 
the illnesses running in their family, or mentioning a specific family member with the 
disease.  The second category was entitled “physical stress” and included attributions like 
viruses, bacteria, toxins, pregnancy, other illnesses, and exposure to certain 
environmental triggers.  It also included individuals who mentioned that where they lived 
(e.g. Pacific Northwest or Midwest) and having a lack of sunlight affected them getting 
their disease.  The third category was emotional stress and included responses that were 
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limited to “stress” or when participants mentioned other types of emotional stressors or 
psychological distress.  It also included individuals who indicated that “overworking” 
caused their disease.  The fourth category was reactions to medications or vaccines.  
Participants who indicated a specific medication or vaccine that they took, mentioned 
drug abuse, flu shots, antibiotics, or “statin” drugs fell into this category.  A response that 
was observed multiple times in this category was “Statin cholesterol-reducing 
medications” or “Lipitor”.  Finally, participants who indicated that they did not know 
what caused their disease were in category five.  Participants who left the question blank 
were coded as missing.   
 As a follow up to the first open-ended question, another open-ended question was 
asked about whether participants had received a medical explanation for the cause of 
their disease.  Most of the respondents indicated simply “yes” or “no” in response to this 
question so it was determined that involving multiple coders for this question was not 
necessary, thus, it was coded solely by the primary investigator.  The categories that 
emerged for this question were: yes, without a response given; no or don’t know; 
genetics; physical causes like a bacteria, virus, or environmental exposure; and emotional 
stress.  Participants who left the question blank were coded as missing. 
 For the second question about positive consequences, eight categories emerged 
from the data.  The first category was personal growth and included responses about 
increased positive personal characteristics of any sort, self-efficacy or determination, 
patience, or the ability to rely on one’s self.  This category did not include responses 
about growth as it related to other people or growth around learning more about the 
disease.  The second category was related to helping others with autoimmune diseases.  
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Many participants indicated that they were more sympathetic towards others with 
autoimmune diseases or having the disease helped them relate better to other people.  
They indicated an increased motivation to give back or help others.  This category was 
disease-specific and did not include overall social support.  The third category was re-
evaluating one’s priorities and included individuals who wrote about having a greater 
appreciation of life or learning about what was important to them.  The fourth category 
was awareness of self-care and the body’s limits and included discussions of being more 
able to say “no,” ability to take care of one’s body (including diet changes and exercise 
changes), the ability to ask for help, and other comments related to setting boundaries and 
taking care of one’s self.  The fifth category was social support and included mentioning 
specific individuals that respondents felt closer to as well as indicating disease support-
groups or online communities as beneficial consequences of their diagnosis.  The sixth 
category was religious/spiritual beliefs and included comments like “Becoming closer to 
God”.  The seventh category was all other responses.  Some individuals indicated that a 
positive benefit was getting out of things (e.g. the military, carrying heavy things, 
physical labor) and these responses were included here.  Finally, the last category was 
none/don’t know.  This category included all people who responded that they didn’t know 
or were not able to think of any positive benefits.  Participants who left the question 
blank were coded as missing. 
 For the third question about willingness to seek counseling, seven categories 
emerged from the data.  The first category was responses that indicated the participant 
was currently in therapy or had been previously and had positive views of therapy.  The 
second category included responses that pointed to characteristics of a potential therapist 
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or therapy in general.  This included comments about not being able to access specific 
types of therapy in their location, looking for a specific theoretical orientation, looking 
for a Christian therapist, being worried that taking another pill would not be helpful, and 
wanting to work with someone who could understand having a chronic illness because 
they had “walked in their shoes”.  Others indicated familiarity with the process of therapy 
and gave well-articulated reasons for not wanting to seek therapy (e.g. not wanting to talk 
about their emotions).  The third category was worsened symptoms.  These participants 
indicated that they would seek therapy if they became more depressed or suicidal, if their 
physical symptoms worsened or became terminal, if family members encouraged them to 
go, or if their distress was affecting their relationships.  The fourth category was if barrier 
removal.  The most common barriers were related to cost, transportation, time, and 
mobility.  The fifth category was at the suggestion of medical professionals.  The 
presence of this category indicates that participants trusted their doctors to direct them to 
psychotherapy if necessary.  The sixth category was responses that indicated that 
participants did not believe it was necessary for them to seek therapy at this time.  It 
conveyed a general willingness to go to therapy if they needed to in the future.  Also, 
respondents who were coded in the sixth category conveyed an openness to therapy and 
did not make negative statements about their likelihood of seeking therapy.  Finally, the 
last category was if participants were not interested or conveyed that no factors would 
change their adamancy that they would not seek therapy.  Respondents who indicated 
“nothing” were also put into this category.  Though, “nothing” could have multiple 
meanings in the context of this question, it was impossible to determine the intended 
meaning of “nothing,” so the participants who stated it were grouped with the seventh 
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category.  Participants who left the question blank were coded as missing. 
 One Way ANOVAs were conducted on some of the open-ended questions for 
further analysis.  On the positive consequence question, participants were grouped into 
two categories based on the benefit they indicated.  Individuals who responded with a 
benefit that was not related to personal growth were grouped together.  These included 
the groups that stated that a benefit was increased awareness of the disorder or a desire to 
help others since these categories were very disease-specific, that they had learned the 
importance of self-care which were focused on exercise and diet, other, none, or had 
missing data.  These were categorized together since it was judged that they had not 
determined a significant positive and personal consequence of their disorder.  Individuals 
who responded with a significant personal quality, that they had re-evaluated their life 
priorities, gained social support, or increased religious or spiritual benefits were grouped 
in the other category.  These two groups were compared, using ANOVAs on depression, 
well-being, and social support.  No significant difference emerged between the two 
groups.  Depression: F (1, 186)=.726, p=.395; Overall well-being: F (1, 172)=.372, 
p=.543; Social Support: F (1, 196)=1.279, p=.259.  
 Further analysis was conducted on individuals who had been given a medical 
explanation versus those who had not.  Individuals who answered that they had not 
received a cause from a medical professional were in one category and all other responses 
were in another category.  One way ANOVAs were conducted on these cases to determine 
if there were any differences between the groups on depression, well-being, health 
promoting behaviors, or disease severity.  No significant effects were found.  Depression: 
F(1, 185)=.103, p=.749; Well-being: F(1,171)=.073, p=.787; Health promoting behaviors: 
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F(1, 163)=.324, p=.570; Disease severity: F(1,124)=1.511, p=.221. 
 A more extensive description of what fell into each category was discussed in the 
Methods chapter.  Overall, participants reported many causes of their disease, some 
interesting positive consequences, and a variety of reasons why they would or would not 
seek psychotherapy.  A further discussion of these results is found in the following 
chapter.   
Participants were also asked if they had received a medical explanation for their 
disorder.  The answers to this question were coded by the graduate student researcher.  
An overwhelming majority of the participants had not received a medical explanation for 
the cause of their disease, indicated that the did not know, or stated that they were told 
that there was no known cause.  132 participants, or 61.1% responded in this way.  
Another 33 left this question blank (15.3%).  Some 29 (13.4%) of the participants just 
indicated “yes” but did not elaborate on the given cause of the disorder.  The remaining 
participants explicated the medical cause that was told to them with 9 (4.2%) stating that 
it was due to genetics, 8 (3.7%) indicating that it was from a toxin, bacteria, or virus, 5 
(2.3%) claiming it was due to emotional stress or overworking.  Taken together, only 51 
(23.6%) had been given any kind of medical explanation for the cause of their disease, 
yet 121 (56.0%) indicated a personal belief that a particular attribution was responsible 




Table 15: Responses to the qualitative questions 
Description of category Number of 
participants  
% of sample 
Question 1: “What do you believe caused your autoimmune disease?”  
Missing 37 17.1% 
Genetics/Heredity 39 18.1% 
Physical stress (bacteria, virus, environmental exposure) 42 19.4% 
Emotional stress/overworking 26 12.0% 
Reactions to medications or vaccines 14 6.5% 
Don’t know 58 26.9% 
Question 2: “What is a positive consequence you have experienced as a result of having 
an autoimmune disease?” 
Missing 41 19.0% 
Personal growth 23 10.6% 
Helping others with autoimmune diseases 24 11.1% 
Re-evaluating one’s priorities 23 10.6% 
Awareness of self-care and body’s limits 30 13.9% 
Social support 26 12.0% 
Religious/spiritual beliefs 12 5.5% 
Other (e.g. getting out of things) 6 2.8% 
None/Don’t know 31 14.4% 
Question 3: “What would affect your willingness to seek counseling or psychotherapy?” 
Missing 53 24.5% 
Currently in therapy/positive views 5 2.3% 
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Characteristics of therapist/therapy 21 9.7% 
Symptoms worsen 17 7.9% 
Barriers removed (e.g. cost, transportation, time) 47 21.8% 
Medical personnel suggest it 2 0.9% 
Don’t need it but willing if situation changes 37 17.1% 
Not interested/don’t believe it would help 34 15.7% 
 
 
Summary of Findings. 
 A few of the findings will be highlighted here with more discussion to follow in 
the next chapter.  First, it was found that disease severity and social support are not 
related, suggesting that an individuals’ ability to access and utilize social support is 
unrelated to the severity of their autoimmune disease.   
 Second, a significant relationship was found between self-efficacy and depression 
suggesting that individuals who believe they can handle the consequences of their disease 
report lower depression or individuals with lower depression believe they can handle the 
consequences of their disease.  
 Third, it was found that depression and social support predict both positive well-
being and health promoting behaviors.  Depression and social support added significant 
contributions to the regression model predicting well-being and healthy behaviors.  Self-
efficacy and disease severity did not add significant contributions to this model.  It was 
found that self-efficacy does not mediate the relationship between depression and 
positive well-being but social support does. 
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 Fourth, a cluster analysis revealed four different clusters that react to their 
autoimmune disease in four different ways.  The cluster analysis showed that people may 
react really well to their disease, like the Healthy Exemplars, or they may react really 
poorly, like the Maladjusted Unwell.  It also showed that individuals may still have high 
levels of arthritis self-efficacy with moderate to low levels of the other biopsychosocial 
variables.  Specifically, the first cluster, the Healthy Exemplars, do everything right, as 
their name indicates.  They engage in high levels of health promoting behaviors, have 
high self-efficacy and positive well-being, low levels of depression and disease severity, 
and high levels of social support.  They could be considered a model of how to cope with 
an autoimmune disease.  Second, the Efficacious Managers, were significant based on 
their high levels of self-efficacy without any other significant variables.  Third, the 
Maladjusted Unwell, reacted exactly the opposite as the Healthy Examplars of cluster 
one.  They had very low-levels of positive well-being, not a lot of social support, low 
self-efficacy and healthy behaviors, and high levels of depression and disease severity.  
In effect, they did everything wrong in coping with their autoimmune disease.  Finally, 
cluster four had moderate scores on all of the variables, which could suggest that having 
an autoimmune disease had not changed their ways of reacting to the world or that they 
had already integrated their autoimmune disease into their identity.  The cluster analysis 
suggests that, in general, people may react strongly favorably, strongly unfavorably, or 
not at all to their autoimmune disease.  The variables that predict these reactions will be 
discussed more in the following chapter. 
 Finally, qualitative data for three open-ended questions were analyzed by three 
independent raters.  These results will be explored in more detail in the following chapter.  
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In addition, a discussion of how these results compare to the results of previous studies 







 This study was designed to explore the role of biopsychosocial variables in 
affecting well-being and health promoting behaviors in individuals with autoimmune 
diseases.  Another purpose was to further explore the psychosocial health of these 
individuals and determine if there are factors that define living with an autoimmune 
disease.  Because there has been little research on the psychosocial health of people 
living with autoimmune diseases, it was hoped that this study would lay the groundwork 
for future studies research in this area. 
 This chapter will begin with a discussion of the results of the research questions, 
hypotheses, and additional analyses.  Limitations of the study, implications for research 
and practice, conclusions, and other reflections on the study will then be discussed. 
Overall summary of results. 
 There were three overarching findings of the current study that are worth 
highlighting to frame the discussion.  First, only depression and social support, 
representing psychological and social aspects of the biopsychosocial model, uniquely 
predicted positive well-being and healthy behaviors whereas disease severity (biomedical 
variable) did not, when all three components of the model were considered together.  
Previous studies have also shown depression and social support to predict well-being in 
other chronically ill populations (e.g., Kettman & Altmaier, 2008) but it was 
hypothesized that the demographic and biological variables in the current study would 
predict well-being, which was not found.  Previous studies have consistently found links 
between disease severity and well-being, so the finding from the current study is an 
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anomaly (Westbrook & Nordholm, 1986, Barsky et al., 1999; Mangelli et al., 2002).  As 
discussed later in the chapter, variation on how disease severity was measured in the 
current study as well as the variety of disorders that were represented may partially 
explain this unexpected result.   
 Second, a cluster analysis was conducted in the current study and it was found that 
individuals with autoimmune diseases form natural groupings based on their data that 
provide additional information about how biopsychosocial factors covary with this 
disease.  For example, one group of participants reported lower levels of physical, 
psychological, and social distress across the selected variables while another group 
reported consistently higher levels of distress.  A third group reported moderate levels of 
all of the biopsychosocial variables of interest.  Thus, we can conclude that reactions to 
autoimmune diseases can take many forms and reported levels of negative symptoms 
tend to show some uniformity in terms of being low, medium, or high.   
 Third, the sample in the current study reported slightly higher psychosocial 
functioning than expected based on previous studies on similar populations.  Contrary to 
expectations, much of this sample reported levels of depression that did not meet the cut-
off for clinical depression.  This was surprising because previous studies have shown 
higher rates of clinical depression in populations with autoimmune diseases than found in 
this sample (e.g. Mangelli et al., 2002, Nagyova et al., 2005).  Unfortunately, though, 
many participants did report levels of depression that would meet clinical criteria and the 
overall rate of depression was still higher than what has been found in the general 
population.  Approximately 42% of this sample reported clinical levels of depression, 
whereas only 5-10% of the general population would qualify for clinical depression at 
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any point in time and 16% will be depressed at some point during their lifetime with 
higher levels expected for women (Kessler et al., 2003).  It is clear that depression is still 
an issue for individuals with autoimmune diseases.  
 The sample also appeared to have higher levels of social support than reported by 
previous studies conducted on individuals with autoimmune diseases, which have 
typically concluded that social support and social networks are negatively affected after 
autoimmune diagnoses (Fyrand et al., 2000; Fyrand et al., 2001; Fyrand et al., 2002; 
Evers et al., 1998). Based on the lower than expected levels of distress found in the 
present study, as compared to what was expected based on the findings of previous 
studies, it might be that there are characteristics of the present sample  that differ from 
previous samples of this population.  Relationships between the variables of interest will 
be explored more in a discussion of the results. 
Discussion of Results: Hypotheses 
Hypothesis One 
 It was hypothesized that there would be a negative relationship between disease 
severity and social support.  Contrary to the hypothesis, disease severity and social 
support were not correlated.  Previous studies found that the longer people had been 
diagnosed with an autoimmune disease, the less social support they reported (Fyrand et 
al., 2002).  Typically, greater lengths of time since diagnosis are associated with 
worsened severity, however length and severity are not always the same construct.  
Disease severity and longer disease length were also related to smaller social networks 
(an important component of social support) and decreased quality of social support 
(Fyrand et al., 2000; Fyrand et al., 2001).   
 
110 
 The current findings may be explained by a number of factors.  First, a wide range 
of diseases were represented in the current study.  Though they were all similar in that 
they were classified under the general umbrella diagnosis of autoimmune diseases, with 
some commonality among symptoms, perhaps the variation in diseases might explain 
why this hypothesis was not supported.  The previous studies were conducted primarily 
on groups of individuals with rheumatoid arthritis, while the current sample was 
comprised of individuals who had many different diagnoses.  It is possible that current 
respondents had a wider range of symptoms than previous studies and may not respond to 
their social support networks in the same ways.  For example, individuals with 
gastrointestinal autoimmune diseases may be able to manage their symptoms more 
consistently than individuals with significant pain or deformity from a connective tissue 
autoimmune disease so that social plans are not as disrupted due to disease symptoms. 
 The current finding may also be due to the measurement methods chosen since 
previous studies used different tests of social support.  Since the Medical Outcomes 
Study-Social Support Scale examines social support from a variety of perspectives, as 
long as participants had social support that was positive in one area (e.g. supportive 
spouse but no close friends), they could score highly on the scale.  People may report 
high levels of support if they became closer to a few significant people in their lives, even 
if they were more distanced from friends and acquaintances.   This quote from a 
participant illustrates this point.  
I don't share my illness with many people outside my husband and children.  I look 
so fit, hail and hearty--even when I am not.  People don't want to hear about it.  
They don't believe I am ill.  So why share.  Most people who I have shared with act 
like I am putting on an act.  My husband and children can tell when I am well and 
they know when I am not.  I don't have many friends--friends take time and effort.  
There are times when I sleep 12 hours a day for a few months.  It is hard to 
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maintain friendships when you "drop out" for months over and over again.  I really 
try to concentrate on what is most important relationship-wise...I don't have a huge 
amount of energy to give to relationships so I choose to concentrate what I have on 
only the most important people--my husband, children, a special nephew, my 
brothers.  Others I deal with only as much as necessary--including my sister, aunt, 
cousins, old friends. 
 
 Overall, this participant scored highly on the MOS-SSS, even though she had high 
levels of physical impairment and felt more distant from her friends through the disease 
process.  She shared that she became closer to her immediate family but more isolated 
from friends.  She chose to focus her limited energy on relationships that mattered the 
most to her, which still gave her a high level of social support.  Measuring social support 
using the MOS-SSS in the current study might have contributed to higher scores for the 
sample if many participants had areas of both strength and weakness in their social 
support networks to which other inventories may have been more sensitive. 
 Another explanation for these results might be related to other mediators or 
moderators between physical health and social support.  For example, Plach, Heidrich, 
and Waite (2003) found that role quality was a mediator of the relationship between 
physical health and social support.  They surveyed women with rheumatoid arthritis and 
found that women in poor health reporting high role quality were less depressed than 
women reporting a poor role quality.  Another result of the Plach et al. study was that 
women with high levels of pain along with high role quality had more purpose in life than 
corresponding women with high levels of pain and low role quality.  Regardless of 
physical health status, role quality had a significant impact on psychological well-being.  
Like the participant who was quoted above saying that she chose to spend time with 
people close to her who could understand her situation, the results of the Plach, Heidrich, 
and Waite (2003) study suggest that the relationship between disease severity and social 
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support may be more complicated than hypothesized.   
 It is possible that the current sample had higher levels of social support compared to 
previous samples, but quotes from participants indicated that social support was still an 
area of concern for many of the participants.  Many individuals wrote about how others 
did not understand what they were going through, suggesting that there may be 
something other than the biomedical factors of the disease itself that affect the 
relationship between disease severity and social support.  For example, quality of social 
support may be related to having close friends understand the full experience of one’s 
struggles in life including chronic illness.  In the process of recruiting participants, I 
received over 40 questions via email asking if a certain kind of disease that a friend had 
qualified as an autoimmune disease or not.  This suggests that at the same time that 
friends and acquaintances may be aware that a friend or family member has some type of 
an autoimmune disease and may find it easy to pass on information, they may not be 
aware of the details of the disease like others who were more closely connected to the 
individual or who are more knowledgeable about the disease.  It is possible that people 
with autoimmune diseases share the intimate details of their disease only with people in 
their inner circle, so most friends and some relatives may not have an accurate perception 
of the disease process.  
 Two quotes from participants illustrate the possibility that individuals may not 
share the full experience of their disease with friends.  For example, “[My disease is…] 
often a lonely, frustrating journey. Since RA is experienced differently by everyone, there 
is not one path to follow. So visiting with others with the disease can often be scary, if 
someone is more disabled, or dismissed if not as serious as my RA.” This idea is also 
 
113 
supported by quotes like “[In my family] we focus on the positives.  Friends: It is hard for 
people who have not experienced chronic illness to really ‘get it’.  I don't look sick so it 
can be hard to understand my lack of energy, my need to pick and choose the things I 
spend my energy on - from the outside it looks like laziness I'm sure.” 
 Technological advances have also changed the way that individuals can receive 
social support.  Online support groups, reference websites, emails, and cell phones may 
have increased access to social support for individuals whose autoimmune disease has 
left them housebound.  Previous studies that showed that increased disability was 
associated with decreased social support were conducted before the widespread use of 
technology-aided forms of social support.  In addition, since the survey was conducted 
online, the current sample may have been even more likely to access support through 
newer, high-tech forums. 
 The finding that disease severity and social support were not correlated in the 
present study does not support Fyrand et al. (2002)’s study, which showed that 
individuals who had rheumatoid arthritis for a longer period of time reported less social 
support.  Though longevity and severity are correlated, the current study examined 
disease functionality rather than disease longevity, which also may partially explain the 
difference between these findings and the Fyrand et al. (2002) study.  The WHO-DAS II 
investigated impact of disability on functionality and may not have been the best measure 
of disease severity.    
 Overall, social support may be based on a number of individual factors rather than 
anything that can be generalized across individuals with autoimmune diseases.  Future 
research should explore the relationship between disease severity and social support to 
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clarify the complexities that may be unique to living with an autoimmune disease.  
Hypothesis Two 
 The second hypothesis predicted that there would be a negative relationship 
between self-efficacy and depression.  This hypothesis was supported, suggesting that 
individuals with higher levels of disease self-efficacy had lower levels of depression.  
This finding suggests that perceived depression is related to how well individuals believe 
they can manage their disease.  Further analyses revealed that self-efficacy was correlated 
with disease severity, suggesting that people viewed their ability to manage their disease 
relative to their perceived disease severity.  In other words, higher levels of disease 
severity were related to lower levels of perceived disease self-efficacy and this 
relationship was demonstrated with a medium effect size. 
 These results support the findings of Barlow, Cullen, and Rowe (2002), who found 
that psychological health was correlated with self-efficacy and physical health status was 
also correlated with self-efficacy in a sample of individuals with rheumatoid arthritis.  
Previous studies have examined the important link between self-efficacy and well-being, 
depression, and performance in a variety of settings.  
 The connection between self-efficacy and depression has been strongly supported 
in other samples of people with chronic illness.  Orengo et al. (2001) found that 
psychosocial factors like depression and self-efficacy were highly correlated and 
contributed to disability in individuals with rheumatoid arthritis.  Using a regression 
model, pain, depression, and self-efficacy accounted for 67% of the variance in predicted 
disability status.  Unlike the current study, pain added a significant contribution to the 
regression model.  The relationship between self-efficacy and depression has been widely 
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studied in individuals with rheumatoid arthritis, more than other autoimmune diseases.   
 Evidence suggests that this relationship holds important promise for increasing 
overall well-being and has the potential for beneficial interventions.  The relationship 
between self-efficacy and depression has been evaluated in some studies including Smarr 
et al. (1997) where an intervention designed to improve stress management and self-
efficacy was successful in raising scores on depression and self-efficacy measures in 
individuals with RA and showed relevance to other clinically important measures of 
disease severity (Smarr et al., 1997).  The general effects of self-efficacy have been found 
in pain management as well, such that higher self-efficacy for managing pain is 
associated with less disability and depression and use of better pain coping strategies 
(Turner et al., 2005). 
 Though previous studies have also found similar results as the current study, Lowe 
et al. (2008) pointed out that self-efficacy can be a factor that is variable in terms of how 
it affects outcomes for different individuals.  For some, self-efficacy contributes to more 
effective coping mechanisms, but for others, self-efficacy does not seem to translate to 
coping.  Lowe et al. also suggested that self-efficacy might be related to the manner in 
which cognitive coping strategies are implemented.  Specifically, they found that the 
relationship between coping and emotional outcome variables differed according to 
global self-efficacy appraisals (Lowe et al., 2008).  Though depression and self-efficacy 
have been consistently shown to be associated with one another, the relationship between 
depression and self-efficacy is complex and holds promise for many other studies on the 
impact of these psychological variables in chronic illness. 
 The relationship between self-efficacy and other variables was explored in further 
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analyses to examine the potential mediating effects of self-efficacy.  These results will be 
discussed later in this chapter.   
Discussion of Results: Research Questions 
Research Questions One and Two 
 The first research question investigated how biopsychosocial variables affect 
positive well-being in individuals with autoimmune diseases.  The second research 
question examined these same variables’ effect on health-promoting behaviors.  The 
biopsychosocial variables that were examined as predictors were disease severity 
(biological variable), depression (psychological variable), arthritis self-efficacy 
(psychological variable) and social support (social variable).  For both Research Question 
1 and Research Question 2, depression and social support were the only variables that 
were unique predictors of positive well-being and general health promoting behaviors.  
This suggests that higher levels of social support and lower levels of depression may be 
more important than perceived pain or disease severity in predicting overall outcome 
variables like well-being and health-promoting behaviors.  Disease severity and self-
efficacy did not uniquely predict either well-being or health promoting behaviors.  The 
results for both research questions were similar so an overview of each predictor variable 
will be discussed briefly followed by a discussion of the separate outcomes of each 
regression analysis. 
 Previous studies have found that depression and social support are the most 
meaningful contributors to predicting outcome variables such as well-being for 
individuals with chronic disease.  The findings of the present study support these 
previous findings.  For example, Kettman and Altmaier (2008) found that social support 
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was the most important predictor of depression in individuals who had undergone a bone 
marrow transplant.  Social support (as measured by the MOS-SSS) before the transplant 
predicted depression after the transplant (as measured by the CES-D), even more 
accurately than pre-transplant levels of depression (Kettman & Altmaier, 2008).  The 
predictive validity of depression and social support in predicting well-being and health-
promoting behaviors in the current study as well as post-transplant levels of depression in 
the Kettman and Altmaier (2008) study suggest that psychosocial variables may be even 
more important than biomedical variables in understanding the experience of living with 
a chronic illness.  
 Although studies like Mangelli et al. (2002), Barsky et al. (1999), and Westbrook 
and Nordholm (1986) also found significant relationships between depression, well-
being, and social support, unlike the present study, they also found that biomedical 
measures of disease severity were significant predictors.  However, it is important to note 
that these studies used clinician ratings and blood samples to indicate disease severity.   
The results of the current study differ from these studies because disease severity was not 
a significant predictor of well-being or general health promoting behaviors.   
 The broad range of diseases that was included in the current study and the 
measurement of disability may explain these findings.  The measure of disease severity 
used in the current study (WHO-DAS II) was designed to be broad enough to capture a 
variety of sources of disability, but it may not had enough specificity to capture the 
specific autoimmune-related symptoms that most affect well-being and health promoting 
behaviors in this population.  Also, since the data was self-report in nature whereas 
previous studies had clinicians give severity ratings or used blood tests, it is possible that 
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the current study did not measure disease severity as accurately as past research. 
 Unlike the current study, previous studies have found concurrent links between both 
psychosocial and biomedical factors in predicting well-being.  Friedman et al. (2007) 
found that participants with more social support scored higher on positive well-being.  In 
addition, the participants who had higher well-being had lower levels of inflammatory 
factor in their blood, again suggesting a relationship between biological factors and well-
being.  However, psychological variables were not investigated in the Friedman et al. 
(2007) study.  
 Neither of the regression models for research question one and research question 
two showed a significant contribution from the biomedical variable, disease severity, or 
the psychological variable, self-efficacy.  This study utilized self-report ratings of 
physical symptoms.  It is possible that the results of this study differ from some previous 
research because of the manner in which symptoms were measured.  Specifically, pain 
and even some common symptoms of autoimmune diseases like joint stiffness can be 
subjective from person to person.  In contrast, some previous studies used objective 
measures of severity like measuring levels of severity indicators in the blood (e.g. 
Friedman et al., 2007).  Since previous studies have shown that individuals who are more 
depressed also report higher levels of pain (Barsky et al., 1999), using self-report 
indicators of biological variables may be fraught with confounds, however both methods 
for measuring disease severity do have their place in research.  Individuals with lower 
well-being may already perceive their pain as worse or experiencing more severe pain 
may go hand in hand with depression.  Future studies could measure levels of 
interleukins or joint synovial fluid for an objective disease-severity measure of the 
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importance of depression and social support in disease outcomes.   
 Self-efficacy did not predict well-being or health-promoting behaviors in either 
regression.  The relationship between self-efficacy and depression was significant in the 
previous hypothesis but self-efficacy did not add any predictive validity to the current 
research questions.  The Arthritis Self-Efficacy measure that was used in the current 
study was specific for use with autoimmune diseases that have a musculoskeletal 
component but it may not have effectively detected self-efficacy for other disease-related 
variables.  It may have been too general of a measure for the broad range of diagnoses in 
the current study, thus explaining its lack of significance in these regression models.  
Also, the Functional Self-Efficacy subscale of the ASE has been highly correlated with 
other measures of disease severity, perhaps making this more of a measure of severity 
rather than psychological self-efficacy. 
 Given that the biomedical variables did not add predictive value to the regression 
models, it raises the question of the value of the biopsychosocial model (e.g. importance 
of examining all three components) in understanding chronic disease.  The findings of the 
current study suggest that psychosocial variables may be more predictive of health status 
than biomedical variables, at least for a general population of individuals with 
autoimmune diseases.  Although the biopsychosocial model was developed to emphasize 
the importance of considering psychological and social factors in addition to biological 
variables in predicting health outcomes, it was expected that the biomedical variables 
would account for unique variance in predicting outcomes in the current study. However, 
the diffuse sample and self-report severity indices may have contributed to the results and 
make it difficult to draw conclusions about the usefulness of the biopsychosocial model 
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in investigating this population.   This issue is discussed further in the implications for 
research section of this chapter. 
Research Question Three 
Role of Self-Efficacy as a Mediator 
 The third research question examined whether possible mediating variables existed 
in the relationship between the biopsychosocial variables and positive well-being.  The 
first analysis examined self-efficacy as a mediator between depression and well-being 
and found that self-efficacy was not a significant mediator of the relationship between 
depression and positive well-being.  This finding differs from previous research because 
self-efficacy has been shown to play a role in mediating psychological variables in other 
studies (e.g. Lowe, 2008).  One difference in the current study may have been that the 
self-efficacy variable that was used was Arthritis Self-Efficacy.  Since the Arthritis Self-
Efficacy measure encompasses three types of self-efficacy (pain, function, and other 
symptoms), its mediating effects may have been limited by its broad definition of self-
efficacy.  More focused measures, like the Pain Self Efficacy measure used in Turner et 
al. (2005) study have found evidence for mediation.  The instrument measures 
individual’s beliefs that they can manage the pain, functional impairment, and other 
symptoms of their disease.  Since the two variables of interest here were depression and 
well-being and the ASE measure focuses more on the physical symptoms than on 
cognitive appraisal of a situation as do most other measures of self-efficacy, the lack of a 
mediation effect may be partially explained.   
 In previous studies, the functional self-efficacy subscale has been so highly 
correlated with actual functionality that it has been used as a proxy for disease severity 
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(Lowe et al., 2008).  In this study, psychological predictor variables seemed to predict 
outcomes but disease severity did not have a relationship with outcome.  That the ASE 
measure has overlap with both disease severity and psychological constructs like self-
efficacy and disease severity variables but did not predict outcomes in this study may 
partially explain the lack of mediation in this study.   
 The Arthritis Self-Efficacy measure incorporates both physical and psychological 
items where previous studies on self-efficacy in other disease groups focus on one or the 
other.  For example, Edwards et al. (2001) found that high levels of self-efficacy 
predicted low levels of disease severity in African Americans with Sickle Cell Disease, 
and self-efficacy also predicted psychological symptoms like anxiety and depression.  
They used a more general measure of self-efficacy than the disease-specific one used in 
the current study, leading to a more clear prediction model.   
 It is clear that self-efficacy has a relationship with both depression and well-being 
based on their significant correlations but its role as a mediator was not supported in this 
sample.  Given that self-efficacy as a construct has been found to be important in 
predicting well-being in other samples, the role of self-efficacy, using a different 
measure, would be worth investigating in future research. 
Research Question Three 
Role of Social Support as a Mediator 
 The next research question evaluated whether social support was a mediator of the 
relationship between depression and positive well-being.  Results showed that social 
support was a significant mediator of the relationship between depression and well-being.  
Frazier, Tix, and Barron (2004) state that mediator variables help explain “how or why 
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one variable predicts or causes an outcome variable…a mediator is the mechanism 
through which a predictor influences an outcome variable (116).”  Given that definition, 
social support can be interpreted as one mechanism through which depression influences 
positive well-being.  In other words, social support may influence how or why depression 
predicts well-being. 
The connection between social support and positive well-being was explored by 
Friedman et al. (2007), where they found that participants with more social support 
scored higher on positive well-being.  Another study about social support that was 
previously discussed was the Mohr et al. (1999) study, which found that people with 
Multiple Sclerosis commonly experienced deteriorated relationships after their diagnoses 
and that they had feelings of victimization after being diagnosed.   
 This relationship has been shown in previous studies (Kettman & Altmaier, 2008) 
and has important implications for the study of chronic illness.  If one’s level of social 
support directly impacts well-being, future research should explore ways to improve 
well-being through social interventions.  
Research Question Four 
 The fourth research question examined how natural groupings would form among 
individuals with autoimmune diseases on the predictor variables of interest (depression, 
self-efficacy, social support, and disease severity) using cluster analysis. 
 Cluster analysis helps to simplify data and allows researchers to interpret 
participant responses in grouped form.  It is important to recognize that the clusters do 
not include all of the richness of the participant’s data and by using a reductionistic 
technique, the statements that can be made about the clusters are just generalizations. 
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However, cluster analyses can help see the ways that variables tend to cluster together in 
groups of participants, allowing us to make judgments about possible interventions or 
implications that can be helpful for groups of people with autoimmune diseases.  They 
also allow us to see what natural groupings tend to form in the data. 
 One of the most interesting findings about the clusters that resulted from the current 
study is that there were two groups who represented the extremes on the biopsychosocial 
variables.  Cluster One was doing relatively well while Cluster Three was doing 
relatively poorly.  Cluster One, the healthy exemplars, reported doing well on all 
variables as compared to the other clusters, while Cluster Three, the Maladjusted Unwell 
reported doing poorer on all of the variables compared to all of the other clusters.  The 
other two clusters fell somewhere in between.   
 These clusters helped elucidate the patterns through which the participants tended 
to vary in similar ways.  Unlike the group data, which was used in the regressions, 
correlations, and in determining the overall means and standard deviations for the study, 
the cluster analysis showed that groups of participants reacted similarly in overwhelming 
positive, negative, or neutral ways.   
 Overall this cluster solution helps point to an important issue for individuals with 
autoimmune diseases; there is not one way of adjusting to being diagnosed with an 
autoimmune disease.  Based on individual characteristics like depression and social 
support, people will react either really well or really poorly.  The other clusters had 
moderate scores on almost all of the variables, suggesting that another type of reaction to 
autoimmune diseases can be fairly moderate, when compared to other individuals with 
the diseases.   
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 Cluster One, the Healthy Exemplars, report ideal levels of distress and symptoms 
compared to the other clusters.  Future research could explore what factors affect 
membership in cluster one since they reported doing so well.  This cluster reported 
significantly better scores on all of the variables than the other clusters.  Interestingly, this 
was true for each of the six variables.  The members of this cluster had a positive attitude 
about their ability to get through difficult times or “flare-ups” of their diseases.  When 
asked what a positive consequence of having an autoimmune disease is, these individuals 
said things like, “I've learned to take one day at a time and try to get the most joy out of it 
you can.  And people that truly care and love you will be there to help out when you need 
it.  You find out who you can truly count on.”   
 Even when negative or stigmatizing comments were made to individuals in cluster 
one, they found a way to stay positive.  For example, “I always found it amusing when 
people would ask me about what disease I had and I would answer lupus, I would get that 
"what is it and are you contagious" question.  When I would explain it was an auto-
immune disease almost every time they would back away from me like I had just said 
AIDS or leprosy!  You gotta see the humor in life and people.  I'm glad I have a great 
sense of humor!” 
 In sharp contrast, participants in Cluster Three, the Maladjusted Unwell, perceived 
that they were not doing well on the selected variables.  When asked what a positive 
consequence of having an autoimmune disease is, one member of this cluster said, 
“What? Stupid question!” and “There has not been any positive consequences to having 
any autoimmune disease!”  These individuals reported poor health and high levels of 
depression.  They reported low levels of social support and low levels of disease self-
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efficacy.  They scored low on overall well-being as well as in their amount of health-
promoting behaviors.  Cluster Three seems to represent the opposite end of the 
continuum of functioning compared to Cluster One, which was doing so well.  In many 
ways, this cluster exemplifies the “worst case scenario” for people with autoimmune 
disease.  One implication for future research is to find ways to reduce the negative 
emotions and symptoms of individuals in this group. 
 Cluster Two, the Efficacious Managers, had the highest levels of self-efficacy of all 
of the clusters.  They had relatively low levels of disease severity, but not as low as 
Cluster One.  The high level of disease self-efficacy in Cluster Two was the only variable 
of interest that did not vary with the other variables as expected.  Cluster One had high 
levels of all of the desirable variables (social support, self-efficacy, well-being, and 
health promoting behaviors) and low levels of the less-than-desirable variables 
(depression and disease severity), while Cluster Three had low levels of those desirable 
variables and high levels of the less-than-desirable variables.  Cluster Four had moderate 
levels of all of the variables.  In Clusters One, Three, and Four, the variables “hung 
together” as expected but Cluster Two had the only example of an elevated level on one 
variable, compared to the other clusters, with moderate levels on the others.  Due to this 
one unexpected finding, their name emphasizes that they thought they could do well in 
managing their health: the Efficacious Managers.  A quote from a member of Cluster 
Two illustrates the value of self-efficacy for this group: “I have learned that if you put 
your mind to it, you can accomplish anything that you want to, even if it is difficult.  
When I feel good I try to do the things that I want to do, even if the next day I know I will 
suffer.”  Her quote indicates that she believes she can do anything she wants to, but that 
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she may have to pay the consequences (either physical, psychological, or both) the 
following day.  The moderate levels of the variables besides self-efficacy may be due to 
them averaging out over time (e.g. some good days, some bad days).   
 Cluster Four, the Impervious Moderates, reported moderate levels of all of the 
variables.  There are many possible explanations for this.  Perhaps they are not affected 
by autoimmune diseases as much as the other clusters are, perhaps they have integrated 
their disease into their identity, or perhaps they are just individuals who were more 
moderate on the variables before having an autoimmune disease and have not changed 
much.  It is really not possible to speculate on why this cluster was moderate compared to 
the other clusters since a complete analysis of this was not conducted.  There is no way to 
compare clusters on their levels of these variables before having an autoimmune disease 
so it is difficult to know which ways of reacting (or not-reacting) are due to their 
autoimmune disease, other factors in their life, other medical issues, or their personality 
in general.   
 When asked about a positive consequence of her autoimmune disease, this 
Impervious Moderate wrote, “Just one.  I am much more aware and understanding of 
others with any kind of disability.”  She did not indicate that she was positively or 
negatively affected in any extreme ways and she was only able to come up with a short 
positive explanation for the question.  Her answer was not about herself but that she had 
learned too be more aware of others.   
 Interestingly, the clusters that resulted from the current study were straightforward 
in that participants tended to react in expected ways.  No clusters appeared where 
participants were doing really well on some variables and really poorly on others.  This 
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may also be because there were high levels of correlations found between many of the 
biopsychosocial variables (See Table 6).  Given that many doctors (and participants in the 
study) mentioned stress as a cause of autoimmune diseases, perhaps autoimmune diseases 
are more linked to psychological functioning.  As was true with the clusters, if one thing 
is good, the rest is good, and if one thing is bad, the rest is bad too.   
Qualitative Data. 
 There were three questions analyzed using qualitative methods.  These questions 
were included in the study to give a more detailed view of the sample and were not 
intended to be used for quantitative analyses.  Since rigorous qualitative methods were 
not applied in the current study, the data are presented here for descriptive purposes.  
Future studies should expand on the qualitative questions used here in semi-structured 
interviews or focus groups. 
 Because people with autoimmune diseases often misattribute the cause of their 
disease or blame themselves for their illness, the first question was included to assess the 
causal attributions that individual respondents held and if they were supported by medical 
professionals.  For the first question, “What do you believe caused your disease?” the 
category where 27% of the respondents were placed was  “don’t know.”  Since the causes 
of autoimmune diseases are largely unknown, this was not a surprising result.  However, 
over half of the sample (56%) indicated a specific cause for their disease.  Interestingly, 
only 24% of the sample had received a medical explanation for the cause of their disease, 
yet many still had personal attributions for their disorder.  The number of participants 
who responded “genetics” (which could be viewed as something beyond their control) 
and "some kind of physical or psychological stress" (which could be viewed as somewhat 
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within their control) was approximately equal.  It is important to note that there was a 
tone of self-blame in some individuals in the physical stress group and especially in the 
next largest category, emotional stress.  These individuals in the emotional stress group in 
particular seemed to blame themselves for working too much or not dealing with the 
psychological or emotional stressors in their lives, which they believed led to the 
development of their disease.  Though the completeness and reliability of the 
corresponding question about participants’ knowledge of a medical cause for their disease 
was lacking, it did become clear that some participants had been given a medical 
explanation for their disease but still believed it was due to something they had done 
wrong (e.g. “drinking too much Diet Pepsi”).  Further analysis of this question, through a 
more complete qualitative research study, would be beneficial in understanding if and 
when people blame themselves for the etiology of their disease.   
 The difference between the number of participants who articulated a cause (56%) 
and those who had received a medical explanation (24%) illustrates a gap that has also 
been observed in previous literature.  It is possible that holding a belief that a specific 
factor caused one’s disease may allow people to make sense out of something that has 
happened to them or to feel protected against other types of illness or believe that their 
family members will not be similarly affected if they are able to avoid the perceived 
cause. 
 It is important to think about the results of this causality question in light of 
previous research on attributions for illness.  Westbrook and Nordholm (1986) found that 
accurate attributions were tied to lower levels of depression, more positive coping, and 
less need for counseling.  They compared people with high-lifestyle involvement diseases 
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(heart attack and stroke) to people with low-lifestyle involvement diseases (arthritis and 
cancer).  They found that people who were more accurately blaming themselves for some 
lifestyle-related reason that they developed heart disease or strokes were doing better.  
Conversely, when individuals with low-lifestyle involvement diseases blamed 
themselves, they were doing worse (Westbrook & Nordholm, 1986).  Since the causes of 
autoimmune diseases are unknown and not likely due to lifestyle involvement, self-blame 
in this population is likely to have harmful effects.   
 One response from this study demonstrated this paradox.  When asked what she 
thinks caused her autoimmune disease, she responded: “I am not sure, I have heard that 
maybe a virus can cause MS.  When I am really depressed, I can talk myself in to a 
punishment from sins of my past.  I am really not sure.”  When asked if she had received 
a medical explanation for her disorder, she responded, “Most doctors will say that they 
don't know for sure what the cause is.”  Another individual had been told by her doctor 
that the explanation was genetics and she thought, “Well besides my father having it, I 
being in recovery have also seen a number of people getting clean who were cocaine 
addicts have also been DX with MS.  I also am a recovering cocaine addict.”  She, like 
other participants, blamed themselves for decisions or lifestyle choices they had made in 
the past, yet at the same time seemed to be aware that these attributions were not 
supported by the medical profession. 
 For the second question about positive benefits of their diagnosis, a wide range of 
responses was observed.  The largest group of respondents indicated that having an 
autoimmune disease had allowed them to be more aware of their limits, their own body, 
and how to balance their time.  Many people in this group discussed making changes to 
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their lifestyles to improve their overall health through diet, exercise, and stress 
management.  They also learned how to ask for help and recognized their limits.   
 The next categories had roughly similar numbers of participants.  First, social 
support was often cited as a benefit of their diagnosis.  This tended to take the form of 
specifying a relationship (e.g. with a spouse) that had improved or that the participant felt 
closer to a specific person as a result of their disease.  This category was similar to the 
one about helping others with autoimmune diseases.  Respondents who indicated that 
they benefited through developing empathy for others, an ability to relate to family 
members or friends with autoimmune diseases, or that they had a different view of 
disability fell into the category of helping others.  They differed from the social support 
respondents because the focus of their positive benefits was towards other people rather 
than receiving help from others or becoming closer to specific people.   
 Another positive benefit reported was personal growth, when people indicated a 
specific way that they had grown or changed as a result of their disease.  Similarly, about 
the same proportion of participants indicated that they had re-evaluated their priorities or 
focused on what was most important in their lives.  With many of these responses, the 
positive benefits had some relationship to social support.  That was observed directly 
with the fifth category and indirectly by helping others with autoimmune diseases.  Some 
personal growth was related to improvement on individual characteristics that improved 
relationships (e.g. became a better listener) and re-evaluating one’s priorities often meant 
that the respondent was choosing to spend more time with their families or other 
important people in their lives.  Since the sample as a whole reported high levels of social 
support, as indicated in the results section and measured by the MOS-SSS, it is not 
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surprising that so many participants cited positive benefits that had a relationship to 
social support.  The other category of benefits is religious/spiritual beliefs.  Just under 6% 
of the participants indicated that they became closer to God, more spiritual, or more 
committed to their religious faith.   
 Previous studies have found that individuals who are able to find more positive-
benefits as a result of having a chronic illness report less severe levels of pain (Katz et al., 
2001).  Though no significant differences were found between participants who were able 
to identify positive benefits and those who did not in the current study, further analysis of 
this relationship between benefit-finding and disease severity is warranted.   
 Finally, for the third question about willingness to seek psychotherapy, the largest 
number of responses related to the removal of barriers like cost, transportation, and not 
having enough time to go to therapy.  Approximately equal numbers of participants 
indicated that they did not need it but would be willing to go if something changed but 
for now are not interested.  These responses were from people who were generally 
willing to seek therapy and did not express resistance or reasons not to go to therapy.  
Some of the answers to this open-ended question were rather short (e.g. “nothing”) so it 
was difficult to interpret which category to place these responses in.  It was determined 
that these answers would be categorized together, though without a more complete 
context for understanding them, it is unclear if that was the correct decision.  A more 
complete discussion of this issue will follow in the limitations section.  It is also 
important to note that this open-ended question had more missing data than the other 
questions.  It is possible that respondents were less willing to answer questions about 
counseling than other issues or considered these questions less germane to the purpose of 
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the study.     
 Other responses to this question included specific comments about therapist 
characteristics or the therapy process, which were categorized together.  Another category 
was related to worsening symptoms, such that respondents would seek psychotherapy or 
counseling if they became more depressed or suicidal or their emotional state started to 
affect their relationships.  Overall, since the sample reported slightly less depression and 
reported more social support than expected, it is not surprising that many respondents 
indicated a reluctance to seek therapy.  
 The findings from the open-ended questions give a fuller picture of the sample.  
From the first question about causes of one’s disease, it is clear that people with 
autoimmune disease have a variety of different explanations for the cause of their disease, 
regardless of if what is espoused by their doctors.  Secondly, some individuals with 
autoimmune diseases have been able to find a silver lining to their experience with their 
disease, while other respondents had difficulty answering that question.  Finally, 
willingness to seek psychotherapy was found in some of the participants but significant 
barriers (both personal and logistical) exist for a large portion of the sample.  Some of the 
barriers to seeking therapy that were mentioned were unique to individuals with 
autoimmune diseases and suggest some important implications for practice which will be 
discussed later in this chapter.   
 These three questions that were included in the study to give a more detailed view 
of the sample and were not intended to be used for quantitative analyses.  Since rigorous 
qualitative methods were not applied in the current study, the data were presented here 
for descriptive purposes.  Future studies should expand on the qualitative questions used 
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here in semi-structured interviews or focus groups to include follow up questions that 
help clarify the context of the answers.  Overall, the results from the open-ended 
questions did present some interesting findings for future research and implications for 




 Several limitations existed in the current study.  First, the sample was 
overwhelmingly white.  While there are some autoimmune diseases that are more 
common among white individuals, the proportions of white participants do not match the 
norms for the diseases.  A number of explanations exist for this including the population 
demographics of Iowa, where most of the participants were recruited, being primarily 
white.  The 2000 census estimates that the population of Iowa as a whole is 94.6% white, 
which is similar to the 94% white in the current study (www.quickfacts.census.gov, 
2008). Also, since snowball sampling was used as one of the methods of data collection, 
many people who participated in the study shared the information about the survey with 
individuals they were related to or whom they knew, who would likely be of the same 
race.  This limitation should be addressed in future research.  One way of addressing this 
discrepancy in future research is to oversample from minority populations.  More 
involvement from clinics like the NIAMS Cardozo Community Health Clinic, which 
serves less than 10% white clients, would be a great improvement to the body of research 
that currently exists on autoimmune diseases.  
 All sampling methods have some limitations.  Conducting an online survey has its 
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own unique pitfalls as well as its benefits.  Some of the problems with online research in 
general are difficulty determining a response rate, especially when participants are 
recruited in part through snowball techniques.  This was a problem for the current study 
but the limitations of this method were outweighed by the ability to collect a larger 
sample size from individuals with a variety of different diagnoses.  Some online research 
uses password-protected websites to collect data but that was not done in the current 
study due to the desire to collect data from a wide-range of participants that may not have 
access to the passwords.  This was a limitation because data was missing on many items, 
which may have been attributed to people who were not serious about the study.  Though 
it is doubtful that participants contaminated data in large numbers, it is a consideration 
that many people viewed the survey without following through on completing it.   
 Some benefits of online surveys were apparent as well.  Data collection was a 
relatively fast process, and a sample from a large geographic range of participants was 
possible.  A broad range of diagnoses with good representation of the population of 
autoimmune diseases as a whole was collected.  Collectors were created in Survey 
Monkey to track the number of participants.  Some people clicked on the first page of the 
survey to agree that they would participate but did not fill out the survey.  Though there 
are some limitations to collecting data through online surveys, the number of surveys 
collected in a short period of time was a benefit in the current study.   
 One other limitation is that the variety of diagnoses represented were fairly broad 
but represented few enough individuals that analysis of the differences between the 
subgroups was not possible.  Though the “umbrella” of autoimmune diseases that were 
represented in the current study was discussed in detail with physicians from the National 
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Institutes of Arthritis and Musculoskeletal and Skin Diseases, there was still enough 
variability in the types of symptoms represented among the diseases that the sample was 
fairly broad.  Diseases that were not connective tissue or musculoskeletal autoimmune 
diseases were dropped from the final sample.   
 The WHO-DAS II was not the best measure of disease severity.  It is a better 
estimate of perceived impairment and is used to correspond with levels of functional 
impairment.  The WHO-DAS II had good sensitivity for pain and functional impairment, 
but may have allowed for under-representation of the severity of other autoimmune 
symptoms.  In future studies, the range of disease severity could be more limited or a 
specific type of disease or length of time since diagnosis could be specified.  Most of the 
measures were not disease-specific but future studies should include a measure of 
biological symptoms of severity that is not self-report data to fully determine the impact 
of the disease.   
 Another limitation is that the current study was cross-sectional.  Future studies 
could benefit from utilizing a longitudinal perspective.  No significant effects for time 
since diagnosis were found in the current study but a longitudinal study may do a better 
job of capturing the highs and lows of remission and relapse associated with autoimmune 
diseases.  A possible way of doing this would be to use journaling at various time-points 
to capture variation in symptoms across time.  Also, since this study was self-report in 
nature, participants were only reporting their own experience.  This is a significant 
limitation of the current study because participants may have under- or over-reported 
their disease severity.   
 As discussed earlier, depression may skew the experience of disease symptoms or 
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pain levels and some people may not have given an accurate representation of symptoms 
of autoimmune diseases.  People with more severe depression may not have elected to 
participate in the study.  Since many individuals with autoimmune diseases are used to 
interacting with people who are not familiar with the nature of their symptoms or even 
the name of their diagnosis, it also might be that people living with autoimmune diseases 
become used to “putting on a happy face”.  When given the opportunity to report on their 
symptoms, they may be so used to trying to fit in with others or avoid complaining, that 
they simply did not accurately report their symptoms. 
 Overall, participants indicated that their health was similar to levels reported in 
previous studies.  When asked, “Based on what you know about your disease (or 
compared to others), how severe is your autoimmune disease?” on a scale of 1-10, the 
mean was 4.58 with a SD=2.46.  As part of the WHO-DAS II, when asked, “How do you 
rate your overall health in the past 30 days?” on a scale of 1-5, the mean was 2.64 with a 
SD=0.971.  This suggests that the current sample was similar to previous samples on 
biomedical issues but had some better psychological and social outcomes.   
 Missing data was also a limitation in this study.  A detailed explanation of the 
decision-making process associated with the missing data is provided in the results 
section.  The length of the survey may have led to an increased amount of missing data in 
this sample.  Although there was a substantial amount of missing data in this sample, the 
results were not different when missing data was replaced using the common methods 
recommended by Allison (2008) and available in SPSS.  Perhaps some participants were 
skipping select items or scales with confusing wording; hopefully a shorter survey would 
be beneficial in reducing the amount of missing data and individuals who were deterred 
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from taking the survey in the first place.  In addition, counterbalancing of the measures 
may aid in reducing missing data. 
 A limitation was present in the analysis of the qualitative data as well.  First, the 
open-ended questions were designed for participants to write answers to the questions in 
detail but many participants were terse with their responses.  Better qualitative data 
would have been gathered through in-person interviews or a survey that was solely 
focused on open-ended responses.  The qualitative data was at the end of the survey and 
respondents may have developed some survey fatigue by that point, thus limiting their 
answers.  In addition, since participants became accustomed to filling out Likert-scale 
questions, it may have been difficult and burdensome to change question modalities to 
respond to the open-ended questions.   
 In the qualitative coding process, there was some difficulty interpreting the answers 
that participants had to some of the items due to their short answers.  For example, on the 
question about willingness to seek psychotherapy, many participants indicated “nothing”.  
They could mean that “Nothing would ever change my mind about not wanting to go to 
therapy” or “I’m already in therapy and so nothing would change my willingness to do it” 
or that "Nothing affects my willingness to seek therapy." Though another question about 
history of counseling/therapy was asked, the data on that question was not thorough 
enough to analyze, nor would it be appropriate to make judgments about the intention of 
a given response just because it was matched to data about their history of therapy. 
 
Implications for future research. 
 The current study was largely exploratory in nature because there is a lack of 
 
138 
research on autoimmune diseases in general and the psychosocial impact of these 
diseases in particular.  The purpose of this study was to evaluate the impact of 
biopsychosocial variables on well-being and health-promoting behaviors. 
 Future research should expand on the findings from the current study.  One area of 
research that should be investigated is whether the unique contributions of individual 
diseases matter when doing psychosocial research or if the common factors that are 
significant across studies are more relevant to future research.  Many studies on chronic 
illness in general have similar results that show that social support and depression are 
both important predictors of well-being and other outcomes but there has been little 
evidence differentiating how those processes are different for individuals with different 
diseases.  In other words, does it make sense for us to research psychosocial issues for 
different disease groups separately (e.g. studies on breast cancer, HIV, autoimmune 
diseases, etc…) or are the experiences of individuals with chronic illness similar enough 
that we can group them together?  The results of the current study were almost identical 
to those of Kettmann and Altmaier (2008) in that depression and social support were the 
only variables of interest that accounted for unique variance in predicting the outcome 
variables, yet their study was conducted with individuals who had undergone a bone 
marrow transplant—an entirely different physical experience.  It is possible that the 
within-group differences for one type of disease are greater than or equal to the between-
group differences for individuals with different types of chronic illness.  Perhaps the 
biomedical differences between groups are not as important as the psychological and 
social factors and people’s perceptions of their situations (e.g. pain perception). 
 The findings of the current study and those of the Kettman and Altmaier (2008) 
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study may be similar because some psychosocial variables, like depression and social 
support, consistently predict well-being and other outcome variables and are relevant 
across multiple situations.  A strength of the biopsychosocial model is that it allows 
researchers and clinicians to recognize the importance of psychological and social factors 
in the context of biomedical factors; in a way, the true strength of the biopsychosocial 
model is providing a lens through which biomedical variables can be considered in a 
psychosocial light.  However, a limitation is that variables like depression and social 
support seem to be “common factors” that predict positive life outcomes and positive 
health outcomes in general, regardless of the specifics of the situation.  These can be 
likened to the “common factors” approach in understanding therapy process and outcome 
research; meaning that factors like having a positive relationship with one’s therapist and 
symptom reduction are beneficial regardless of the type of therapy studied (Wampold, 
2001).  Perhaps among the common factors in predicting health outcomes are depression 
and social support.   
 Another implication is whether the biopsychosocial model should be modified to 
encompass this finding that depression and social support have the largest impact on 
individuals’ experiences with their chronic illness.  It may be that a body of evidence has 
shown that quality of life can be improved by reducing depression and increasing social 
support, both of which represent areas that are possible to intervene and are appropriate 
for counseling psychologists to focus on with their clients. One benefit of research 
examining the biopsychosocial model is that it supports Engel's view that a medical 
model alone may not be the best way to predict the effects of disease (Hoffman & 
Driscoll, 2000).   
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 Not only does it appear that psychosocial issues are at least as important, if not 
more important in dealing with a chronic illness but psychosocial issues have also been 
shown to have a large impact on physical symptoms.  For example, Barsky et al. (1999) 
found that individuals who were less depressed reported less pain but also had 
significantly less joint swelling, when objective measures were used to measure that 
biomedical outcome.  Their study showed a clear impact of the psychosocial issues 
surrounding a chronic illness and proved that helping individuals feel better 
psychologically had a drastic impact on their health. Even if similar examples of 
psychosocial factors improving biomedical health are not found across all disease 
categories, greater perceptions of well-being and increased quality of life are substantial 
benefits for all individuals.   The current study provided support for continued use of the 
biopsychosocial model as a way of conceptualizing and interpreting research on chronic 
illness. 
 Future research should also aim to encompass different ways of understanding 
disease severity including objective measures as well as self-report data (like measuring 
blood levels of interleukins or monitoring joint swelling) as well as asking family 
members to share their experiences too.  Some benefits exist in using multiple types of 
data.  In the current study, the self-report nature of the survey might have skewed the 
results to show a more positive view of the individuals with autoimmune diseases 
because they did not self-report that they were depressed or doing badly as often as they 
wrote about it in the open-ended questions.  
 Future research could streamline the measurement of disease severity, perhaps 
creating instruments that are more robust for use in different populations that also have 
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high levels of specificity.  There were three different measures of functionality and 
severity that were used in the current study.  First, previous studies have shown that the 
Arthritis Self-Efficacy: Function scale correlates significantly with people’s actual 
functionality (Barlow et al., 2000); belief in one’s ability to manage symptoms seems to 
be an important construct in understanding disability.  Second, the measure that was used 
to assess symptomatology in the current study was the WHO-DAS II, which assesses 
physical as well as some psychological and social impairment related to disability.  
Finally, participants were asked one item in the demographics section where they had to 
rank the severity of their disease, as compared to other individuals with autoimmune 
diseases, on a scale of 1-10.  These three different indicators can all be used to describe 
the functionality of the sample.  Along with objective measures of severity like joint 
counts, interleukin levels in the bloodstream, or physician ratings of symptoms, there is 
much room for improvement in measuring the biomedical factors associated with 
autoimmune diseases.  Combining self-efficacy, self-report symptom, comparisons to 
others with objective measures could be a productive direction for future research.   
Implications for practice.  
The psychological symptoms that were investigated in the current study, 
depression and self-efficacy, are commonly associated with psychological distress among 
people with chronic physical illnesses.  The ongoing and higher levels of distress 
associated with autoimmune diseases versus adults in general and the promising results of 
psychosocial interventions with individuals with other types of chronic illnesses suggest 
that psychosocial and psychotherapeutic interventions could be extremely valuable for 
autoimmune populations.  One avenue for improving the significant life stressors that 
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may be associated with autoimmune diseases is psychotherapy (Westbrook & Nordholm, 
1986) as seeking psychotherapy generally has the implicit goal of enhancing one’s 
psychological well-being.  The current study found support for the predictive role of 
depression and social support in enhanced well-being, factors which psychotherapy is 
designed to help improve.  This study found that around 42% of the participants would 
reach clinical levels of depression, suggesting that there are many individuals in this 
population who could benefit from psychotherapy.   
The results of the cluster analysis showed that people tended to have low, 
medium, or high levels of impairment on all of the biopsychosocial variables that were 
included in the current study.  This might suggest that individuals who are doing poorly 
on one variable may have other areas of functioning that could benefit from remediation.  
An implication for clinicians is that poor functioning in one area may serve as a “red 
flag” that other areas may also be worse than expected.  For example, if an individual 
with autoimmune disease reports high levels of depression; low levels of social support 
and self-efficacy and high levels of disease severity may also be found.  This finding 
should encourage clinicians to look beneath the surface and do a full investigation of 
well-being if individuals appear to be doing poorly in one area.   
Previous studies have found that psychotherapy can be effective with individuals 
with autoimmune diseases.  Therapy interventions have helped individuals with 
rheumatoid arthritis reduce pain and joint swelling (O’Leary et al., 1988) as well as ease 
the psychological and social distress associated with autoimmune diseases (Astin et al., 
2002).  The significance of depression and social support in the current study could 
suggest important therapy interventions.  Individual or group therapy could be helpful in 
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reducing symptoms of depression while group therapy could aid in providing social 
support and teaching participants the skills they need to access support elsewhere.  
Disease-specific support groups, either in-person or online, may be especially helpful in 
assisting individuals with autoimmune diseases in improving their perceived levels of 
social support.   
One clinical application of the current study is that the recruitment for this survey 
happened online and a wide variety of individuals participated with different diseases.  As 
shown in Table 14, many different autoimmune diseases were represented.  The utility of 
the internet for connecting individuals with different diseases was clearly demonstrated in 
the current study based on the variety of diseases that participants reported having.  At 
least one online support group through the Multiple Sclerosis Society encouraged their 
members to participate in this research.  Many respondents had similar comments in the 
open-ended question section of the study and could benefit from open dialogue through 
chat rooms, blogs, or other online mechanisms of communicating with others.  Given the 
results that social support functioned as a significant mediator in the current study, it 
would be beneficial to form online support groups and encourage medical professionals 
to endorse them too. 
Although this study did not examine the benefits of specific interventions, some 
practice implications can also be gleaned through analysis of the qualitative question 
about psychotherapy.  Participants were asked what factors would affect their willingness 
to seek psychotherapy and a large number of them mentioned that barriers that have 
deterred them from entering therapy.  The sample was split almost evenly among those 
who had been in therapy and those who had not.  Many people commented that they 
 
144 
would go to therapy “if depressed or suicidal” of “if necessary,” suggesting that they 
were open to it if they felt worse. 
 A couple of participants stated that they felt comfortable talking to their physicians 
about everything they needed or would go to counseling if their doctor recommended it.  
For example, “Neither [psychotherapy or counseling] have been suggested by my 
physicians.  If necessary, I would be willing.”  This could be problematic for many 
individuals with autoimmune diseases considering that one study found that only 10% of 
individuals in therapy were referred by their doctors (Cunningham & Edmonds, 1996).  
Though all of the participants had some contact with medical doctors, only two 
individuals mentioned anything about them in any of the qualitative questions, perhaps an 
indication of the mind-body dualism that is still present in medical treatment.   
 The most common response to “What would affect your willingness to seek 
psychotherapy or counseling?” was “nothing could”.  Many of them were disinterested 
and indicated that there were no factors that could change their minds.  Others did not 
think it could be helpful in dealing with their autoimmune disease.  About half of the 
participants had previously participated in therapy or counseling of some sort, and some 
of those who had participated reported having a negative experience that had affected 
their future willingness to seek therapy again.  Others mentioned financial issues or 
logistical issues like finding the time, being able to get out of the house, “finding a 
qualified person,” and transportation problems.  Some of the logistical issues related to 
transportation and mobility may be unique to individuals with autoimmune disease, such 
that innovative therapeutic interventions that incorporate technology may be especially 
helpful for this population. 
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 As discussed in the review of the literature, seeking therapy may also be uniquely 
difficult for individuals with a chronic physical illness because they have so many 
medical appointments that they must attend to monitor their physical health that they do 
not have the time or energy left to talk to a therapist. As one participant put it, “Time and 
health [would affect my decision to seek counseling or psychotherapy]. It takes a great 
deal of time going to all my doctors so I do not have much more time for extras.” Some 
were able to recognize their personal difficulties in seeking out or participating in therapy 
to the fullest extent stating, “I struggle with the ability to discuss my personal problems, 
so it is difficult for me to cooperate in therapy.” And, “It's hard to want to work through 
all that stuff emotionally it is very draining and finding the strength and courage to do it 
is very hard.”  
Others did not believe that a counselor could understand their perspective on 
living with an autoimmune disease, perhaps addressing some of the alienation and 
misinformation they have received from other professionals: “[I] do not believe it would 
help unless they have walked in my shoes.”  Building empathy for chronic physical 
illness among therapists is especially important so that when a physically ill individual 
does seek out therapy, the therapist is ready for the case.  Given the unique presentation 
of autoimmune diseases, mental health professionals should make an effort to educate 
themselves about chronic illness, especially if a client presents with an unfamiliar 
disorder. 
Some individuals responded that they received enough support from their families 
and friends and did not need therapy, while others indicated that they would rely on their 
doctors to refer them to counseling if needed.  In the current study, no participants 
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mentioned a positive benefit of their autoimmune disease being related to attention from 
their doctors.  Many individuals talked about the beneficial support of family members or 
friends or even disease-related support groups but no one mentioned the care from or 
relationship with their doctors as being a positive benefit.  One implication of this finding 
is that since people are relying on their doctors for psychological referrals, or at least 
some psychosocial guidance, it is imperative that medical professionals be made more 
aware of the importance of psychosocial issues in the process of chronic disease.  
Another implication is that the participants in the current study were not overwhelmingly 
excited about traditional therapy but other modalities, perhaps even online 
psychoeducational support groups would be beneficial.   
The results of the current study suggest that depression and social support are 
predictors of psychological well-being, so doctors and nurses need to be more attuned to 
the psychosocial wellness of the individuals with whom they work.  As a corollary, 
counselors, psychologists, and psychotherapists also need to be more educated about how 
chronic physical illness takes a toll on one’s emotional health.   
Conclusions. 
 In response to the lack of information about how biopsychosocial variables affect 
positive well-being and health-promoting behaviors in individuals with autoimmune 
disorders, the current study investigated the impact of depression, self-efficacy, disease 
severity, and social support on those important outcome variables.  Because of the 
importance of positive well-being and health-promoting behaviors on overall mental and 
physical health, they were chosen as the outcome variables of interest in this study.  In 
addition, well-being and health-promotion are both important variables because of they 
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have implications for prevention and clinical interventions.   
 In the current study, psychological and social variables predicted unique variance in 
outcomes whereas biomedical variables did not.  These results suggest that the 
psychological and social aspects that go along with the diseases may be more important 
that disease symptoms. Though people with autoimmune diseases commonly report being 
told their disease is “all in their head,” the results of this study suggests that how 
individuals perceive and react to their disease may be based more on psychosocial 
variables than on characteristics or symptoms of their disease.  In other words, 
psychological and social variables may be the lens through which the actual 
symptomatology, disease progression, or severity is viewed.  It is possible that actions to 
alleviate depression and to stay connected to friends, family, and significant others 
through the ups and downs of an autoimmune disease may be most helpful in improving 
well-being and staying healthy.  It is easier to intervene with these psychosocial variables 
than with disease symptoms. 
 Though individuals with autoimmune diseases may go through the cycles of relapse 
and remission, lengthy and difficult diagnosis processes, isolation and stigmatization, and 
painful physical symptoms; the results of the current study indicate that having friends 
and significant others, and alleviating stress and depression are important objectives that 
seem to be an important part of doing well.  For the individual described in the 
introduction chapter who was attempting to balance the many demands in her life as well 
as struggling with rheumatoid arthritis, hopefully the results of this study will encourage 
medical professionals to acknowledge the importance of her psychological and social 
needs in addition to the biomedical symptoms they are already treating.  In summary, 
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autoimmune diseases have significant biomedical, psychological, and social 








Age: (Select One) [18-24; 25-34; 35-44; 45-54; 55-64; 65-74; 75-84; 85 or above] 
 
Gender:  [Female  or Male] 
 
Race/ethnicity: [Asian/Asian-American/Pacific Islander; White/European-American; 
Middle-Eastern/Arab; Asian Indian/Pakistani; Hispanic/Latino(a); Biracial/Multiracial;  
Black/African-American; Native American/Native Alaskan] 
Other (please specify)  _________________ 
 
Highest degree completed: (Select One) [Elementary School; Middle School/Junior High 
School; High School; Technical School; Two-Year College; Some Four-Year College; 
Four Year College Degree; Some Graduate School, Masters Degree, Doctorate or 
Professional Degree]
 
What type of autoimmune disease(s) do you have: _________________ 
 
How long ago were you diagnosed with this disease(s)? (Select One) [Within the past 
month; 1-6 months ago; 6 months-1 year ago; 1-2 years ago; 2-5 years ago; 5-10 years 
ago; 10-20 years ago; more than 20 years ago] 
 




Number of hours per week that you work for pay: (Select One)  [0; 1-5; 6-20; 21-40; 41-
60; more than 60] 
 
Has your autoimmune disease(s) affected your ability to work?  [No/ Yes] 
 If yes, how? _________________ 
 
How has your autoimmune disease affected your relationships (e.g. partner/spouse, 
children, friends, etc…)? [No/ Yes] 
 If yes, how? 
 




Who do you live with?   





Does anyone else in your family have an autoimmune disease?  [No/ Yes]  
 If yes, who and what kind? _________________ 
 
Based on what you know about your illness (or compared to other people you know with 
the disease), how severe is your autoimmune disease? 
 
 1 2 3 4 5 6 7 8 9 10 
 Not at all  Extremely 
 severe severe 
 
 




















Have you ever been in therapy/counseling before?  [No/ Yes] 
If yes, please describe how long ago, length of time in therapy, and type of 
















How do you rate your overall health in the past 30 days?  
 
Very good   Good  Moderate   Bad   Very Bad  
 
This questionnaire asks about difficulties due to health conditions.  Health conditions 
include diseases or illnesses, other health problems that may be short or long lasting, 
injuries, mental or emotional problems, and problems with alcohol or drugs.  
 
Think back over the last 30 days and answer these questions thinking about how much 
difficulty you had doing the following activities.  For each question, please circle only 
one response.  
 
In the last 30 days, how much difficulty did you have in:  
 
 Understanding and communicating  
 
1. Concentrating on doing something for ten minutes?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
2. Remembering to do important things?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
3. Analyzing and finding solutions to problems in day to day life?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
4. Learning a new task, for example, learning how to get to a new place?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
5. Generally understanding what people say?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
6. Starting and maintaining a conversation?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
Getting around  
 
1. Standing for long periods such as 30 minutes?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
2. Standing up from sitting down?  





3. Moving around inside your home?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
4. Getting out of your home?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
5. Walking a long distance such as a kilometre (or equivalent)?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
In the last 30 days, how much difficulty did you have in:  
 
Self Care  
 
1. Washing your whole body?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
2. Getting dressed?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
3. Eating?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
4. Staying by yourself for a few days?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
5. Dealing with people you do not know?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
6.  Maintaining a friendship?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
7.  Getting along with people who are close to you?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
8.  Making new friends?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
9. Sexual activities?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
10. Taking care of your household responsibilities?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
  
11. Doing most important household tasks well?  






12. Getting all the household work done that you needed to do?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
13. Getting your household work done as quickly as needed?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
IF YOU WORK (PAID, NON-PAID, SELF EMPLOYED) OR GO TO SCHOOL, 
COMPLETE QUESTIONS 1-4 BELOW. OTHERWISE, SKIP TO THE NEXT PAGE.  
 
In the last 30 days, how much difficulty did you have in:  
 
1. Your day to day work/school?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
2. Doing your most important work/school tasks well?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
3. Getting all the work done that you need to do?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
4.  Getting your work done as quickly as needed?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
In the last 30 days:  
 
Participation in Society  
 
1. How much of a problem did you have in joining in community activities (for example,   
festivities, religious or other activities) in the same way as anyone else can?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
2. How much of a problem did you have because of barriers or hindrances in the world 
around you?  
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
3. How much of a problem did you have living with dignity because of the attitudes and 
actions of others? 
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
4. How much time did you spend on your health condition, or its consequences? 
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
5. How much have you been emotionally affected by your health condition?  
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None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
6. How much has your health been a drain on the financial resources of you or your 
family? 
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
  
7. How much of a problem did your family have because  
    of your health problems? 
None  Mild   Moderate   Severe  Extreme/ Cannot Do  
 
8. How much of a problem did you have in doing things by yourself for relaxation or 
pleasure? 





Center for Epidemiologic Studies Depression Scale (CES-D) 
 
Below is a list of some of the ways you may have felt or behaved. Please indicate how 
often you have felt this way during the past week: (circle one number on each line)  
 
Rarely or none Some or  Occasionally or a moderate All the time 
Of the time  a little of the time amount of time 
(less than 1 day) (1-2 days)   (3-4 days)    (5-7days)  
0   1   2    3 
 
During the past week... 
 
1. I was bothered by things that  
    usually don’t bother me...................................... ...0  1 2  3  
 
2. I did not feel like eating;  
    my appetite was poor .............................................0 1 2 3  
 
3. I felt that I could not shake off the blues  
    even with help from my family..............................0 1 2 3  
 
4. I felt that I was just as good as other people ..........0 1 2 3  
 
5. I had trouble keeping my mind  
    on what I was doing........................................... ....0 1 2 3  
 
6. I felt depressed .......................................................0 1 2 3  
 
7. I felt that everything I did was an effort ................0 1 2 3  
 
8. I felt hopeful about the future ................................0 1 2 3  
 
9. I thought my life had been a failure .......................0 1 2 3  
 
10. I felt fearful ..........................................................0 1 2 3  
 
11. My sleep was restless...........................................0 1 2 3  
 
12. I was happy ..........................................................0 1 2 3  
 
13. I talked less than usual .........................................0 1 2 3  
 




15. People were unfriendly ........................................0 1 2 3  
 
16. I enjoyed life ........................................................0 1 2 3  
 
17. I had crying spells ................................................0 1 2 3  
 
18. I felt sad................................................................0 1 2 3  
 
19. I felt that people disliked me................................0 1 2 3  
 







For each of the following questions, please circle the number that corresponds to how 
certain you are that you can do the following tasks regularly at the present time.  
 
Self-Efficacy Pain Scale  
Very    1   2   3   4   5   6   7   8   9   10   Very 
Uncertain                                             Certain 
 
1. How certain are you that you can decrease your pain quite a bit?  
  
2. How certain are you that you can continue most of your daily activities?  
  
 
3. How certain are you that you can keep arthritis pain from interfering with your sleep?  
 
4. How certain are you that you can that you can make a small-to-moderate reduction in your 
arthritis pain by using methods other than taking extra medication?  
 
5. How certain are you that you can make a large reduction in your arthritis pain by using methods 
other than taking extra medication?   
Self-Efficacy Function Scale  
Very    1   2   3   4   5   6   7   8   9   10   Very 
Uncertain                                             Certain 
 
 
1. How certain are you that you can walk 100 feet on flat ground in 20 seconds?  
2. How certain are you that you can that you can walk 10 steps downstairs in 7 seconds?  
3. How certain are you that you can get out of an armless chair quickly, without using 
your hands for support?  
4. How certain are you that you can button and unbutton 3 medium-size buttons in a row 




5. How certain are you that you can cut 2 bite-size pieces of meat with a knife and fork 
in 8 seconds?  
 
6. How certain are you that you can turn an outdoor faucet all the way on and all the 
way off?  
7. How certain are you that you can scratch your upper back with both your right and 
left hands?  
 
8. How certain are you that you can get in and out of the passenger side of a car without 
assistance from another person and without physical aids?  
 
9. How certain are you that you can put on a long-sleeve front-opening shirt or blouse 
(without buttoning) in 8 seconds?  
Self-Efficacy Other Symptoms Scale   
Very    1   2   3   4   5   6   7   8   9   10   Very 
Uncertain                                             Certain 
 
 
1. How certain are you that you can control your fatigue?  
2. How certain are you that you can regulate your activity so as to be active without 
aggravating your arthritis?  
3. How certain are you that you can do something to help yourself feel better if you are 
feeling blue?  
 
4. As compared with other people with arthritis like yours, how certain are you that you 
can manage arthritis pain during your daily activities?  
5. How certain are you that you can manage your arthritis symptoms so that you can do 
the things you enjoy doing?  












People sometimes look to others for companionship, assistance, or other types of support.  
How often is each of the following kinds of support available to you if you need it?  
Circle one number on each line. 
 
None of the time=1 
A little of the time=2 
Some of the time=3 
Most of the time=4 
All of the time=5 
 
1. Someone you can count on to listen to you when you need to talk      
1 2 3 4 5 
  
2. Someone to give you information to help you understand a situation   
1 2 3 4 5  
 
3. Someone to give you good advice about a crisis   
1 2 3 4 5  
 
4. Someone to confide in or talk to about yourself or your problems  
1 2 3 4 5  
 
5. Someone whose advice you really want  
1 2 3 4 5  
 
6. Someone to share your most private worries and fears with  
1 2 3 4 5  
 
7. Someone to turn to for suggestions about how to deal with a personal problem  
1 2 3 4 5  
 
8. Someone who understands your problems  
1 2 3 4 5  
 
9. Someone to help you if you were confined to bed  
1 2 3 4 5  
 
 
10. Someone to take you to the doctor if you needed it  
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1 2 3 4 5  
 
 
11. Someone to prepare your meals if you were unable to do it yourself   
1 2 3 4 5  
 
12. Someone to help with daily chores if you were sick  
1 2 3 4 5  
 
13. Someone who shows you love and affection  
1 2 3 4 5  
 
14. Someone to love and make you feel wanted  
1 2 3 4 5  
 
15. Someone who hugs you  
1 2 3 4 5 
 
16. Someone to have a good time with  
1 2 3 4 5  
 
17. Someone to get together with for relaxation  
1 2 3 4 5  
 
18. Someone to do something enjoyable with  
1 2 3 4 5  
 
19. Someone to do things with you get your mind off things 








Please choose one response per row that best represents how you feel. 
 
Disagree  Disagree Disagree Agree  Agree  Agree 
Strongly Moderately Slightly Slightly Moderately Strongly 
1  2  3  4  5  6 
 
 1. I am quite good at managing the many responsibilities of my daily life 
 
 2. I generally do a good job of taking care of my personal finances and affairs 
 
 3. I am good at juggling my time so that I can fit everything in that needs to be 
done 
 
 4. I have been able to build a home and a lifestyle for myself that is much to 
my liking 
 
 5. I do not fit very well with the people and the community around me 
 
 6. I often feel overwhelmed by my responsibilities 
 
 7. I have difficulty arranging my life in a way that is satisfying to me 
 
 8. I think it is important to have new experiences that challenge how you think 
about the world 
 
 9. I have the sense that I have developed a lot as a person over time 
 
 10. I am not interested in activities that will expand my horizons 
 
 11. I don't want to try new ways of doing things – my life is fine the way it is 
 
 12. When I think about it, I haven't really improved much as a person over the 
years 
 
 13. I do not enjoy being in new situations that require me to change my old 




 14.There is a truth in the saying that you can't teach an old dog new tricks 
 
 15. Most people see me as loving and affectionate 
 
 16. I enjoy personal and mutual conversations with family members or friends 
 
 17. People would describe me as a giving person, willing to share my time 
with others 
 
 18. I know that I can trust my friends and they know that they can trust me 
 
 19. I often feel lonely because I have few close friends with whom to share 
my concerns 
 
 20. I don't have many people who want to listen when I need to talk 
 
 21. It seems to me that most other people have more friends than I do 
 
 22. I am an active person in carrying out the plans I set for myself 
 
 23.I enjoy making plans for the future and working to make them a reality 
 
 24. I tend to focus on the present, because the future nearly always brings me 
problems 
 
 25. My daily activities often seem trivial and unimportant to me 
 
 26. I don't have a good sense of what it is I am trying to accomplish in life 
 
 27. I used to set goals for myself, but that now seems a waste of time 
 
 28. I sometime feel I have done all there is to do in life 
 
 29. I have made some mistakes in the past, but feel that all in all everything 
has worked out for the best 
 
 30. The past had its ups and downs, but in general I wouldn't want to change it 
 
 31. When I compare myself with friends and acquaintances, it makes me feel 




 32. In general, I feel confident and positive about myself 
 
 33. I feel that many of the people I know have got more out of life than I have 
 34. In many ways, I feel disappointed about my achievements in life 
 
 35. My attitude about myself is probably not as positive as most people feel 
about themselves 
 
 36. I am not afraid to voice my opinions even when they are in opposition to 
the opinions of most people 
 
 37. My decisions are not usually influenced by what everyone else is doing 
 
 38. I have confidence in my opinions even if they are contrary to the general 
consensus 
 
 39. Being happy with myself is more important than having others approve of 
me 
 
 40. I tend to worry what other people think of me 
 
 41. I often change my mind about decisions if my friends and family disagree 
 








DIRECTIONS: This questionnaire contains statements about your present way of life or 
personal habits. 
 
Please respond to each item as accurately as possible, and try not to skip any item. 
Indicate the frequency with which you engage in each behavior by circling: 
 
N for never  S for sometimes       O for often      or R for routinely 
 
1. Discuss my problems and concerns with people close to me.  
 
2. Choose a diet low in fat, saturated fat, and cholesterol.  
 
3. Report any unusual signs or symptoms to a physician or other health professional.  
 
4. Follow a planned exercise program.  
 
5. Get enough sleep.  
 
6. Feel I am growing and changing in positive ways. 
 
7. Praise other people easily for their achievements.  
 
8. Limit use of sugars and food containing sugar (sweets).  
 
9. Read or watch TV programs about improving health.  
 
10. Exercise vigorously for 20 or more minutes at least three times a week. 
 
11. Take some time for relaxation each day.  
 
12. Believe that my life has purpose.  
 
13. Maintain meaningful and fulfilling relationships with others.  
 
14. Eat 6-11 servings of bread, cereal, rice and pasta each day.  
 
15. Question health professionals in order to understand their instructions.  
 
16. Take part in light to moderate physical activity (such as sustained walking  




17. Accept those things in my life which I can not change.  
 
18. Look forward to the future.  
 
19. Spend time with close friends.  
 
20. Eat 2-4 servings of fruit each day.  
 
21. Get a second opinion when I question my health care provider's advice.  
 
22. Take part in leisure-time (recreational) physical activities (such as swimming,  
      dancing, bicycling). 
 
23. Concentrate on pleasant thoughts at bedtime.  
 
24. Feel content and at peace with myself.  
 
25. Find it easy to show concern, love and warmth to others.  
 
26. Eat 3-5 servings of vegetables each day.  
 
27. Discuss my health concerns with health professionals.  
 
28. Do stretching exercises at least 3 times per week.  
 
29. Use specific methods to control my stress.  
 
30. Work toward long-term goals in my life.  
 
31. Touch and am touched by people I care about.  
 
32. Eat 2-3 servings of milk, yogurt or cheese each day.  
 
33. Inspect my body at least monthly for physical changes/danger signs.  
 
34. Get exercise during usual daily activities (such as walking during lunch, using stairs 
      instead of elevators, parking car away from destination and walking). 
 
35. Balance time between work and play.  
 
36. Find each day interesting and challenging.  
 
37. Find ways to meet my needs for intimacy.  
 
38. Eat only 2-3 servings from the meat, poultry, fish, dried beans, eggs, and  




39. Ask for information from health professionals about how to take good care  
      of myself. 
 
40. Check my pulse rate when exercising.  
 
41. Practice relaxation or meditation for 15-20 minutes daily.  
42. Am aware of what is important to me in life.  
 
43. Get support from a network of caring people.  
 
44. Read labels to identify nutrients, fats, and sodium content in packaged food.  
 
45. Attend educational programs on personal health care.  
 
46. Reach my target heart rate when exercising.  
 
47. Pace myself to prevent tiredness.  
 
48. Feel connected with some force greater than myself.  
 
49. Settle conflicts with others through discussion and compromise.  
 
50. Eat breakfast.  
 
51. Seek guidance or counseling when necessary.  
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